Document:

HTML

 Exhibit 10.10 

EXECUTION VERSION 
 CONSENT
AGREEMENT 
 Dated April 18, 2019 

between 
 CBG HOLDINGS LLC

 and 
 CANOPY GROWTH
CORPORATION 

 TABLE OF CONTENTS 

 

							
	 	  	Page	 
		
	 ARTICLE 1 DEFINITIONS
	  	 	2	 
	 1.1
	  	Definitions	  	 	2	 
	 1.2
	  	Schedules and Exhibits	  	 	7	 
		
	 ARTICLE 2 CONSENT AND OTHER TRANSACTIONS
	  	 	7	 
	 2.1
	  	Consent to Project Frontrunner	  	 	7	 
	 2.2
	  	Amendment and Restatement of Warrants	  	 	8	 
	 2.3
	  	Repurchase of Common Shares	  	 	8	 
	 2.4
	  	Company Covenants Regarding Project Frontrunner	  	 	9	 
	 2.5
	  	Trademark and Technology License	  	 	9	 
	 2.6
	  	Voting Support Agreements	  	 	10	 
		
	 ARTICLE 3 REPRESENTATION AND WARRANTIES
	  	 	10	 
	 3.1
	  	Representations and Warranties of the Company	  	 	10	 
	 3.2
	  	Representations and Warranties of CBG	  	 	10	 
		
	 ARTICLE 4 CONDITIONS PRECEDENT
	  	 	10	 
	 4.1
	  	Company’s Conditions Precedent for the Closing	  	 	10	 
	 4.2
	  	CBG Conditions Precedent for Closing	  	 	11	 
		
	 ARTICLE 5 COVENANTS
	  	 	12	 
	 5.1
	  	Actions to Satisfy Closing Conditions	  	 	12	 
	 5.2
	  	Consents, Approvals and Authorizations	  	 	12	 
	 5.3
	  	Company Approval	  	 	13	 
	 5.4
	  	Company Circular	  	 	13	 
	 5.5
	  	Company Meeting	  	 	15	 
	 5.6
	  	Interim Period Covenants	  	 	16	 
	 5.7
	  	CBG Acquisitions	  	 	16	 
		
	 ARTICLE 6 TERMINATION
	  	 	16	 
	 6.1
	  	Termination	  	 	16	 
		
	 ARTICLE 7 GENERAL PROVISIONS
	  	 	17	 
	 7.1
	  	Governing Law	  	 	17	 
	 7.2
	  	Notices	  	 	17	 
	 7.3
	  	Expenses	  	 	18	 
	 7.4
	  	Severability	  	 	18	 
	 7.5
	  	Entire Agreement	  	 	18	 
	 7.6
	  	Assignment; No Third-Party Beneficiaries	  	 	18	 
	 7.7
	  	Amendment; Waiver	  	 	18	 
	 7.8
	  	Injunctive Relief	  	 	19	 
	 7.9
	  	Rules of Construction	  	 	19	 
	 7.10
	  	Currency	  	 	19	 

  
 -i- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	Page	 
	 7.11
	  	Further Assurances	  	 	19	 
	 7.12
	  	Public Notices/Press Releases	  	 	20	 
	 7.13
	  	Public Disclosure	  	 	20	 
	 7.14
	  	Counterparts	  	 	20	 

  
 -ii- 

 CONSENT AGREEMENT 

THIS CONSENT AGREEMENT, dated April 18, 2019 (this “Agreement”), is made by and between CBG Holdings LLC, a limited
liability company existing under the laws of the State of Delaware (“CBG”) and Canopy Growth Corporation, a corporation existing under the federal laws of Canada (the “Company”). 

RECITALS 
  

	(A)	 On November 2, 2017, GCILP purchased from the Company: (i) 18,876,901 Common Shares; and (ii) 18,876,901
Initial Warrants. 

  

	(B)	 On November 1, 2018, CBG, an affiliate of GCILP, purchased from the Company: (i) 104,500,000 Common
Shares; and (ii) 139,745,453 Warrants. 

  

	(C)	 The Company proposes to enter into the Arrangement Agreement (including the Plan of Arrangement) to undertake
the Arrangement on the terms and conditions more particularly set forth in the Arrangement Agreement (“Project Frontrunner”). 

  

	(D)	 Pursuant to the Amended and Restated Investor Rights Agreement, the entering into of the Arrangement Agreement
by the Company, and the completion of Project Frontrunner, are subject to the prior written consent of CBG. 

  

	(E)	 CBG and the Company wish to enter into this Agreement for the purposes of setting forth the agreements and
understandings with respect to the terms and conditions upon which CBG is prepared to grant its consent to Project Frontrunner. 

  

	(F)	 The transactions contemplated by this Agreement require the approval of the Company Shareholders pursuant to
the rules of the TSX and MI 61-101. 

  

	(G)	 The Board (other than directors, if any, who abstained from voting on the transactions contemplated by this
Agreement) has unanimously determined, after receiving financial and legal advice, that the transactions contemplated by this Agreement are in the best interests of the Company and fair to the Company Shareholders (other than CBG and its affiliates)
and has resolved to recommend that the Company Shareholders vote in favour of the transactions contemplated by this Agreement, all subject to the terms and conditions contained in this Agreement. 

 

	(H)	 Concurrently with the execution and delivery of this Agreement, the Parties and GCILP entered into the Second
Amended and Restated Investor Rights Agreement. 

 NOW, THEREFORE, in consideration of the foregoing and the mutual agreements
contained herein and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereby agree as follows: 

 ARTICLE 1 

DEFINITIONS 
  

	1.1	 Definitions 

Whenever used in this Agreement, the following terms shall have the meanings set forth below: 

“Affiliate” means, with respect to any Person, any Person now or hereafter existing, directly or indirectly, Controlled by, Controlling, or
under common Control with, such Person, whether on or after the date hereof. 
 “Agreement” has the meaning ascribed to such term in the
Preamble. 
 “Amended and Restated Investor Rights Agreement” means the amended and restated investor rights agreement dated
November 1, 2018 entered into between CBG, GCILP and the Company. 
 “Amended Warrants” means the Tranche A Amended Warrants, the
Tranche B Amended Warrants and the Tranche C Amended Warrants to be entered into, issued and delivered on Closing. 
 “Applicable Law”
means, with respect to any Person, property, transaction, event or other matter, (a) any foreign or domestic constitution, treaty, law, statute, regulation, code, ordinance, principle of common law or equity, rule, municipal by-law, Order or other requirement having the force of law and/or (b) any policy, practice, protocol, standard or guideline of any Governmental Authority which, although not necessarily having the force of law,
is regarded by such Governmental Authority as requiring compliance as if it had the force of law (collectively, the “Law”) relating or applicable to such Person, property, transaction, event or other matter and also includes, where
appropriate, any interpretation of the Law (or any part thereof) by any Person having jurisdiction over it, or charged with its administration or interpretation. 

“Approval Resolution” means the resolution of the Company Shareholders which is to be considered at the Company Meeting with respect to the
transactions contemplated by this Agreement, including the approval of the amendment and restatement of the Warrants, the Share Issuance Proposal and the Top-Up Resolution, substantially in the form attached
as Exhibit B. 
 “Arrangement” means the arrangement under Section 288 of the Business Corporations Act (British Columbia) on
the terms and subject to the terms and conditions set out in the Plan of Arrangement, subject to any amendments or variations to the Plan of Arrangement, made in accordance with the terms of the Arrangement Agreement or the Plan of Arrangement. 

“Arrangement Agreement” means the arrangement agreement dated the same date as this Agreement entered into between the Company and
Frontrunner, including the schedules thereto, providing for, among other things, the Arrangement, as the same may be amended, supplemented or restated. 

“Board” means the board of directors of the Company from time to time. 

  
 -2- 

 “Business Day” means a day other than a Saturday, Sunday or other day on which commercial
banks in Smiths Falls, Ontario are authorized or required by Law to close. Any event the scheduled occurrence of which would fall on a day that is not a Business Day shall be deferred until the next succeeding Business Day. 

“Canadian Securities Regulators” means, collectively, the securities commissions or other securities regulatory authorities in each of the
Qualifying Provinces. 
 “Cannabis ” and “cannabis” means (i) all living or dead material, plants, seeds, plant parts
or plant cells from any cannabis species or subspecies (including sativa, indica and ruderalis), including wet and dry material, trichomes, oil and extracts from cannabis (including cannabinoid or terpene extracts from the cannabis plant), and
(ii) biologically or synthetically synthesized analogs of cannabinoids extracted from the cannabis plant using micro-organisms, including but not limited to (A) cannabis and marijuana, as defined pursuant to Applicable Law, including the
Cannabis Act and (B) Industrial Hemp as defined in the Industrial Hemp Regulations issued under the Cannabis Act or other Applicable Law. 

“Cannabis Act” means S.C. 2018, c.16, “An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the
Criminal Code and other Acts” (Canada), as amended from time to time and as the same may come into force. 
 “CBG Group”
means CBG, GCILP and their Affiliates. 
 “Closing ” means the closing of the issuance, execution and delivery of the Amended Warrants
pursuant to and in accordance with the terms and conditions of this Agreement. 
 “Common Share” means a common share in the capital of the
Company or such other shares or other securities into which such common share is converted, exchanged, reclassified or otherwise changed, as the case may be, from time to time. 

“Company” has the meaning ascribed to such term in the Preamble. 

“Company Board Recommendation” has the meaning ascribed to such term in Section 5.4(c). 

“Company Circular” means the notice of the Company Meeting to be sent to the Company Shareholders and the accompanying management information
and proxy circular, including all schedules, appendices and exhibits thereto and enclosures therewith, to be sent to the Company Shareholders in connection with the Company Meeting, as amended, supplemented or otherwise modified from time to time.

 “Company Meeting” means the special meeting of Company Shareholders to be called and held in accordance with applicable Law to consider
certain matters in respect of Project Frontrunner and the Approval Resolution. 
 “Company Shareholders” means the holders of Common
Shares. 
 “Contract” means any agreement, indenture, contract, lease, deed of trust, licence, option, instruments, arrangement,
understanding or other commitment, whether written or oral. 

  
 -3- 

 “Control” means: 
  

	 	(a)	 in relation to a corporation, the direct or indirect beneficial ownership at the relevant time of shares of
such corporation carrying more than 50% of the voting rights ordinarily exercisable at meetings of shareholders of the Company where such voting rights are sufficient to elect a majority of the directors of the Company; 

 

	 	(b)	 in relation to a Person that is a partnership, limited liability company or joint venture, the direct or
indirect beneficial ownership at the relevant time of more than 50% of the ownership interests of the partnership, limited liability company or joint venture in circumstances where it can reasonably be expected that the Person can direct the affairs
of the partnership, limited liability company or joint venture; and 

  

	 	(c)	 in relation to a trust, the direct or indirect beneficial ownership at the relevant time of more than 50% of
the property settled under the trust; 

 and the words “Controlled by”, “Controlling” and similar words
have corresponding meanings; the Person who directly or indirectly Controls a Controlled Person or entity shall be deemed to Control a corporation, partnership, limited liability company, joint venture or trust which is Controlled by the Controlled
Person or entity, and so on. 
 “Court” means the Supreme Court of British Columbia. 

“Depositary” has the meaning ascribed to such term in the Arrangement Agreement. 

“Effective Date” has the meaning ascribed to such term in the Arrangement Agreement. 

“Fairness Opinion” means the opinion of Greenhill & Co. Canada Ltd., the financial advisor to the Company, to the effect that as of
the date of such opinion, subject to the assumptions and limitations to be set out in the written opinion related thereto, the transactions contemplated by this Agreement are fair, from a financial point of view, to the Company. 

“Frontrunner” means Acreage Holdings, Inc., a corporation existing under the laws of the Province of British Columbia. 

“GCILP” means Greenstar Canada Investment Limited Partnership, a limited partnership existing under the laws of the Province of British
Columbia. 
 “Governmental Authority” means: 
  

	 	(a)	 any domestic or foreign government, whether national, federal, provincial, state, territorial, municipal or
local (whether administrative, legislative, executive or otherwise); 

  

	 	(b)	 any domestic or foreign agency, authority, ministry, department, regulatory authority, court, central bank,
bureau, board or other instrumentality having legislative, judicial, taxing, regulatory, prosecutorial or administrative powers or functions of, or pertaining to, government, including: (i) Health Canada and other applicable regulatory
authorities with oversight of the Cannabis industry and any business or operations within the Cannabis industry generally; (ii) the United States Alcohol and Tobacco Tax and Trade Bureau; and (iii) the United States Department of Justice;

  
 -4- 

	 	(c)	 any court, commission, individual, arbitrator, arbitration panel or other body having adjudicative, regulatory,
judicial, quasi-judicial, administrative or similar functions; and/or 

  

	 	(d)	 the TSX, the NYSE and any other stock or securities exchange, marketplace or trading market upon which the
Company has sought and obtained listing of its securities. 

 “Initial Warrants” means the Common Share purchase warrants
issued by the Company to GCILP in connection with the private placement transactions completed on November 2, 2017, with each Initial Warrant entitling GCILP to acquire one Common Share for the exercise price set forth therein. 

“Material Adverse Effect” means any change (including a decision to implement such a change made by the Board or by senior management who
believe that confirmation of the decision of the Board is probable), event, violation, inaccuracy, circumstance, development or effect that is, individually or in the aggregate, or would reasonably be expected to be, individually or in the
aggregate, materially adverse to the business, assets (including intangible assets), capitalization, liabilities (contingent or otherwise), condition (financial or otherwise), prospects or results of operations of the Company, taken as a whole,
whether or not arising in the ordinary course of business. 
 “MI 61-101” means Multilateral
Instrument 61-101 – Protection of Minority Security Holders in Special Transactions of the Canadian Securities Administrators. 

“Misrepresentation” has the meaning ascribed to such term under Securities Laws. 

“NYSE” means the New York Stock Exchange. 

“Order” means any order, directive, judgment, decree, injunction, decision, ruling, award or writ of any Governmental Authority. 

“Outside Date” means August 31, 2019 or such later date as may be agreed to by the Parties in writing. 

“Parties” means CBG and the Company, and a “Party” means either of them. 

“Person” means any individual, corporation, partnership, firm, joint venture, association, joint-stock company, trust, unincorporated
organization, Governmental Authority or other entity. 
 “Plan of Arrangement” means the plan of arrangement attached as Schedule A to the
Arrangement Agreement, subject to any amendments or variations made in accordance with the terms of the Arrangement Agreement or the Plan of Arrangement. 

“Purchaser Call Option” has the meaning ascribed to such term in the Plan of Arrangement. 

  
 -5- 

 “Purchaser Call Option Exercise Notice” has the meaning ascribed to such term in the Plan
of Arrangement. 
 “Project Frontrunner” has the meaning ascribed to such term in the Preamble. 

“Qualifying Provinces” means, collectively, all of the provinces of Canada except Québec. 

“Regulatory Approval” means (i) approval of the TSX of the transactions contemplated by this Agreement, including amendment of the
Tranche A Warrants and Tranche B Warrants and the exercise price for the Amended Warrants and the listing on the TSX of all Common Shares referred to hereunder; (ii) supplemental listing approval of the NYSE for the issuance and listing on the
NYSE of the Common Shares referred to hereunder; and (iii) any other approval which may be required to give effect to the consummation of the transactions contemplated by this Agreement in accordance with Applicable Law, or by or from any
Governmental Authority, as determined by CBG, acting reasonably. 
 “Repurchase Period” has the meaning ascribed to such term in
Section 2.3(a). 
 “Second Amended and Restated Investor Rights Agreement” means the second amended and restated investor rights
agreement between CBG, GCILP and the Company dated the date of this Agreement. 
 “Securities Laws” means, collectively, the applicable
securities laws of each of the provinces and territories of Canada and the respective regulations, instruments and rules made under those securities laws, together with all applicable published policy statements, notices, blanket orders and rulings
of the securities commissions or securities regulatory authorities of Canada and of each of the provinces and territories of Canada and applicable U.S. securities laws. 

“Share Issuance Proposal” means the ordinary resolution of Company Shareholders approving the issuance of Common Shares pursuant to the Plan
of Arrangement and in connection with the Arrangement. 
 “Shareholder Approval” means the requisite approval of the Approval Resolution by
a simple majority of the votes cast on the Approval Resolution by the Company Shareholders present in person or represented by proxy at the Company Meeting (excluding the votes cast by CBG, GCILP and any other Company Shareholders that are required
to be excluded in accordance with the requirements of the TSX, NYSE and MI 61-101). 
 “Top-Up Resolution” means the issuance by the Company of Common Shares that CBG and/or GCILP has the right to subscribe for under the Investor Rights Agreement based on the Common Shares issuable under the
Arrangement. 
 “Trademark and Technology License” has the meaning ascribed to that term in the Arrangement Agreement. 

“Tranche A Amended Warrants” means the Amended Warrants to be issued pursuant to Section 2.2 to be designated as “Tranche A common
share purchase warrants”. 
 “Tranche A Warrants” means the Warrants designated as “Tranche A common share purchase
warrants”. 

  
 -6- 

 “Tranche B Amended Warrants” means the Amended Warrants to be issued pursuant to
Section 2.2 to be designated as “Tranche B common share purchase warrants”. 
 “Tranche B Warrants” means the Warrants
designated as “Tranche B common share purchase warrants”. 
 “Tranche C Amended Warrants” means the Amended Warrants to be issued
pursuant to Section 2.2 to be designated as “Tranche C common share purchase warrants”. 
 “Transaction Agreements” means
this Agreement, the Second Amended and Restated Investor Rights Agreement and the Amended Warrants. 
 “Triggering Event Date” has the
meaning ascribed to such term in the Plan of Arrangement. 
 “TSX” means the Toronto Stock Exchange. 

“Underlying Shares” means Common Shares for which, as applicable, the Warrants and/or the Amended Warrants are exercisable. 

“Violation” has the meaning ascribed to such term in Section 2.5. 

“Warrant” means a Tranche A Warrant and/or a Tranche B Warrant, in each case, issued by the Company to CBG on November 1, 2018, and
entitling CBG to acquire one Common Share per Warrant for the applicable exercise price set forth therein. 
  

	1.2	 Schedules and Exhibits 

The following schedules and exhibits form an integral part of this Agreement: 
  

					
	Schedule A	  	–	  	Purchaser Representations and Warranties
	Schedule B	  	–	  	Company’s Representations and Warranties
	Exhibit A	  	–	  	Forms of Warrant Certificates
		  		  	- Amended and Restated Tranche A Warrant Certificate
		  		  	- Amended and Restated Tranche B Warrant Certificate
		  		  	- Tranche C Warrant Certificate
	Exhibit B	  	–	  	Approval Resolution
	Exhibit C	  	–	  	Form of Voting Support Agreement

 ARTICLE 2 

CONSENT AND OTHER TRANSACTIONS 
  

	2.1	 Consent to Project Frontrunner 

CBG hereby grants its consent to the entering into of the Arrangement Agreement and the completion of Project Frontrunner, subject to the terms and conditions
set forth in, and the Closing of the transactions contemplated by, this Agreement. 

  
 -7- 

	2.2	 Amendment and Restatement of Warrants 

 

	 	(a)	 On the Effective Date, the Company will issue the Amended Warrants to CBG in exchange for the certificates
representing the Warrants. 

  

	 	(b)	 The Amended Warrants shall be in the forms attached as Exhibit A. 

 

	2.3	 Repurchase of Common Shares 

 

	 	(a)	 At any time and from time to time during the period commencing on the date hereof and ending on the date that
is 24 months after the date that all of the Tranche A Warrants have been exercised by CBG (the “Repurchase Period”), the Company shall purchase for cancellation, whether by way of normal course issuer bid, substantial issuer bid,
self tender offer, or otherwise, the lesser of: 

  

	 	(i)	 27,378,866 Common Shares (subject to customary adjustments for share splits, consolidations or other changes to
the outstanding share capital of a similar nature); and 

  

	 	(ii)	 that number of Common Shares that can be purchased during the Repurchase Period in consideration for an
aggregate purchase price of $1,582,995,262. 

  

	 	(b)	 The Company shall provide a report to CBG on a quarterly basis confirming the aggregate number of Common Shares
purchased for cancellation and the average purchase price therefor. 

  

	 	(c)	 If, for any reason, the Company has not within the Repurchase Period, purchased for cancellation Common Shares
required to be purchased pursuant to Section 2.3(a), the Company hereby agrees and acknowledges that CBG will be credited an amount (the “Credit Amount”) that will reduce the aggregate exercise price otherwise payable by CBG
upon each exercise of either: (i) prior to the Effective Date, the Tranche B Warrants; or (ii) on or following the Effective Date, the Tranche B Amended Warrants and/or Tranche C Amended Warrants, as the case may be, equal to the
difference between: 

  

	 	(i)	 $1,582,995,262; and 

  

	 	(ii)	 the actual purchase price paid by the Company in purchasing Common Shares pursuant to Section 2.3(a).

  

	 	(d)	 Each of the Parties acknowledges that the agreements contained in Section 2.3(c) are an integral part of
the transactions contemplated in this Agreement and that without these agreements, the other Party would not enter into this Agreement. If CBG exercises its Tranche B Warrants, Tranche B Amended Warrants and/or Tranche C Amended Warrants and
receives the full amount of the credit owing pursuant to Section 2.3(c), the Credit Amount shall be deemed to be liquidated damages which are a genuine pre-estimate of the losses or damages which CBG will
have suffered or incurred as a result of a failure of the Company to satisfy its purchase obligations in Section 2.3(a), and are not penalties. The Company irrevocably waives any right it may have to raise as a defence that any such liquidated
damages are excessive or punitive. 

  
 -8- 

	 	(e)	 Notwithstanding any other provision of this Agreement, if the Effective Date shall have occurred, this
Section 2.3 shall indefinitely survive any termination of this Agreement. 

  

	2.4	 Company Covenants Regarding Project Frontrunner 

The Company covenants and agrees that without the prior written consent of CBG, such consent not to be unreasonably withheld, and notwithstanding anything to
the contrary contained in the Arrangement Agreement: 
  

	 	(a)	 the Company will not exercise the Purchaser Call Option prior to the Triggering Event Date;

  

	 	(b)	 the Company will not deliver the Purchaser Call Option Exercise Notice to the Depositary prior to the
Triggering Event Date; 

  

	 	(c)	 the Company will not amend, modify, supplement or restate the Arrangement Agreement (including the Plan of
Arrangement); and 

  

	 	(d)	 the Company will not waive any terms, covenants or conditions set forth in the Arrangement Agreement (including
the Plan of Arrangement). 

  

	2.5	 Trademark and Technology License 

The Company agrees that if at any time: 
  

	 	(a)	 the CBG Group has received any notification or communication (whether orally or in writing) from a Governmental
Authority of any violation or contravention of Applicable Law or any liability to the CBG Group under Applicable Law; 

  

	 	(b)	 the CBG Group has received any notification or communication (whether orally or in writing) from a Governmental
Authority, which the CBG Group has determined, in its sole discretion, would be expected to result in a violation or contravention of Applicable Law or any actual liability to the CBG Group under Applicable Law; or 

 

	 	(c)	 there has been a change in Applicable Law, or the interpretation or application of Applicable Law by any
Governmental Authority, which the CBG Group has determined, in its sole discretion, would be expected to result in a violation or contravention of Applicable Law or any actual liability to the CBG Group under Applicable Law, 

(each, a “Violation”) in each case, as a result of the Trademark and Technology License, CBG will have the right to direct and cause the
Company to terminate the Trademark and Technology License by delivering written notice to the Company. In the event CBG exercises such right, the Company will use its commercially reasonably efforts to cure the Violation, including by

  
 -9- 

 
negotiating and effecting amendments to the Trademark and Technology License. CBG agrees that it will take all commercially reasonable efforts to assist the Company following reasonable request
by the Company to address such Violation. If the Violation has not been cured to the satisfaction of CBG within 30 days from the delivery by CBG of its written notice to the Company in accordance with this Section 2.5, the Company shall
promptly and, in any event, within two Business Days thereafter, terminate the Trademark and Technology License and provide CBG with evidence of the actions taken to effect, and the effectiveness of, the termination of the Trademark and Technology
License. Notwithstanding the foregoing, if at any time within the 30 day cure period, CBG has determined in its sole discretion that (i) the Violation is not reasonably capable of being cured within such 30 day period, or (ii) failure to
immediately terminate the Trademark and Technology License would have an adverse effect on the CBG Group or result in an actual and immediate violation of Applicable Law, the Company shall immediately terminate the Trademark and Technology License
and provide CBG with evidence of such termination. For purposes of this Section 2.5, any reference to Applicable Law shall include, for certainty, any Laws applicable to the United States and the rules of the NYSE so long as the rules of the
NYSE remain applicable to the CBG Group. 
  

	2.6	 Voting Support Agreements 

The Company covenants and agrees that within three Business Days following the date of this Agreement, the Company shall deliver voting support agreements in
favour of CBG in the form attached hereto as Exhibit C executed and delivered by each executive officer and director of the Company (other than CBG’s designated directors). 

ARTICLE 3 

REPRESENTATION AND WARRANTIES 
  

	3.1	 Representations and Warranties of the Company 

The Company represents and warrants to CBG each of the matters contained in Schedule B to this Agreement as of the date hereof and as of the Effective Date,
and acknowledges that CBG is relying on such representations and warranties in connection with entering into this Agreement and the transactions contemplated herein. 
  

	3.2	 Representations and Warranties of CBG 

CBG represents and warrants to the Company each of the matters contained in Schedule A to this Agreement as of the date hereof and as of the Effective Date,
and acknowledges that the Company is relying on such representations and warranties in connection with entering into this Agreement and the transactions contemplated herein. 

ARTICLE 4 
 CONDITIONS
PRECEDENT 
  

	4.1	 Company’s Conditions Precedent for the Closing 

The Company’s obligation to complete the transactions contemplated by this Agreement on the Effective Date shall be subject to the satisfaction or waiver
(at the Company’s sole discretion), as applicable, of the following conditions: 

  
 -10- 

	 	(a)	 all of the representations and warranties of CBG made in or pursuant to this Agreement shall be true and
correct in all respects as of the Effective Date and with the same effect as if made at and as of the Effective Date and the Company shall have received a certificate from a senior officer of each of CBG and (on their behalf and without personal
liability), in form and substance satisfactory to the Company, acting reasonably, confirming same; 

  

	 	(b)	 Shareholder Approval shall have been obtained; 

 

	 	(c)	 all Regulatory Approvals shall have been obtained; and 

 

	 	(d)	 there shall be no Applicable Law or issued or pending Order, injunction, proceeding, judgment or ruling filed
or imposed by any Governmental Authority for the purpose of enjoining, restricting or preventing the consummation of the transactions contemplated in this Agreement. 

If any of the foregoing conditions in this Section 4.1 have not been satisfied by the Outside Date, the Company may elect not to complete the
transactions contemplated by this Agreement by notice in writing to CBG, provided that, for certainty, if the Company does so elect, the consent of CBG under this Agreement shall be null and void. For greater certainty, if any of the foregoing
conditions has not been satisfied or waived, the Company will not be permitted to, and will not, complete Project Frontrunner. 
  

	4.2	 CBG Conditions Precedent for Closing 

The consent provided by CBG in Article 2 and the completion of the transactions contemplated by this Agreement on the Effective Date shall be subject to the
satisfaction or waiver (at CBG’s sole discretion), as applicable, of the following conditions: 
  

	 	(a)	 all of the representations and warranties of the Company made in or pursuant to this Agreement shall be true
and correct in all respects as of the Effective Date and with the same effect as if made at and as of the Effective Date and CBG shall have received a certificate from a senior officer of the Company (on the Company’s behalf and without
personal liability), in form and substance satisfactory to CBG, acting reasonably, confirming same; 

  

	 	(b)	 the Company shall have performed or complied with, in all respects, all of its obligations, covenants and
agreements under this Agreement required to be performed or complied with prior to the Closing and CBG shall have received a certificate from a senior officer of the Company (on the Company’s behalf and without personal liability), in form and
substance satisfactory to CBG, acting reasonably, confirming same; 

  

	 	(c)	 Shareholder Approval shall have been obtained; 

 

	 	(d)	 all Regulatory Approvals shall have been obtained; 

 

	 	(e)	 there shall be no Applicable Law or issued or pending Order, injunction, proceeding, judgment or ruling filed
or imposed by any Governmental Authority for the purpose of enjoining, restricting or preventing the consummation of the transactions contemplated in this Agreement; 

  
 -11- 

	 	(f)	 the Common Shares shall continue to be listed for trading on the TSX and the NYSE as at the Effective Date;

  

	 	(g)	 the Company shall have executed and delivered each of the Amended Warrants. 

If any of the foregoing conditions in this Section 4.2 have not been satisfied or waived, or if this Agreement has been terminated in accordance with
Section 6.1, the conditional consent granted by CBG in Article 2 shall be deemed to be null and void and of no force or effect, and the Company shall not have, and be deemed to not have obtained, CBG’s consent to consummate Project
Frontrunner. 
 ARTICLE 5 

COVENANTS 
  

	5.1	 Actions to Satisfy Closing Conditions 

Each of the Parties shall take commercially reasonable efforts to ensure satisfaction of each of the conditions set forth in Article 4. 

 

	5.2	 Consents, Approvals and Authorizations 

 

	 	(a)	 The Company covenants that it shall prepare, file and diligently pursue until received all necessary consents,
approvals and authorizations of any Person and make such necessary filings, as are required to be obtained under Applicable Law with respect to this Agreement and the transactions contemplated hereby (excluding, for greater certainty, the
preparation or filing of a prospectus, offering memorandum, registration statement or similar document in any jurisdiction). 

  

	 	(b)	 The Company shall keep CBG fully informed regarding the status of such consents, approvals and authorizations,
and CBG, its representatives and counsel shall have the right to participate in any substantive discussions with the TSX, the NYSE and any other applicable regulatory authority in connection with the transactions contemplated by this Agreement and
provide input into any applications for approval and related correspondence, which will be incorporated by the Company, acting reasonably. The Company will provide notice to CBG (and its counsel) of any proposed substantive discussions with the TSX
and the NYSE in connection with the transactions contemplated by this Agreement. On the date all such consents, approvals and authorizations have been obtained by the Company and all such filings have been made by the Company, the Company shall
notify CBG of same. 

  

	 	(c)	 Without limiting the generality of the foregoing, the Company shall promptly make all filings required by the
TSX and the NYSE to obtain applicable Regulatory Approvals. If the approval of the TSX is “conditional approval” subject to the making of customary deliveries to the TSX after an applicable Effective Date, the Company shall ensure that
such filings are made as promptly as practicable after such closing date and in any event within the time frame contemplated in the conditional approval letter from the TSX. 

  
 -12- 

	 	(d)	 The Company shall, promptly after the date hereof, seek, and continue to use commercially reasonable efforts to
seek until obtained, the consent of each Person which is required in connection with the transactions contemplated hereby, but excluding, for greater certainty, the preparation or filing of a prospectus, offering memorandum, registration statement
or similar document in any jurisdiction. 

  

	 	(e)	 The Company shall, promptly after the date hereof, seek, and continue to use commercially reasonable efforts to
seek until obtained, the, waiver of any rights of a third party that could be reasonably expected to be exercisable or triggered by operation of any “change of control” or similar provision under any Contract in connection with or as a
result of the transactions contemplated herein. 

  

	5.3	 Company Approval 

The Company represents and warrants to CBG, acknowledging that CBG is relying upon such representations and warranties in entering into this Agreement, that
the Board has received the Fairness Opinion and, after consultation with its financial advisor and legal counsel, has unanimously determined that (i) the transactions contemplated by this Agreement are in the best interests of the Company and
fair to the Company Shareholders (other than CBG and its affiliates) and (ii) the Company will recommend that Company Shareholders vote in favour of the Approval Resolution. 

 

	5.4	 Company Circular 

 

	 	(a)	 The Company shall in accordance with the terms of the Arrangement Agreement: (i) prepare the Company Circular
together with any and all other documents required by, and in compliance in all material respects with, all applicable Laws on the date of the mailing thereof; (ii) file the Company Circular with all Canadian Securities Regulators in all
jurisdictions where the same is required to be filed and with the TSX; and (iii) send the Company Circular to the Company Shareholders as required under all applicable Laws. 

 

	 	(b)	 On the date of mailing thereof, the Company shall ensure that the Company Circular shall be complete and
correct in all material respects, shall not contain any Misrepresentation and shall contain sufficient detail to permit the Company Shareholders to form a reasoned judgment concerning the matters to be placed before them at the Company Meeting
(except that the Company shall not be responsible for any information relating to CBG and its Affiliates that was provided by CBG expressly for inclusion in the Company Circular nor any information relating to Frontrunner and its Affiliates that was
provided by Frontrunner expressly for inclusion in the Company Circular). 

  

	 	(c)	 The Company Circular shall (i) include a written copy of the Fairness Opinion (and the Company shall
provide an advance copy thereof to CBG for its review and consideration); and (ii) state that the Board (other than directors, if any, who abstained from voting on the transactions contemplated by this Agreement) has

  
 -13- 

	 	
received the Fairness Opinion and unanimously determined, after receiving legal and financial advice, that the transactions contemplated by this Agreement are in the best interests of the Company
and fair to the Company Shareholders (other than CBG and its affiliates) and recommend that the Company Shareholders vote in favour of the Approval Resolution (the “Company Board Recommendation”); and (iii) include
statements that each of the Company Shareholders signing voting support agreements have agreed to vote their Common Shares in favour of the Approval Resolution. 

 

	 	(d)	 CBG shall provide to the Company all information regarding CBG and its Affiliates as reasonably requested by
the Company or as required by applicable Laws for inclusion in the Company Circular. CBG shall ensure that any such information will not include any Misrepresentation including concerning CBG and its Affiliates. 

 

	 	(e)	 CBG and its legal counsel shall be given a reasonable opportunity to review and comment on the Company Circular
and other related documents prior to the Company Circular and other related documents being printed and filed with the Governmental Authorities, and reasonable consideration shall be given to any comments made by CBG and its legal counsel; provided
that all information relating solely to CBG, the Parent and their affiliates included in the Company Circular shall be in form and substance satisfactory to CBG, acting reasonably. The Company shall provide CBG with final copies of the Company
Circular prior to its mailing to the Company Shareholders. 

  

	 	(f)	 CBG and the Company shall each promptly notify each other if at any time before the Effective Date either
becomes aware that the Company Circular contains a Misrepresentation, or that the Company Circular otherwise requires an amendment or supplement and the Parties shall co-operate in the preparation of any
amendment or supplement to the Company Circular as required or appropriate, and the Company shall promptly mail or otherwise publicly disseminate any amendment or supplement to the Company Circular to the Company Shareholders and, if required by the
Court or applicable Laws, file the same with the Governmental Authorities and as otherwise required. 

  

	 	(g)	 The Company Circular shall disclose to the Company Shareholders as follows: 

 

	 	(i)	 if Project Frontrunner is approved by the shareholders of Frontrunner and the Court in accordance with the
terms of the Arrangement Agreement, but the Approval Resolution is not approved by the Company Shareholders, then the Company will not complete Project Frontrunner and the Arrangement Agreement will be terminated; and 

 

	 	(ii)	 if Project Frontrunner is not approved by the shareholders of Frontrunner and the Court in accordance with the
terms of the Arrangement Agreement, the Company will not issue the Amended Warrants. 

  
 -14- 

	5.5	 Company Meeting 

 

	 	(a)	 The Company agrees to convene and conduct the Company Meeting in accordance with the Company’s articles
and by-laws and applicable Law in accordance with the terms of the Arrangement Agreement. 

  

	 	(b)	 Unless otherwise agreed to in writing by CBG or this Agreement is terminated in accordance with its terms or
except as required by applicable Law or by a Governmental Authority, the Company shall take all steps reasonably necessary to hold the Company Meeting and to cause the Approval Resolution to be voted on and approved at such meeting.

  

	 	(c)	 The Company shall solicit proxies of the Company Shareholders in favour of the transactions contemplated by
this Agreement and all matters to be approved by the Company Shareholders as set out in the Approval Resolution, and take all other actions reasonably requested by CBG to obtain the approval of the Approval Resolution by the Company Shareholders, if
so requested, including using the services of investment dealers and proxy solicitation agents, and cooperating with any Persons engaged by CBG, to solicit proxies in favour of the approval of the Approval Resolution, and take all other actions
reasonably requested by CBG to obtain the Shareholder Approval and such other matters as may be necessary to be approved in connection with the transactions contemplated by this Agreement. 

 

	 	(d)	 The Company shall give notice to CBG of the Company Meeting and allow CBG’s representatives and legal
counsel to attend the Company Meeting. 

  

	 	(e)	 The Company shall advise CBG as reasonably requested, and on a daily basis on each of the last seven Business
Days prior to the Company Meeting, as to the aggregate tally of the proxies and votes received in respect of such meeting and all matters to be considered at such meeting. 

 

	 	(f)	 The Company shall advise CBG of any written communication from any Company Shareholder in opposition to the
transactions contemplated by this Agreement. 

  

	 	(g)	 The Company shall not change the record date for the Company Shareholders entitled to vote at the Company
Meeting, including in connection with any adjournment or postponement of the Company Meeting, unless required by Law or with the prior written consent of CBG. 

 

	 	(h)	 The Company shall not waive the deadline for the submission of proxies by Company Shareholders for the Company
Meeting without the prior written consent of CBG. 

  

	 	(i)	 In the event any of CBG or its Affiliates is legally entitled to vote as a Company Shareholder in respect of
the Approval Resolution, and provided that the Company is not then in breach of this Agreement, CBG shall vote and shall cause its Affiliates to vote all Common Shares held by them in favour of the Approval Resolution. 

  
 -15- 

	5.6	 Interim Period Covenants 

The Company hereby covenants and agrees as follows: 
  

	 	(a)	 the Company shall not complete Project Frontrunner unless and until the transactions contemplated by this
Agreement are completed on the terms and conditions of this Agreement; 

  

	 	(b)	 neither the Company nor the Company Board will fail to unanimously recommend or withdraw, amend, modify or
qualifies, or publicly propose or state an intention to withdraw, amend, modify or qualify, the Company Board Recommendation. 

  

	5.7	 CBG Acquisitions 

Notwithstanding Section 5.2(a) of the Second Amended and Restated Investor Rights Agreement, CBG agrees that it will not acquire additional Common Shares
(a) on the TSX, the NYSE or any other stock exchange, marketplace or trading market on which the Common Shares are then listed; or (b) through private agreement transactions with existing holders of Common Shares, unless and until the
Effective Date has occurred or all of the Warrants have been exercised by CBG. Notwithstanding any other provision of this Agreement, this Section 5.7, shall indefinitely survive any termination of this Agreement. 

ARTICLE 6 
 TERMINATION

  

	6.1	 Termination 

This Agreement shall terminate upon the earliest of: 
  

	 	(a)	 the date on which this Agreement is terminated by the mutual consent of the Parties; 

 

	 	(b)	 written notice by the Company to CBG in the event the Closing has not occurred on or prior to the Outside Date;

  

	 	(c)	 written notice by either Party to the other if the Company Meeting is duly convened and held and the
Shareholder Approval shall not have been obtained; provided that the Company may not terminate this Agreement pursuant to this Section 6.1(b) if the failure to obtain the Shareholder Approval has been caused by, or is a result of, a breach by
the Company of any of its representations or warranties or the failure of the Company to perform any of its covenants or agreements under this Agreement; or 

  

	 	(d)	 written notice by either Party to the other if the Effective Date shall not have occurred on or prior to
December 31, 2019; provided that either Party will have the right to request the other Party’s consent to an extension beyond December 31, 2019 on no more than two occasions by a period of up to six months per occasion, such consent
not to be unreasonably withheld as long the Company and Frontrunner are continuing to diligently cause the occurrence of the Effective 

  
 -16- 

	 	
Date, including the continuing performance of their covenants under the Arrangement Agreement; provided, further, that, if the Effective Date shall not have occurred, in no event shall this
Agreement be extended beyond December 31, 2020 on which date, if the Effective Date shall not have occurred, this Agreement shall automatically terminate. 

ARTICLE 7 
 GENERAL
PROVISIONS 
  

	7.1	 Governing Law 

This Agreement shall be governed by and construed and interpreted in accordance with the Laws of the Province of Ontario and the federal Laws of Canada
applicable therein irrespective of the choice of Laws principles. 
  

	7.2	 Notices 

All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be given or made (and shall be deemed to
have been duly given or made upon receipt) by delivery in person, by overnight courier service or by registered or certified mail (postage prepaid, return receipt requested) to the respective Parties at the following addresses (or at such other
address for a Party as shall be specified in a notice given in accordance with this Section 7.2): 
 if to the Company: 

1 Hershey Drive, 
 Smiths Falls,
Ontario K7A 0A8 
 Attention: Chief Executive Officer 

with a copy (which shall not constitute notice) to: 

Cassels Brock & Blackwell LLP 

40 King Street West, Suite 2100 

Toronto, Ontario M5H 3C2 

Attention: Jonathan Sherman 
 if
to CBG: 
 c/o Constellation Brands, Inc. 

207 High Point Drive, Bldg. 100 

Victor, New York 14564 

Attention: General Counsel 

  
 -17- 

 and with a copy (which shall not constitute notice) to: 

Osler, Hoskin & Harcourt LLP 

100 King Street West, Suite 6200 

Toronto, Ontario M5X 1B8 

Attention: Emmanuel Pressman and James R. Brown 
  

	7.3	 Expenses 

Except as otherwise specifically provided in this Agreement: (a) each Party shall bear any costs and expenses incurred in connection with exercising its
rights and performing its obligations under this Agreement; and (b) CBG and the Company shall be jointly responsible for any filing fees payable for or in respect of any application, notification or other filing made in respect of any
Regulatory Approval process in respect of the transactions contemplated by the transactions contemplated by this Agreement. 
  

	7.4	 Severability 

If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced under any Applicable Law or as a matter of public policy,
all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated as originally contemplated to
the greatest extent possible. 
  

	7.5	 Entire Agreement 

This Agreement (including the Schedules and Exhibits hereto), together with the Second Amended and Restated Investor Rights Agreement and the Amended Warrants,
constitute the entire agreement of the Parties with respect to the subject matter of this Agreement and supersede all prior agreements and undertakings, both written and oral, between or on behalf of the Parties with respect to the subject matter of
this Agreement. 
  

	7.6	 Assignment; No Third-Party Beneficiaries 

 

	 	(a)	 This Agreement shall not be assigned by any Party hereto without the prior written consent of the other Party.

  

	 	(b)	 This Agreement is for the sole benefit of the Parties and their permitted successors and assigns and nothing in
this Agreement, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. 

 

	7.7	 Amendment; Waiver 

No provision of this Agreement may be amended or modified except by a written instrument signed by both Parties. No waiver by any Party of any provision hereof
shall be effective unless explicitly set forth in writing and executed by the Party so waiving. The waiver by either Party hereto of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any other subsequent
breach. 

  
 -18- 

	7.8	 Injunctive Relief 

The Parties agree that irreparable harm would occur for which money damages would not be an adequate remedy at Law in the event that any of the provisions of
this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, the Parties agree that, in the event of any breach or threatened breach of this Agreement by a Party, the non-breaching Party will be entitled, without the requirement of posting a bond or other security, to equitable relief, including injunctive relief and specific performance, and the Parties shall not object to the
granting of injunctive or other equitable relief on the basis that there exists an adequate remedy at Law. Such remedies will not be the exclusive remedies for any breach of this Agreement but will be in addition to all other remedies available at
Law or equity to each of the Parties. 
  

	7.9	 Rules of Construction 

Interpretation of this Agreement shall be governed by the following rules of construction: (a) words in the singular shall be held to include the plural
and vice versa, and words of one gender shall be held to include the other gender as the context requires; (b) references to the terms Article, Section, paragraph, and Schedule are references to the Articles, Sections, paragraphs, and Schedules
to this Agreement unless otherwise specified; (c) the word “including” and words of similar import shall mean “including, without limitation,”; (d) provisions shall apply, when appropriate, to successive events and
transactions; (e) the headings contained herein are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement; (f) a reference to a statute includes all regulations and rules made pursuant
to the statute and, unless otherwise specified, the provisions of any statute, regulation or rule which amends, supplements or supersedes any such statute, regulation or rule; and (g) this Agreement shall be construed without regard to any
presumption or rule requiring construction or interpretation against the party drafting or causing any instrument to be drafted. 
  

	7.10	 Currency 

All references in this Agreement to “dollars” or “$” are expressed in Canadian currency, unless otherwise specifically indicated. 

 

	7.11	 Further Assurances 

Each of the Parties shall promptly do, make, execute, deliver, or cause to be done, made, executed or delivered, all such further acts, documents and things as
the other Parties may reasonably require from time to time for the purpose of giving effect to the Transaction Agreements and shall use reasonable efforts and take all such steps as may be reasonably within its power to implement to their full
extent the provisions of the Transaction Agreements. 

  
 -19- 

	7.12	 Public Notices/Press Releases 

CBG and the Company shall each publicly announce the transactions contemplated hereby promptly following the execution of this Agreement by CBG and the
Company, and the content, text and timing of each Party’s announcement shall be approved by the other Party in advance, acting reasonably. CBG and the Company agree to co-operate in the preparation of
presentations, if any, to CBG’s shareholders or the Company’s shareholders regarding the transactions contemplated by this Agreement. No Party shall issue any press release or otherwise make public announcements with respect to this
Agreement without the consent of the other Party (which consent shall not be unreasonably withheld or delayed); provided that, except as required by Applicable Law, in no circumstance shall any such disclosure by, or regulatory filing of, the
Company or any of its Affiliates include the name of any member of CBG Group without CBG’s prior written consent, in its sole discretion. 
  

	7.13	 Public Disclosure 

During the period from the date hereof to the Closing, except as may be required by Applicable Law or with the prior written consent of CBG, the Company shall
not make any public disclosures or public announcements, or undertake or give effect to any corporate actions, in each case that could reasonably be expected to hinder, delay or materially interfere with the consummation of the transactions
contemplated under this Agreement. 
  

	7.14	 Counterparts 

This Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall
constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or electronic transmission shall be as effective as delivery of a manually executed counterpart of this Agreement. 

[Signature page follows] 

  
 -20- 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed on the date first
written above. 
  

			
	CBG HOLDINGS LLC
		
	By:	 	/s/ Garth Hankinson
		 	Name: Garth Hankinson
		 	Title:   President
	
	CANOPY GROWTH CORPORATION
		
	By:	 	/s/ Bruce Linton
		 	Name: Bruce Linton
		 	Title:   Chairman and Co-Chief Executive Officer

 Consent Agreement 

 SCHEDULE A 

REPRESENTATIONS AND WARRANTIES OF CBG 
 CBG
represents and warrants to and in favour of the Company and acknowledges that the Company is relying on such representations and warranties in connection with this Agreement and the transactions contemplated therein: 

 

	 	(a)	 this Agreement has been duly authorized, executed and delivered by CBG and constitutes a legal, valid and
binding obligation of CBG enforceable against CBG in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar Laws affecting creditors’ rights generally, and will not violate or
conflict with the constating documents of CBG or the terms of any restriction, agreement or undertaking to which CBG is subject; 

  

	 	(b)	 CBG is a valid and subsisting limited liability company existing under the Laws of its jurisdiction of
organization and no steps or proceedings have been taken by any Person, voluntary or otherwise, requiring or authorizing the dissolution or winding up of CBG; 

 

	 	(c)	 CBG has the necessary corporate power and authority to execute and deliver the Transaction Agreements to which
it is a party and to observe and perform its covenants and obligations hereunder and thereunder and has taken all necessary action in respect thereof; 

  

	 	(d)	 all information about the CBG Group provided by CBG to the Company for inclusion in the Company Circular will
be true and accurate and will not include any Misrepresentation including concerning the CBG Group. 

  
 Schedule A-1 

 SCHEDULE B 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company represents and warrants to and in favour of CBG and acknowledges that CBG is relying on such representations and warranties in connection with
this Agreement and the transactions contemplated therein: 
  

	 	(a)	 this Agreement has been duly authorized, executed and delivered by the Company and constitutes a legal, valid
and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar Laws affecting creditors’ rights generally, and
will not violate or conflict with the constating documents of the Company or the terms of any restriction, agreement or undertaking to which the Company is subject; 

 

	 	(b)	 the Company has been duly incorporated and is validly existing as a corporation under the Laws of the
jurisdiction in which it was incorporated and no steps or proceedings have been taken by any Person, voluntary or otherwise, requiring or authorizing the dissolution or winding up of the Company; 

 

	 	(c)	 the Company has the necessary corporate power and authority to execute and deliver the Transaction Agreements
and to observe and perform its covenants and obligations hereunder and thereunder and has taken all necessary action in respect thereof; 

  

	 	(d)	 the Amended Warrants described in this Agreement have been duly authorized and created and the Underlying
Shares to be issued have been duly authorized and reserved for issuance and, when issued, delivered and paid for in full, will be validly issued and fully paid shares in the capital of the Company; 

 

	 	(e)	 subject to the receipt of the Regulatory Approvals, each of the execution and delivery of this Agreement, the
performance by the Company of its obligations hereunder, the amendments to the Warrants and the consummation of the transactions contemplated in this Agreement and the other Transaction Agreements: (i) does not and will not conflict with or
result in a breach or violation of any of the terms or provisions of, or constitute a default under (whether after notice or lapse of time or both), (A) any Law applicable to the Company; (B) the articles,
by-laws or resolutions of the directors or shareholders of the Company; (C) any Contract to which the Company is a party or by which the Company is bound except where such conflict, breach, violation or
default would not result in a Material Adverse Effect; or (D) any judgment, decree or Order binding the Company or the property or assets thereof; and (ii) does not affect the rights, duties and obligations of any parties to a Contract,
nor give a party the right to terminate the Contract, by virtue of the application of terms, provisions or conditions in the Contract, except where those rights, duties or obligations, or rights to terminate, are affected in a manner that would not
result in a Material Adverse Effect; and 

  
 Schedule B-1 

	 	(f)	 no consent, approval, authorization, Order, filing, registration or qualification of or with any court,
Governmental Authority or any other Person is required for the execution, delivery and performance by the Company of the Transaction Agreements or for the consummation of the transactions contemplated by the Transaction Agreements, except
(i) such as have been obtained; (ii) Regulatory Approval, which will be obtained by the Effective Date; and (iii) any conditions precedent required to be satisfied under the Arrangement Agreement in connection with Project
Frontrunner. 

  
 Schedule B-2 

 EXHIBIT A 

FORMS OF AMENDED WARRANT CERTIFICATE 

Form of Tranche A Amended Warrant Certificate 

(see attached) 

 TRANCHE A 

AMENDED AND RESTATED 

COMMON SHARE PURCHASE WARRANT 
 THE
SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR U.S. STATE SECURITIES LAWS.
THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY, ONLY (A) TO CANOPY GROWTH CORPORATION (THE “CORPORATION”), (B) OUTSIDE THE UNITED STATES
IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE U.S. SECURITIES ACT
PROVIDED BY (I) RULE 144 THEREUNDER IF AVAILABLE OR (II) RULE 144A THEREUNDER, IF AVAILABLE, AND IN EACH CASE IN ACCORDANCE WITH APPLICABLE U.S. STATE SECURITIES LAWS, (D) IN ANOTHER TRANSACTION THAT DOES NOT REQUIRE REGISTRATION
UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS, OR (E) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT, PROVIDED THAT, IN THE CASE OF TRANSFERS PURSUANT TO (C)(I) OR (D) ABOVE, THE
HOLDER HAS, PRIOR TO SUCH TRANSFER, FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OR OTHER EVIDENCE OF EXEMPTION, IN EITHER CASE REASONABLY SATISFACTORY TO THE CORPORATION. DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE “GOOD
DELIVERY” IN SETTLEMENT OF TRANSACTIONS ON STOCK EXCHANGES IN CANADA.” 
 THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR
ON BEHALF OF A U.S. PERSON OR PERSON IN THE UNITED STATES UNLESS THIS WARRANT AND SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE OR
EXEMPTIONS FROM SUCH REGISTRATION REQUIREMENTS ARE AVAILABLE. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE U.S. SECURITIES ACT. 

WARRANTS TO PURCHASE COMMON SHARES OF 

CANOPY GROWTH CORPORATION 
  

					
	 Warrant Certificate Number:
	 		  	Number of Warrants:
			
	 2018 – A-1
	 		  	88,472,861
			
		 		  	Date:
			
		 		  	●, 2019

 Effective as of the date hereof, this Warrant Certificate amends,
re-evidences, restates, replaces and supersedes 88,472,861 common share purchase warrants issued by the Company to the Holder (as each such term is defined below) pursuant to the tranche A common share
purchase warrant dated November 1, 2018 (the “Original Warrant Certificate”). 

 THIS CERTIFIES THAT, for value received, CBG Holdings LLC (the “Holder”) is
entitled, at any time prior to the Expiry Time, to purchase, at the Exercise Price, one fully paid, validly issued and non-assessable Common Share for each Warrant vested and exercisable under this Warrant
Certificate, by surrendering to the Company, at its principal office at 1 Hershey Drive, Smith Falls, Ontario, K7A 0A8, this Warrant Certificate, together with a Subscription Form, duly completed and executed, and immediately available funds by wire
transfer of lawful money of Canada payable to or to the order of the Company for an amount equal to the Exercise Price multiplied by the number of Common Shares subscribed for, on and subject to the terms and conditions set forth below. 

Nothing contained herein shall confer any right upon the Holder to subscribe for or purchase any Common Shares at any time after the Expiry
Time, and from and after the Expiry Time, this Warrant Certificate and all rights hereunder shall be void and of no value. 
  

	1.	 Defined Terms 

Capitalized terms used in this Warrant Certificate, including the preamble, shall have the following meanings: 

“Adjustment Period” means the period commencing on the date hereof and ending at the Expiry Time. 

“Affiliate” means, with respect to any Person, any Person now or hereafter existing, directly or indirectly, Controlled by,
Controlling, or under common Control with, such Person, whether on or after the date hereof. 
 “Business Day” means a day
other than a Saturday, Sunday or other day on which commercial banks in Smiths Falls, Ontario are authorized or required by law to close. Any event the scheduled occurrence of which would fall on a day that is not a Business Day shall be deferred
until the next succeeding Business Day. 
 “Capital Reorganization” has the meaning ascribed to such term in
Section 8(a)(iv). 
 “Common Share” means a common share in the capital of the Company or such other shares or other
securities into which such common share is converted, exchanged, reclassified or otherwise changed, as the case may be, from time to time. 

“Company” means Canopy Growth Corporation, a corporation existing under the federal laws of Canada, and its successors and
assigns. 
 “Control” means: 
  

	 	(a)	 in relation to a corporation, the direct or indirect beneficial ownership at the relevant time of shares of
such corporation carrying more than 50% of the voting rights ordinarily exercisable at meetings of shareholders of the Company where such voting rights are sufficient to elect a majority of the directors of the Company; 

 

	 	(b)	 in relation to a Person that is a partnership, limited liability company or joint venture, the direct or
indirect beneficial ownership at the relevant time of more than 50% of the ownership interests of the partnership, limited liability company or joint venture in circumstances where it can reasonably be expected that the Person can direct the affairs
of the partnership, limited liability company or joint venture; and 

  
 -2- 

	 	(c)	 in relation to a trust, the direct or indirect beneficial ownership at the relevant time of more than 50% of
the property settled under the trust; 

 and the words “ Controlled by”, “Controlling”
and similar words have corresponding meanings; the Person who directly or indirectly Controls a Controlled Person or entity shall be deemed to Control a corporation, partnership, limited liability company, joint venture or trust which is Controlled
by the Controlled Person or entity, and so on. 
 “Current Market Price” means, at the relevant time of reference, the price
per share equal to the volume-weighted average trading price of the Common Shares on the TSX for the five Trading Days immediately preceding the relevant record date. 

“Exercise Price” means $50.40. 

“Expiry Time” means 5:00 p.m. (Toronto time) on November 1, 2023. 

“NYSE” means the New York Stock Exchange. 

“Person” means an individual, corporation, partnership, unincorporated syndicate, unincorporated organization, trust, trustee,
executor, administrator, or other legal representative, or any group or combination thereof. 
 “Rights Offering” has the
meaning ascribed to such term in Section 8(a)(ii). 
 “Rights Period” has the meaning ascribed to such term in
Section 8(a)(ii). 
 “Special Distribution” has the meaning ascribed to such term in Section 8(a)(iii). 

“Subscription Form” means the form of subscription annexed hereto as Schedule “A”. 

“Trading Day” means a day on which the TSX is open for business. 

“TSX” means the Toronto Stock Exchange. 

“United States” means the United States of America, its territories and possessions, any state of the United States and the
District of Columbia. 
 “U.S. Person” means “U.S. person” as defined in Rule 902(k) of Regulation S under the
U.S. Securities Act. 
 “U.S. Securities Act” means United States Securities Act of 1933, as amended. 

“Warrants” means the tranche A Common Share purchase warrants represented by this Warrant Certificate. 

 

	2.	 Vesting of Warrants 

The Warrants represented by this Warrant Certificate are fully vested and are immediately exercisable by the Holder at any time and from time to time,
commencing on the date hereof and prior to the Expiry Time. 

  
 -3- 

	3.	 Exercise of Warrants 

 

	 	(a)	 Subject to Section 2, the rights represented by this Warrant Certificate may be exercised by the Holder,
in whole or in part, by the surrender of this Warrant Certificate, with the attached Subscription Form duly executed, at the principal office of the Company at 1 Hershey Drive, Smiths Falls, Ontario K7A 0A8 (or such other office of the Company as it
may designate by notice in writing to the Holder at the address of such Holder appearing on the books of the Company at any time and from time to time during the period within which the rights represented by this Warrant Certificate may be
exercised) and upon payment to or to the order of the Company of immediately available funds by wire transfer of lawful money of Canada in an amount equal to the Exercise Price per Common Share multiplied by the aggregate number of Common Shares to
be issued on such exercise of this Warrant. In the event that the Holder subscribes for and purchases any such lesser number of Common Shares prior to the Expiry Time, the Holder shall be entitled to receive a replacement Warrant Certificate,
without charge, representing the unexercised balance of the Warrants as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant Certificate shall have been so exercised. 

 

	 	(b)	 The Company agrees that the Common Shares so purchased shall be and be deemed to be issued to the Holder as the
registered owner of such Common Shares as of the close of business on the date on which both this Warrant Certificate shall have been surrendered and payment made for such Common Shares as aforesaid. Certificates for the Common Shares so purchased
shall be delivered to the Holder as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant Certificate shall have been so exercised. 

 

	4.	 Ability to Exercise 

Subject to Section 2, the Warrants may be exercised in whole or in part at any time and from time to time prior to the Expiry Time. After
the Expiry Time, all rights under any outstanding Warrants evidenced hereby, in respect of which the rights of subscription and purchase herein provided for shall not have been exercised, shall wholly cease and terminate and such Warrants shall be
void and of no value or effect. 
  

	5.	 No Fractional Common Shares 

No fractional Common Shares will be issuable upon any exercise of the Warrants and the Holder will not be entitled to any cash payment or
compensation in lieu of a fractional Common Share. 
  

	6.	 Not a Shareholder 

The holding of the Warrants shall not constitute the Holder a shareholder of the Company nor entitle the Holder to any right or interest in
respect thereof, except as expressly provided in this Warrant Certificate. 
  

	7.	 Covenants and Representations of the Company The Company covenants and agrees as follows:

  

	 	(a)	 this Warrant Certificate is a valid and binding obligation of the Company, enforceable against the Company in
accordance with its terms; 

  
 -4- 

	 	(b)	 all Common Shares which may be issued upon the exercise of the rights represented by the Warrants will, upon
issuance, be validly issued, fully paid and non-assessable, free from all taxes, liens and charges with respect to the issue thereof, except with respect to any applicable withholding taxes; and

  

	 	(c)	 during the period within which the rights represented by this Warrant Certificate may be exercised, the Company
will at all times have authorized and reserved a sufficient number of its Common Shares to provide for the exercise of the rights represented by this Warrant Certificate. 

 

	8.	 Anti-Dilution Protection 

 

	 	(a)	 The Exercise Price and the number of Common Shares issuable to the Holder upon the exercise of the Warrants
shall be subject to adjustment from time to time in the events and in the manner provided as follows: 

  

	 	(i)	 If at any time during the Adjustment Period the Company shall: 

 

	 	(A)	 fix a record date for the issue of, or issue, Common Shares to the holders of all or substantially all of the
outstanding Common Shares by way of a share dividend; 

  

	 	(B)	 fix a record date for the distribution to, or make a distribution to, the holders of all or substantially all
of the outstanding Common Shares payable in Common Shares or securities exchangeable for or convertible into Common Shares; 

  

	 	(C)	 subdivide the outstanding Common Shares into a greater number of Common Shares; or 

 

	 	(D)	 consolidate the outstanding Common Shares into a smaller number of Common Shares, 

(any of such events in subsections (A), (B), (C) and (D) above being called a “Common Share Reorganization”), the
Exercise Price shall be adjusted on the earlier of the record date on which holders of Common Shares are determined for the purposes of the Common Share Reorganization and the effective date of the Common Share Reorganization to the amount
determined by multiplying the Exercise Price in effect immediately prior to such record date or effective date, as the case may be, by a fraction: 
  

	 	(A)	 the numerator of which shall be the number of Common Shares outstanding on such record date or effective date,
as the case may be, before giving effect to such Common Share Reorganization; and 

  

	 	(B)	 the denominator of which shall be the number of Common Shares which will be outstanding immediately after
giving effect to such Common Share Reorganization (including, in the case of a distribution of securities exchangeable for or convertible into Common Shares, the number of Common Shares that would have been outstanding had such securities been
exchanged for or converted into Common Shares on such record date or effective date, as the case may be). 

  
 -5- 

 To the extent that any adjustment in the Exercise Price occurs pursuant to this
Section 8(a)(i) as a result of the fixing by the Company of a record date for the distribution of securities exchangeable for or convertible into Common Shares, the Exercise Price shall be readjusted immediately after the expiry of any relevant
exchange or conversion right to the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable after such expiry and shall be further readjusted in such manner upon the expiry of any
further such right. 
  

	 	(ii)	 If at any time during the Adjustment Period the Company shall fix a record date for the issue or distribution
to the holders of all or substantially all of the outstanding Common Shares of rights, options or warrants pursuant to which such holders are entitled, during a period expiring not more than 45 days after the record date for such issue (such period
being the “Rights Period”), to subscribe for or purchase Common Shares or securities exchangeable for or convertible into Common Shares at a price per share to the holder (or in the case of securities exchangeable for or convertible
into Common Shares, at an exchange or conversion price per share) at the date of issue of such securities of less than the Current Market Price of the Common Shares on such record date (any of such events being called a “Rights
Offering”), the Exercise Price shall be adjusted effective immediately after the record date for such Rights Offering to the amount determined by multiplying the Exercise Price in effect on such record date by a fraction:

  

	 	(A)	 the numerator of which shall be the aggregate of: 

 

	 	(1)	 the number of Common Shares outstanding on the record date for the Rights Offering, and 

 

	 	(2)	 the quotient determined by dividing 

 

	 	I.	 either (a) the product of the number of Common Shares offered during the Rights Period pursuant to the
Rights Offering and the price at which such Common Shares are offered, or (b) the product of the exchange or conversion price of the securities so offered and the number of Common Shares for or into which the securities offered pursuant to the
Rights Offering may be exchanged or converted, as the case may be, by 

  

	 	II.	 the Current Market Price of the Common Shares as of the record date for the Rights Offering; and

  

	 	(B)	 the denominator of which shall be the aggregate of the number of Common Shares outstanding on such record date
and the number of Common Shares offered pursuant to the Rights Offering (including in the case of the issue or distribution of securities exchangeable for or convertible into Common Shares the number of Common Shares for or into which such
securities may be exchanged or converted). 

  
 -6- 

 If by the terms of the rights, options, or warrants referred to in this
Section 8(a)(ii), there is more than one purchase, conversion or exchange price per Common Share, the aggregate price of the total number of additional Common Shares offered for subscription or purchase, or the aggregate conversion or exchange
price of the convertible or exchangeable securities so offered, shall be calculated for purposes of the adjustment on the basis of the lowest purchase, conversion or exchange price per Common Share, as the case may be. Any Common Shares owned by or
held for the account of the Company shall be deemed not to be outstanding for the purpose of any such calculation. To the extent that any adjustment in the Exercise Price occurs pursuant to this Section 8(a)(ii) as a result of the fixing by the
Company of a record date for the issue or distribution of rights, options or warrants referred to in this Section 8(a)(ii), the Exercise Price shall be readjusted immediately after the expiry of any relevant exchange, conversion or exercise
right to the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable after such expiry and shall be further readjusted in such manner upon the expiry of any further such right. 

 

	 	(iii)	 If at any time during the Adjustment Period the Company shall fix a record date for the issue or distribution
to the holders of all or substantially all of the outstanding Common Shares of: 

  

	 	(A)	 shares of the Company of any class other than Common Shares; 

 

	 	(B)	 rights, options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common
Shares (other than rights, options or warrants pursuant to which holders of Common Shares are entitled, during a period expiring not more than 45 days after the record date for such issue, to subscribe for or purchase Common Shares or securities
exchangeable for or convertible into Common Shares at a price per share (or in the case of securities exchangeable for or convertible into Common Shares at an exchange or conversion price per share) at the date of issue of such securities to the
holder of at least the Current Market Price of the Common Shares on such record date); 

  

	 	(C)	 evidences of indebtedness of the Company; or 

 

	 	(D)	 any property or assets of the Company; 

and if such issue or distribution does not constitute a Common Share Reorganization or a Rights Offering (any of such non-excluded events being called a “Special Distribution”), the Exercise Price shall be adjusted effective immediately after the record date for the Special Distribution to the amount determined by
multiplying the Exercise Price in effect on the record date for the Special Distribution by a fraction: 
  

	 	(1)	 the numerator of which shall be the difference between: 

 

	 	I.	 the product of the number of Common Shares outstanding on such record date and the Current Market Price of the
Common Shares on such record date, and 

  
 -7- 

	 	II.	 the fair value, as determined in good faith by the directors of the Company, to the holders of Common Shares of
the shares, rights, options, warrants, evidences of indebtedness or property or assets to be issued or distributed in the Special Distribution; and 

  

	 	(2)	 the denominator of which shall be the product obtained by multiplying the number of Common Shares outstanding
on such record date by the Current Market Price of the Common Shares on such record date. 

 Any Common Shares owned by or
held for the account of the Company shall be deemed not to be outstanding for the purpose of such calculation. To the extent that any adjustment in the Exercise Price occurs pursuant to this Section 8(a)(iii) as a result of the fixing by the
Company of a record date for the issue or distribution of rights, options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common Shares referred to in this Section 8(a)(iii), the Exercise Price shall be
readjusted immediately after the expiry of any relevant exercise, exchange or conversion right to the amount which would then be in effect based upon the number of Common Shares issued and remaining issuable after such expiry and shall be further
readjusted in such manner upon the expiry of any further such right. 
  

	 	(iv)	 If at any time during the Adjustment Period there shall occur: 

 

	 	(A)	 a reclassification or redesignation of the Common Shares, any change of the Common Shares into other shares or
securities or any other capital reorganization involving the Common Shares other than a Common Share Reorganization; 

  

	 	(B)	 a consolidation, amalgamation, arrangement or merger of the Company with or into another body corporate which
results in a reclassification or redesignation of the Common Shares or a change of the Common Shares into other shares or securities; 

  

	 	(C)	 the transfer of the undertaking or assets of the Company as an entirety or substantially as an entirety to
another company or entity; 

 (any of such events being called a “Capital Reorganization”), after the
effective date of the Capital Reorganization the Holder shall be entitled to receive, and shall accept, for the same aggregate consideration, upon exercise of the Warrants, in lieu of the number of Common Shares to which the Holder was theretofore
entitled upon the exercise of the Warrants, the kind and aggregate number of shares and other securities or property resulting from the Capital Reorganization which the Holder would have been entitled to receive as a result of the Capital
Reorganization if, on the effective date thereof, the Holder had been the registered holder of the number of Common Shares which the Holder was theretofore entitled to purchase or receive upon the exercise of the Warrants. If necessary, as a result
of any such Capital Reorganization, appropriate adjustments shall be made in the application of the provisions of this Warrant Certificate with respect to the rights and interests thereafter of the Holder to the end that the provisions shall
thereafter correspondingly be made applicable as nearly as may reasonably be possible in relation to any shares or other securities or property thereafter deliverable upon the exercise of the Warrants. 

  
 -8- 

	 	(v)	 If at any time during the Adjustment Period any adjustment or readjustment in the Exercise Price shall occur
pursuant to the provisions of Sections 8(a)(i) or 8(a)(iii) of this Warrant Certificate, then the number of Common Shares purchasable upon the subsequent exercise of the Warrants shall be simultaneously adjusted or readjusted, as the case may be, by
multiplying the number of Common Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment or readjustment by a fraction which shall be the reciprocal of the fraction used in the adjustment or readjustment of the
Exercise Price. 

  

	 	(b)	 The following rules and procedures shall be applicable to adjustments made pursuant to Section 8(a) of
this Warrant Certificate: 

  

	 	(i)	 subject to the following sections of this Section 8(b), any adjustment made pursuant to Section 8(a)
of this Warrant Certificate shall be made successively whenever an event referred to therein shall occur; 

  

	 	(ii)	 no adjustment in the Exercise Price shall be required unless such adjustment would result in a change of at
least one percent in the then Exercise Price and no adjustment shall be made in the number of Common Shares purchasable or issuable on the exercise of the Warrants unless it would result in a change of at least one
one-hundredth of a Common Share; provided, however, that any adjustments which except for the provision of this Section 8(b)(ii) would otherwise have been required to be made shall be carried forward and
taken into account in any subsequent adjustment. Notwithstanding any other provision of Section 8(a) of this Warrant Certificate, no adjustment of the Exercise Price shall be made which would result in an increase in the Exercise Price or a
decrease in the number of Common Shares issuable upon the exercise of the Warrants (except in respect of a consolidation of the outstanding Common Shares); 

  

	 	(iii)	 if at any time during the Adjustment Period the Company shall take any action affecting the Common Shares,
other than an action or event described in Section 8(a) of this Warrant Certificate, which in the opinion of the directors of the Company would have an adverse effect upon the rights of the Holder, the Exercise Price and/or the number of Common
Shares purchasable under the Warrants shall, subject to any necessary regulatory approval, be adjusted in such manner and at such time as the directors of the Company may determine to be equitable in the circumstances, provided that no such action
shall be taken unless and until the Holder has been provided with notice of such proposed action and the consequences thereof; 

  

	 	(iv)	 if the Company sets a record date to determine holders of Common Shares for the purpose of entitling such
holders to receive any dividend or distribution or any subscription or purchase rights and shall thereafter and before the distribution to such holders of any such dividend, distribution or subscription or purchase rights legally abandon its plan to
pay or deliver such dividend, distribution or subscription or purchase rights, then no adjustment in the Exercise Price or the number of Common Shares purchasable under the Warrants shall be required by reason of the setting of such record date;

  
 -9- 

	 	(v)	 no adjustment in the Exercise Price or in the number or kind of securities purchasable on the exercise of the
Warrants shall be made in respect of any event described in Section 8 of this Warrant Certificate if (subject to TSX and NYSE approval) the Holder is entitled to participate in such event on the same terms mutatis mutandis as if the
Holder had exercised the Warrants prior to or on the record date or effective date, as the case may be, of such event. Any such participation by the Holder is subject to regulatory approval; and 

 

	 	(vi)	 in any case in which this Warrant Certificate shall require that an adjustment shall become effective
immediately after a record date for an event referred to in Section 8(a) hereof, the Company may defer, until the occurrence of such event: 

  

	 	(A)	 issuing to the Holder, to the extent that the Warrants are exercised after such record date and before the
occurrence of such event, the additional Common Shares issuable upon such exercise by reason of the adjustment required by such event; and 

  

	 	(B)	 delivering to the Holder any distribution declared with respect to such additional Common Shares after such
record date and before such event; 

 provided, however, that the Company shall deliver to the Holder an appropriate
instrument evidencing the right of the Holder upon the occurrence of the event requiring the adjustment, to an adjustment in the Exercise Price or the number of Common Shares purchasable upon the exercise of the Warrants and to such distribution
declared with respect to any such additional Common Shares issuable on the exercise of the Warrants. 
  

	 	(c)	 At least 10 days prior to the earlier of the record date or effective date of any event which requires or might
require an adjustment in any of the rights of the Holder under this Warrant Certificate, including the Exercise Price or the number of Common Shares which may be purchased under this Warrant Certificate, the Company shall deliver to the Holder a
certificate of the Company specifying the particulars of such event and, if determinable, the required adjustment and the calculation of such adjustment. In case any adjustment for which a notice in this Section 8(c) has been given is not then
determinable, the Company shall promptly after such adjustment is determinable deliver to the Holder a certificate providing the calculation of such adjustment. The Company hereby covenants and agrees that the Company will not take any action which
might deprive the Holder of the opportunity of exercising the rights of subscription contained in this Warrant Certificate, during such 10 day period. 

  

	 	(d)	 In connection with any: (i) reclassification or redesignation of the Common Shares, any change of the
Common Shares into other shares or securities or any other capital reorganization involving the Common Shares other than as set forth in this Section 8; (ii) consolidation, amalgamation, arrangement or merger of the Company with or into another
body corporate which results in a reclassification or redesignation of the Common Shares or a change of the Common Shares into other shares or securities (including, without limitation, pursuant to a “take-over bid”, “tender
offer” or other acquisition of all or substantially all of the outstanding Common Shares); or (iii) sale, transfer or lease to another corporation of all or substantially all the property or assets of the Company, the Holder shall have the
right thereafter, upon payment of the Exercise Price in effect immediately prior to such action, to purchase upon exercise of each Warrant the kind and amount of shares and other securities and property which it would have owned or have been
entitled to receive after the happening of such reclassification, 

  
 -10- 

	 	
redesignation, consolidation, amalgamation, arrangement, merger, sale, transfer or lease had such Warrant been exercised immediately prior to such action, and the Holder shall be bound to accept
such shares and other securities and property in lieu of the Common Shares to which it was previously entitled; provided, however, that no adjustment in respect of dividends, interest or other income on or from such shares or other securities and
property shall be made during the term of a Warrant or upon the exercise of a Warrant. If necessary, as a result of any actions contemplated by this paragraph, appropriate adjustments shall be made in the application of the provisions of this
Warrant Certificate with respect to the rights and interests thereafter of the Holder to the end that the provisions shall thereafter correspondingly be made applicable as nearly as may reasonably be possible in relation to any shares or other
securities or property thereafter deliverable upon the exercise of the Warrants. The provisions of this paragraph shall similarly apply to successive consolidations, mergers, amalgamation, sales, transfers or leases. 

 

	9.	 U.S. Registration 

This Warrant and the Common Shares issuable upon exercise of this Warrant have not been and will not be registered under the U.S. Securities
Act or under state securities laws of any state in the United States. Accordingly, this Warrant may not be transferred or exercised in the United States or by or on behalf of a U.S. Person or a person in the United States unless an exemption is
available from the registration requirements of the U.S. Securities Act and applicable state securities laws and, if required by the Company, the holder of this Warrant has furnished an opinion of counsel of recognized standing in form and substance
reasonably satisfactory to the Company to such effect, as applicable. 
  

	10.	 Authorized Shares 

As a condition precedent to the taking of any action which would require an adjustment pursuant to Section 8 of this Warrant Certificate,
the Company shall take any action which may be necessary in order that the Company has issued and reserved in its authorized capital, and may validly and legally issue as fully paid and non-assessable, all of
the Common Shares (or other shares and securities, if applicable) which the Holder of the Warrants is entitled to receive on the exercise hereof. 
  

	11.	 Mutilated or Missing Warrant Certificate 

Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant Certificate and, in the case
of any such loss, theft or destruction, upon delivery of a bond or indemnity satisfactory to the Company, or, in the case of any such mutilation, upon surrender or cancellation of this Warrant Certificate, the Company will issue to the Holder a new
warrant certificate of like tenor, in lieu of this Warrant Certificate, representing the right to subscribe for and purchase the number of Common Shares which may be subscribed for and purchased hereunder. 

 

	12.	 Merger and Successors 

 

	 	(a)	 Nothing herein contained shall prevent any consolidation, amalgamation or merger of the Company with or into
any other Person or Persons, or a conveyance or transfer of all or substantially all of the properties and estates of the Company as an entirety to any Person lawfully entitled to acquire and operate same, provided, however, that the Person formed
by such consolidation, amalgamation, arrangement or merger or which acquires by conveyance or transfer all or substantially all of the properties and estates of the Company as an entirety shall, simultaneously with such amalgamation, arrangement,
merger, conveyance or transfer, assume the due and punctual performance and observance of all the covenants and conditions hereof to be performed or observed by the Company. 

  
 -11- 

	 	(b)	 In case the Company, pursuant to Section 12(a), shall be consolidated, amalgamated or merged with or into
any other Person or Persons or shall convey or transfer all or substantially all of its properties and estates as an entirety to any other Person, the successor Person formed by such consolidation, amalgamation or arrangement, or into which the
Company shall have been consolidated, amalgamated or merged or which shall have received a conveyance or transfer as aforesaid, shall succeed to and be substituted for the Company hereunder and such changes in phraseology and form (but not in
substance) may be made in this Warrant Certificate as may be appropriate in view of such amalgamation, arrangement, merger or transfer. 

  

	13.	 Amendment 

This Warrant Certificate may only be amended with the prior written consent of the Company and the Holder. 

 

	14.	 Severability 

If any term or other provision of this Warrant Certificate is invalid, illegal or incapable of being enforced under any applicable law or as a
matter of public policy, all other conditions and provisions of this Warrant Certificate shall nevertheless remain in full force and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced,
the Company and the Holder shall negotiate in good faith to modify this Warrant Certificate so as to effect the original intent of the Company and the Holder as closely as possible in a mutually acceptable manner in order that the provisions of this
Warrant Certificate be consummated as originally contemplated to the greatest extent possible. 
  

	15.	 Governing Law 

This Warrant Certificate shall be governed by and construed and interpreted in accordance with the laws of the Province of Ontario and the
federal laws of Canada applicable therein irrespective of the choice of laws principles. 
  

	16.	 Transferability 

Subject only to applicable securities laws, the Warrants represented by this Warrant Certificate are transferable by the Holder to any of its
Affiliates and the term “Holder” shall mean and include any successor, transferee or assignee of the current or any future Holder. The Warrants represented by this Warrant Certificate may be transferred by the Holder completing and
delivering to the Company the transfer form attached hereto as Schedule “B”. For greater certainty, the Warrants represented by this Warrant Certificate are not transferrable except as described in this Section 16 or with the prior
written consent of the Company. 
  

	17.	 Enurement 

This Warrant Certificate and all of its provisions shall enure to the benefit of the Holder and its permitted assigns and successors and shall
be binding upon the Company and its successors and permitted assigns. 

  
 -12- 

	18.	 Notice 

All notices, requests, claims, demands and other communications under this Warrant Certificate shall be in writing and shall be given or made
(and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service or by registered or certified mail (postage prepaid, return receipt requested) to the Holder and the Company at the following
addresses (or at such other address as shall be specified in a notice given in accordance with this Section 18): 
  

	 	(a)	 if to the Holder at: 

c/o Constellation Brands, Inc. 

207 High Point Drive, Bldg. 100 

Victor, New York 14564 

Attention: General Counsel 
 and
with a copy (which shall not constitute notice) to: 
 Osler, Hoskin & Harcourt LLP 

100 King Street West, Suite 6200 

Toronto, Ontario M5X 1B8 

Attention: Emmanuel Pressman and James R. Brown 
  

	 	(b)	 if to the Company at: 

1 Hershey Drive, 
 Smiths Falls,
ON K7A 0A8 
 Attention: Chief Executive Officer 

with a copy (which shall not constitute notice) to: 

Cassels Brock & Blackwell LLP 

40 King Street West, Suite 2100 

Toronto, Ontario M5H 3C2 

Attention: Jonathan Sherman 
  

	19.	 Further Assurances 

The Company shall promptly do, make, execute, deliver, or cause to be done, made, executed or delivered, all such further acts, documents and
things as the Holder may reasonably require from time to time for the purpose of giving effect to this Warrant Certificate and shall use reasonable efforts and take all such steps as may be reasonably within its power to implement to their full
extent the provisions of this Warrant Certificate. 
  

	20.	 Currency 

All dollar amounts referred to in this Warrant Certificate are in Canadian dollars. 

[Signature page follows] 

  
 -13- 

 IN WITNESS WHEREOF the Company has caused this Warrant Certificate to be executed by
a duly authorized signatory effective as of the date first written above. 
  

			
	CANOPY GROWTH CORPORATION
		
	By:	 	 
		 	Name:
		 	Title:

 ACKNOWLEDGEMENT 

IN WITNESS WHEREOF, the Holder hereby acknowledges, confirms and consents to the amendment and restatement of the Original
Warrant Certificate as set out in this Amended and Restated Warrant Certificate. 
  

			
	CBG HOLDINGS LLC
		
	By:	 	 
		 	Name:
		 	Title:

 SCHEDULE “A” 

SUBSCRIPTION FORM 
  

	TO:	 CANOPY GROWTH CORPORATION 

Terms which are not otherwise defined herein shall have the meanings ascribed to such terms in the Warrant Certificate held by the undersigned and issued by
Canopy Growth Corporation (the “Company”). 
 The undersigned hereby exercises the right to acquire
                                 Common Shares of the Company in accordance with
and subject to the provisions of such Warrant Certificate and herewith makes payment of the Exercise Price in full for the said number of Common Shares. 

(Please check the ONE box applicable): 
  

					
	☐	  	A	  	The undersigned holder (i) at the time of exercise of the Warrant is not in the United States; (ii) is not a U.S. Person (iii) is not exercising the Warrant on behalf of a U.S. Person or a person in the United States;
and (iv) did not execute or deliver this exercise form in the United States.
			
	☐	  	B.	  	The undersigned holder (i) purchased the Warrants for its own account or the account of another “accredited investor” as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (“Accredited
Investor”); (ii) is exercising the Warrants solely for its own account or for the account of such other Accredited Investor; (iii) each of it and such other person, if any, was an Accredited Investor on the date the Warrants were
acquired and is an Accredited Investor on the date of exercise of the Warrants; and (iv) the representations and warranties made by the holder or any beneficial purchaser, as the case may be, to the Company in connection with the acquisition of
the Warrants remain true and correct on the date hereof.
			
	☐	  	C.	  	The undersigned holder has delivered to the Company an opinion of counsel (which will not be sufficient unless it is from counsel of recognized standing and in form and substance reasonably satisfactory to the Company) to the effect
that an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws is available.

 The Common Shares are to be issued, registered and delivered as follows: 

 

			
	Name:	  	  

		
	Address in full:	  	  

		
		  	  

 Note: If further nominees are intended, please attach (and initial) a schedule giving these particulars. 

DATED this              day of
                                ,
20        . 
  

					
	  
	 	        	  	  

	Signature Guaranteed	 		  	(Signature of Warrantholder)
	 (if required)
  
	 		  	  
  

 
	
	  

	Print full name
	
	  

	
	  

	Print full address

 Note: 
 The
undersigned holder understands that unless Box A above is checked, the certificate representing the Common Shares issuable upon exercise of the Warrants will bear a legend restricting transfer without registration under the U.S. Securities Act and
applicable state securities laws unless an exemption from registration is available. Certificates representing such Common Shares will not be registered or delivered to an address in the United States unless Box B or Box C above is checked. If Box C
is checked, any opinion tendered must be in form and substance reasonably satisfactory to the Company. Holders planning to deliver an opinion of counsel in connection with the exercise of the Warrant should contact the Company in advance to
determine whether any opinions to be tendered will be acceptable to the Company. 
 If Box B or Box C is checked, any certificate representing the Common
Shares issued upon exercise of this Warrant will bear an applicable United States restrictive legend. 
 Instructions: 

The registered holder may exercise its right to receive Common Shares by completing this form and surrendering this form and the Warrant Certificate
representing the Warrants being exercised to the Company. 
 The signature on this Subscription Form must correspond in every particular with the name shown
on the face of the Warrant Certificate without alteration or any change whatsoever or this Subscription Form must be signed by a duly authorized signing officer of the Holder. If this Subscription Form is signed by a duly authorized signing officer
of the Holder, the Warrant Certificate must be accompanied by evidence of authority to sign. 
 If the Subscription Form indicates that Common Shares are to
be issued to a Person or Persons other than the registered holder of the Warrant Certificate or an affiliate of such registered holder, the endorsement must be signature guaranteed, in either case, by a Canadian chartered bank, or a member of a
recognized Securities Transfer Agents Medallion Program (STAMP). The stamp affixed thereon by the guarantor must bear the actual words “Signature Guarantee”, or “Signature Medallion Guaranteed” or in accordance with industry
standards. 
 The certificates will be mailed by registered mail to the Holder(s) at the address(es) appearing in this Subscription Form. 

If any Warrants represented by this certificate are not being exercised, a new Warrant Certificate will be issued and delivered to the Holder with the Common
Share certificates in accordance with the provisions of the Warrant Certificate. 

 SCHEDULE “B” 

TRANSFER FORM 
  

	TO:	 CANOPY GROWTH CORPORATION 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                                         
                                         
                                   (include name and address of the
transferee)                                  (include number) Warrants exercisable
for common shares of Canopy Growth Corporation (the “Company”) registered in the name of the undersigned on the register of the Company maintained therefor, and hereby irrevocably appoints
                                         
                                         
       the attorney of the undersigned to transfer the said securities on the books maintained by the Company with full power of substitution. 

THE UNDERSIGNED TRANSFEROR HEREBY CERTIFIES AND DECLARES that the Warrants are not being offered, sold or transferred to, or for the account or benefit of, a
“U.S. person” (as defined in Rule 902(k) of Regulation S under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”)) or a person within the United States unless the Warrants are
registered under the U.S. Securities Act and any applicable state securities laws or unless an exemption from such registration is available. 

DATED this
                     day of
                                    ,
20            . 
  

					
	  
	 		  	  

	Signature Guaranteed	 		  	(Signature of Warrantholder)
			
		 		  	  

		 	        	  	Print full name
			
		 		  	  

			
		 		  	  

		 		  	Print full address 

 Instructions: 
 The
signature on this Transfer Form must correspond in every particular with the name shown on the face of the Warrant Certificate without alteration or any change whatsoever or this Subscription Form must be signed by a duly authorized signing officer
of the Holder. If this Subscription Form is signed by a duly authorized signing officer of the Holder, the Warrant Certificate must be accompanied by evidence of authority to sign. 

The endorsement must be signature guaranteed, in either case, by a Canadian chartered bank, or a member of a recognized Securities Transfer Agents Medallion
Program (STAMP). The stamp affixed thereon by the guarantor must bear the actual words “Signature Guarantee”, or “Signature Medallion Guaranteed” or in accordance with industry standards. 

If any Warrants represented by this certificate are not being transferred, a new Warrant Certificate will be issued and delivered to the Holder. 

 Form of Tranche B Amended Warrant Certificate 

(see attached) 
 Exhibit A-3 

 TRANCHE B 

AMENDED AND RESTATED 

COMMON SHARE PURCHASE WARRANT 
 THE
SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR U.S. STATE SECURITIES LAWS.
THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY, ONLY (A) TO CANOPY GROWTH CORPORATION (THE “CORPORATION”), (B) OUTSIDE THE UNITED STATES
IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE U.S. SECURITIES ACT
PROVIDED BY (I) RULE 144 THEREUNDER IF AVAILABLE OR (II) RULE 144A THEREUNDER, IF AVAILABLE, AND IN EACH CASE IN ACCORDANCE WITH APPLICABLE U.S. STATE SECURITIES LAWS, (D) IN ANOTHER TRANSACTION THAT DOES NOT REQUIRE REGISTRATION
UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS, OR (E) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT, PROVIDED THAT, IN THE CASE OF TRANSFERS PURSUANT TO (C)(I) OR (D) ABOVE, THE
HOLDER HAS, PRIOR TO SUCH TRANSFER, FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OR OTHER EVIDENCE OF EXEMPTION, IN EITHER CASE REASONABLY SATISFACTORY TO THE CORPORATION. DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE “GOOD
DELIVERY” IN SETTLEMENT OF TRANSACTIONS ON STOCK EXCHANGES IN CANADA.” 
 THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR
ON BEHALF OF A U.S. PERSON OR PERSON IN THE UNITED STATES UNLESS THIS WARRANT AND SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE OR
EXEMPTIONS FROM SUCH REGISTRATION REQUIREMENTS ARE AVAILABLE. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE U.S. SECURITIES ACT. 

WARRANTS TO PURCHASE COMMON SHARES OF 

CANOPY GROWTH CORPORATION 
  

			
	Warrant Certificate Number:	  	Number of Warrants:
		
	2018 – B-1	  	38,454,444
		
		  	Date:
		
		  	●, 2019

 Effective as of the date hereof, this Warrant Certificate amends,
re-evidences, restates, replaces and supersedes 38,454,444 common share purchase warrants issued by the Company to the Holder (as each such term is defined below) pursuant to the tranche B common share
purchase warrant dated November 1, 2018 (the “Original Warrant Certificate”). 

 THIS CERTIFIES THAT, for value received, CBG Holdings LLC (the “Holder”) is
entitled, at any time prior to the Expiry Time, to purchase, at the Exercise Price, one fully paid, validly issued and non-assessable Common Share for each Warrant vested and exercisable under this Warrant
Certificate, by surrendering to the Company, at its principal office at 1 Hershey Drive, Smith Falls, Ontario, K7A 0A8, this Warrant Certificate, together with a Subscription Form, duly completed and executed, and immediately available funds by wire
transfer of lawful money of Canada payable to or to the order of the Company for an amount equal to the Exercise Price multiplied by the number of Common Shares subscribed for, on and subject to the terms and conditions set forth below. 

Nothing contained herein shall confer any right upon the Holder to subscribe for or purchase any Common Shares at any time after the Expiry
Time, and from and after the Expiry Time, this Warrant Certificate and all rights hereunder shall be void and of no value. 
  

	1.	 Defined Terms 

Capitalized terms used in this Warrant Certificate, including the preamble, shall have the following meanings: 

“Adjustment Period” means the period commencing on the date hereof and ending at the Expiry Time. 

“Affiliate” means, with respect to any Person, any Person now or hereafter existing, directly or indirectly, Controlled by,
Controlling, or under common Control with, such Person, whether on or after the date hereof. 
 “Business Day” means a day
other than a Saturday, Sunday or other day on which commercial banks in Smiths Falls, Ontario are authorized or required by law to close. Any event the scheduled occurrence of which would fall on a day that is not a Business Day shall be deferred
until the next succeeding Business Day. 
 “Capital Reorganization” has the meaning ascribed to such term in
Section 10(a)(iv). 
 “Common Share” means a common share in the capital of the Company or such other shares or other
securities into which such common share is converted, exchanged, reclassified or otherwise changed, as the case may be, from time to time. 

“Company” means Canopy Growth Corporation, a corporation existing under the federal laws of Canada, and its successors and
assigns. 
 “Consent Agreement” means the consent agreement between the Holder and the Company dated April 18, 2019.

 “Control” means: 
  

	 	(a)	 in relation to a corporation, the direct or indirect beneficial ownership at the relevant time of shares of
such corporation carrying more than 50% of the voting rights ordinarily exercisable at meetings of shareholders of the Company where such voting rights are sufficient to elect a majority of the directors of the Company; 

 

	 	(b)	 in relation to a Person that is a partnership, limited liability company or joint venture, the direct or
indirect beneficial ownership at the relevant time of more than 50% of the ownership interests of the partnership, limited liability company or joint venture in circumstances where it can reasonably be expected that the Person can direct the affairs
of the partnership, limited liability company or joint venture; and 

  
 -2- 

	 	(c)	 in relation to a trust, the direct or indirect beneficial ownership at the relevant time of more than 50% of
the property settled under the trust; 

 and the words “ Controlled by”, “Controlling”
and similar words have corresponding meanings; the Person who directly or indirectly Controls a Controlled Person or entity shall be deemed to Control a corporation, partnership, limited liability company, joint venture or trust which is Controlled
by the Controlled Person or entity, and so on. 
 “Current Market Price” means, at the relevant time of reference, the price
per share equal to the volume-weighted average trading price of the Common Shares on the TSX for the five Trading Days immediately preceding the relevant record date. 

“Exercise Price” means $76.68, as may be adjusted in accordance with this Warrant Certificate. 

“Expiry Time” means 5:00 p.m. (Toronto time) on November 1, 2026. 

“NYSE” means the New York Stock Exchange. 

“Person” means an individual, corporation, partnership, unincorporated syndicate, unincorporated organization, trust, trustee,
executor, administrator, or other legal representative, or any group or combination thereof. 
 “Repurchase Period” means
the period commencing on April 18, 2019 and ending on the date that is 24 months after the date that all of the Tranche A Warrants have been exercised by the Holder. 

“Rights Offering” has the meaning ascribed to such term in Section 10(a)(ii). 

“Rights Period” has the meaning ascribed to such term in Section 10(a)(ii). 

“Special Distribution” has the meaning ascribed to such term in Section 10(a)(iii). 

“Subscription Form” means the form of subscription annexed hereto as Schedule “A”. 

“Trading Day” means a day on which the TSX is open for business. 

“Tranche A Warrants ” means the 88,472,861 Common Share purchase warrants represented by the tranche A amended and restated
warrant certificate issued by the Company to the Holder on the date hereof. 
 “Tranche C Warrants” means the 12,818,148
Common Share purchase warrants represented by the tranche C warrant certificate issued by the Company to the Holder on the date hereof. 

“Tranche C Warrant Certificate” means the warrant certificate representing the Tranche C Warrants. 

“TSX” means the Toronto Stock Exchange. 

“United States” means the United States of America, its territories and possessions, any state of the United States and the
District of Columbia. 

  
 -3- 

 “U.S. Person” means “U.S. person” as defined in Rule 902(k) of
Regulation S under the U.S. Securities Act. 
 “U.S. Securities Act” means United States Securities Act of 1933, as amended.

 “Warrants” means the tranche B Common Share purchase warrants represented by this Warrant Certificate. 

 

	2.	 Vesting of Warrants 

The Warrants represented by this Warrant Certificate shall vest and become immediately exercisable once all Tranche A Warrants have been exercised in
accordance with their terms, and shall remain exercisable by the Holder, in whole or in part at any time, and from time to time, thereafter and prior to the Expiry Time. 
  

	3.	 Exercise of Warrants 

 

	 	(a)	 Subject to Section 2, the rights represented by this Warrant Certificate may be exercised by the Holder,
in whole or in part, by the surrender of this Warrant Certificate, with the attached Subscription Form duly executed, at the principal office of the Company at 1 Hershey Drive, Smiths Falls, Ontario K7A 0A8 (or such other office of the Company as it
may designate by notice in writing to the Holder at the address of such Holder appearing on the books of the Company at any time and from time to time during the period within which the rights represented by this Warrant Certificate may be
exercised) and upon payment to or to the order of the Company of immediately available funds by wire transfer of lawful money of Canada in an amount equal to the Exercise Price per Common Share multiplied by the aggregate number of Common Shares to
be issued on such exercise of this Warrant (as such amount may be adjusted in accordance with Section 5). In the event that the Holder subscribes for and purchases any such lesser number of Common Shares prior to the Expiry Time, the Holder
shall be entitled to receive a replacement Warrant Certificate, without charge, representing the unexercised balance of the Warrants as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant
Certificate shall have been so exercised. 

  

	 	(b)	 The Company agrees that the Common Shares so purchased shall be and be deemed to be issued to the Holder as the
registered owner of such Common Shares as of the close of business on the date on which both this Warrant Certificate shall have been surrendered and payment made for such Common Shares as aforesaid. Certificates for the Common Shares so purchased
shall be delivered to the Holder as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant Certificate shall have been so exercised. 

 

	4.	 Ability to Exercise 

Subject to Section 2, the Warrants may be exercised in whole or in part at any time and from time to time prior to the Expiry Time. After
the Expiry Time, all rights under any outstanding Warrants evidenced hereby, in respect of which the rights of subscription and purchase herein provided for shall not have been exercised, shall wholly cease and terminate and such Warrants shall be
void and of no value or effect. 

  
 -4- 

	5.	 Exercise Price Credit 

If, for any reason, the Company has not within the Repurchase Period, purchased for cancellation Common Shares required to be purchased
pursuant to section 2.3 of the Consent Agreement, the Company hereby agrees and acknowledges that the Holder will be credited an amount (the “Credit Amount”) that will reduce the aggregate exercise price otherwise payable by
the Holder upon each exercise of the Warrants represented by this Warrant Certificate equal to the difference between: 
  

	 	(a)	 $1,582,995,262; and 

  

	 	(b)	 the actual purchase price paid by the Company in purchasing Common Shares pursuant to section 2.3 of the
Consent Agreement. 

  

	6.	 No Fractional Common Shares 

No fractional Common Shares will be issuable upon any exercise of the Warrants and the Holder will not be entitled to any cash payment or
compensation in lieu of a fractional Common Share. 
  

	7.	 Not a Shareholder 

The holding of the Warrants shall not constitute the Holder a shareholder of the Company nor entitle the Holder to any right or interest in
respect thereof, except as expressly provided in this Warrant Certificate. 
  

	8.	 Covenants and Representations of the Company The Company covenants and agrees as follows:

  

	 	(a)	 this Warrant Certificate is a valid and binding obligation of the Company, enforceable against the Company in
accordance with its terms; 

  

	 	(b)	 all Common Shares which may be issued upon the exercise of the rights represented by the Warrants will, upon
issuance, be validly issued, fully paid and non-assessable, free from all taxes, liens and charges with respect to the issue thereof, except with respect to any applicable withholding taxes; and

  

	 	(c)	 during the period within which the rights represented by this Warrant Certificate may be exercised, the Company
will at all times have authorized and reserved a sufficient number of its Common Shares to provide for the exercise of the rights represented by this Warrant Certificate. 

 

	9.	 Covenant of the Holder 

 

	 	(a)	 The Holder covenants and agrees that in respect of each Common Share purchased by the Holder or any affiliate
of the Holder, including Greenstar Canada Investment Limited Partnership and Constellation Brands, Inc. and its Subsidiaries (as defined in National Instrument 45-106 – Prospectus Exemptions), (i)
on the TSX, the NYSE or any other stock exchange, marketplace or trading market on which the Common Shares are then listed; or (ii) through private agreement transactions with existing holders of Common Shares, the number of Warrants
represented by this Warrant Certificate shall be reduced by the number of Common Shares so acquired (up to an aggregate maximum reduction of 20,000,000 Common Shares less the number of Common Shares, if any, by which the Tranche C Warrants have been
reduced pursuant to section 9(a) of the Tranche C Warrant Certificate). 

  
 -5- 

	 	(b)	 At the time of exercise of the Warrants, the Holder shall confirm the number of Common Shares purchased as
contemplated by Section 9(a). 

  

	 	(c)	 For certainty, the aggregate reduction in the number of Warrants represented by this Warrant Certificate
pursuant to Section 9(a) hereof and in the number of Tranche C Warrants represented by the Tranche C Warrant Certificate pursuant to section 9(a) thereof shall not exceed 20,000,000 Warrants. 

 

	 	(d)	 The Holder shall have the right, but not the obligation, to surrender this Warrant Certificate at the principal
office of the Company at 1 Hershey Drive, Smiths Falls, Ontario K7A 0A8 (or such other office of the Company as it may designate by notice in writing to the Holder at the address of such Holder appearing on the books of the Company at any time and
from time to time during the period within which the rights represented by this Warrant Certificate may be exercised) and, if the Holder exercises such right, the Holder shall thereafter be entitled to receive a replacement Warrant Certificate,
without charge, representing the reduced balance of the Warrants as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant Certificate shall have been so surrendered and cancelled. If the
Holder does not exercise such right, this Warrant Certificate shall continue to evidence in full the Warrants and the number of Warrants indicated on the cover page of this Warrant Certificate shall be deemed to be reduced by the number of Warrants
contemplated by Section 9(a) hereof. 

  

	10.	 Anti-Dilution Protection 

 

	 	(a)	 The Exercise Price and the number of Common Shares issuable to the Holder upon the exercise of the Warrants
shall be subject to adjustment from time to time in the events and in the manner provided as follows: 

  

	 	(i)	 If at any time during the Adjustment Period the Company shall: 

 

	 	(A)	 fix a record date for the issue of, or issue, Common Shares to the holders of all or substantially all of the
outstanding Common Shares by way of a share dividend; 

  

	 	(B)	 fix a record date for the distribution to, or make a distribution to, the holders of all or substantially all
of the outstanding Common Shares payable in Common Shares or securities exchangeable for or convertible into Common Shares; 

  

	 	(C)	 subdivide the outstanding Common Shares into a greater number of Common Shares; or 

 

	 	(D)	 consolidate the outstanding Common Shares into a smaller number of Common Shares, 

(any of such events in subsections (A), (B) (C) and (D) above being called a “Common Share Reorganization”), the
Exercise Price shall be adjusted on the earlier of the record date on which holders of Common Shares are determined for the purposes of the Common Share Reorganization and the effective date of the Common Share Reorganization to the amount
determined by multiplying the Exercise Price in effect immediately prior to such record date or effective date, as the case may be, by a fraction: 

  
 -6- 

	 	(A)	 the numerator of which shall be the number of Common Shares outstanding on such record date or effective date,
as the case may be, before giving effect to such Common Share Reorganization; and 

  

	 	(B)	 the denominator of which shall be the number of Common Shares which will be outstanding immediately after
giving effect to such Common Share Reorganization (including, in the case of a distribution of securities exchangeable for or convertible into Common Shares, the number of Common Shares that would have been outstanding had such securities been
exchanged for or converted into Common Shares on such record date or effective date, as the case may be). 

 To the extent
that any adjustment in the Exercise Price occurs pursuant to this Section 10(a)(i) as a result of the fixing by the Company of a record date for the distribution of securities exchangeable for or convertible into Common Shares, the Exercise
Price shall be readjusted immediately after the expiry of any relevant exchange or conversion right to the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable after such expiry
and shall be further readjusted in such manner upon the expiry of any further such right. 
  

	 	(ii)	 If at any time during the Adjustment Period the Company shall fix a record date for the issue or distribution
to the holders of all or substantially all of the outstanding Common Shares of rights, options or warrants pursuant to which such holders are entitled, during a period expiring not more than 45 days after the record date for such issue (such period
being the “Rights Period”), to subscribe for or purchase Common Shares or securities exchangeable for or convertible into Common Shares at a price per share to the holder (or in the case of securities exchangeable for or convertible
into Common Shares, at an exchange or conversion price per share) at the date of issue of such securities of less than the Current Market Price of the Common Shares on such record date (any of such events being called a “Rights
Offering”), the Exercise Price shall be adjusted effective immediately after the record date for such Rights Offering to the amount determined by multiplying the Exercise Price in effect on such record date by a fraction:

  

	 	(A)	 the numerator of which shall be the aggregate of: 

 

	 	(1)	 the number of Common Shares outstanding on the record date for the Rights Offering, and 

 

	 	(2)	 the quotient determined by dividing 

 

	 	I.	 either (a) the product of the number of Common Shares offered during the Rights Period pursuant to the
Rights Offering and the price at which such Common Shares are offered, or (b) the product of the exchange or conversion price of the securities so offered and the number of Common Shares for or into which the securities offered pursuant to the
Rights Offering may be exchanged or converted, as the case may be, by 

  
 -7- 

	 	II.	 the Current Market Price of the Common Shares as of the record date for the Rights Offering; and

  

	 	(B)	 the denominator of which shall be the aggregate of the number of Common Shares outstanding on such record date
and the number of Common Shares offered pursuant to the Rights Offering (including in the case of the issue or distribution of securities exchangeable for or convertible into Common Shares the number of Common Shares for or into which such
securities may be exchanged or converted). 

 If by the terms of the rights, options, or warrants referred to in this
Section 10(a)(ii), there is more than one purchase, conversion or exchange price per Common Share, the aggregate price of the total number of additional Common Shares offered for subscription or purchase, or the aggregate conversion or exchange
price of the convertible or exchangeable securities so offered, shall be calculated for purposes of the adjustment on the basis of the lowest purchase, conversion or exchange price per Common Share, as the case may be. Any Common Shares owned by or
held for the account of the Company shall be deemed not to be outstanding for the purpose of any such calculation. To the extent that any adjustment in the Exercise Price occurs pursuant to this Section 10(a)(ii) as a result of the fixing by
the Company of a record date for the issue or distribution of rights, options or warrants referred to in this Section 10(a)(ii), the Exercise Price shall be readjusted immediately after the expiry of any relevant exchange, conversion or
exercise right to the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable after such expiry and shall be further readjusted in such manner upon the expiry of any further such
right. 
  

	 	(iii)	 If at any time during the Adjustment Period the Company shall fix a record date for the issue or distribution
to the holders of all or substantially all of the outstanding Common Shares of: 

  

	 	(A)	 shares of the Company of any class other than Common Shares; 

 

	 	(B)	 rights, options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common
Shares (other than rights, options or warrants pursuant to which holders of Common Shares are entitled, during a period expiring not more than 45 days after the record date for such issue, to subscribe for or purchase Common Shares or securities
exchangeable for or convertible into Common Shares at a price per share (or in the case of securities exchangeable for or convertible into Common Shares at an exchange or conversion price per share) at the date of issue of such securities to the
holder of at least the Current Market Price of the Common Shares on such record date); 

  

	 	(C)	 evidences of indebtedness of the Company; or 

 

	 	(D)	 any property or assets of the Company; 

and if such issue or distribution does not constitute a Common Share Reorganization or a Rights Offering (any of such non-excluded events being called a “Special Distribution”), the Exercise Price shall be adjusted effective immediately after the record date for the Special Distribution to the amount determined by
multiplying the Exercise Price in effect on the record date for the Special Distribution by a fraction: 

  
 -8- 

	 	(1)	 the numerator of which shall be the difference between: 

 

	 	I.	 the product of the number of Common Shares outstanding on such record date and the Current Market Price of the
Common Shares on such record date, and 

  

	 	II.	 the fair value, as determined in good faith by the directors of the Company, to the holders of Common Shares of
the shares, rights, options, warrants, evidences of indebtedness or property or assets to be issued or distributed in the Special Distribution; and 

  

	 	(2)	 the denominator of which shall be the product obtained by multiplying the number of Common Shares outstanding
on such record date by the Current Market Price of the Common Shares on such record date. 

 Any Common Shares owned by or
held for the account of the Company shall be deemed not to be outstanding for the purpose of such calculation. To the extent that any adjustment in the Exercise Price occurs pursuant to this Section 10(a)(iii) as a result of the fixing by the
Company of a record date for the issue or distribution of rights, options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common Shares referred to in this Section 10(a)(iii), the Exercise Price shall be
readjusted immediately after the expiry of any relevant exercise, exchange or conversion right to the amount which would then be in effect based upon the number of Common Shares issued and remaining issuable after such expiry and shall be further
readjusted in such manner upon the expiry of any further such right. 
  

	 	(iv)	 If at any time during the Adjustment Period there shall occur: 

 

	 	(A)	 a reclassification or redesignation of the Common Shares, any change of the Common Shares into other shares or
securities or any other capital reorganization involving the Common Shares other than a Common Share Reorganization; 

  

	 	(B)	 a consolidation, amalgamation, arrangement or merger of the Company with or into another body corporate which
results in a reclassification or redesignation of the Common Shares or a change of the Common Shares into other shares or securities; 

  

	 	(C)	 the transfer of the undertaking or assets of the Company as an entirety or substantially as an entirety to
another company or entity; 

 (any of such events being called a “Capital Reorganization”), after the
effective date of the Capital Reorganization the Holder shall be entitled to receive, and shall accept, for the same aggregate consideration, upon exercise of the Warrants, in lieu of the number of Common Shares to

  
 -9- 

 
which the Holder was theretofore entitled upon the exercise of the Warrants, the kind and aggregate number of shares and other securities or property resulting from the Capital Reorganization
which the Holder would have been entitled to receive as a result of the Capital Reorganization if, on the effective date thereof, the Holder had been the registered holder of the number of Common Shares which the Holder was theretofore entitled to
purchase or receive upon the exercise of the Warrants. If necessary, as a result of any such Capital Reorganization, appropriate adjustments shall be made in the application of the provisions of this Warrant Certificate with respect to the rights
and interests thereafter of the Holder to the end that the provisions shall thereafter correspondingly be made applicable as nearly as may reasonably be possible in relation to any shares or other securities or property thereafter deliverable upon
the exercise of the Warrants. 
  

	 	(v)	 If at any time during the Adjustment Period any adjustment or readjustment in the Exercise Price shall occur
pursuant to the provisions of Sections 10(a)(i) or (a)(iii) of this Warrant Certificate, then the number of Common Shares purchasable upon the subsequent exercise of the Warrants shall be simultaneously adjusted or readjusted, as the case may be, by
multiplying the number of Common Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment or readjustment by a fraction which shall be the reciprocal of the fraction used in the adjustment or readjustment of the
Exercise Price. 

  

	 	(b)	 The following rules and procedures shall be applicable to adjustments made pursuant to Section 10(a) of
this Warrant Certificate: 

  

	 	(i)	 subject to the following sections of this Section 10(b), any adjustment made pursuant to
Section 10(a) of this Warrant Certificate shall be made successively whenever an event referred to therein shall occur; 

  

	 	(ii)	 no adjustment in the Exercise Price shall be required unless such adjustment would result in a change of at
least one percent in the then Exercise Price and no adjustment shall be made in the number of Common Shares purchasable or issuable on the exercise of the Warrants unless it would result in a change of at least one
one-hundredth of a Common Share; provided, however, that any adjustments which except for the provision of this Section 10(b)(ii) would otherwise have been required to be made shall be carried forward and
taken into account in any subsequent adjustment. Notwithstanding any other provision of Section 10(a) of this Warrant Certificate, no adjustment of the Exercise Price shall be made which would result in an increase in the Exercise Price or a
decrease in the number of Common Shares issuable upon the exercise of the Warrants (except in respect of a consolidation of the outstanding Common Shares); 

  

	 	(iii)	 if at any time during the Adjustment Period the Company shall take any action affecting the Common Shares,
other than an action or event described in Section 10(a) of this Warrant Certificate, which in the opinion of the directors of the Company would have an adverse effect upon the rights of the Holder, the Exercise Price and/or the number of
Common Shares purchasable under the Warrants shall, subject to any necessary regulatory approval, be adjusted in such manner and at such time as the directors of the Company may determine to be equitable in the circumstances, provided that no such
action shall be taken unless and until the Holder has been provided with notice of such proposed action and the consequences thereof; 

  
 -10- 

	 	(iv)	 if the Company sets a record date to determine holders of Common Shares for the purpose of entitling such
holders to receive any dividend or distribution or any subscription or purchase rights and shall thereafter and before the distribution to such holders of any such dividend, distribution or subscription or purchase rights legally abandon its plan to
pay or deliver such dividend, distribution or subscription or purchase rights, then no adjustment in the Exercise Price or the number of Common Shares purchasable under the Warrants shall be required by reason of the setting of such record date;

  

	 	(v)	 no adjustment in the Exercise Price or in the number or kind of securities purchasable on the exercise of the
Warrants shall be made in respect of any event described in Section 10 of this Warrant Certificate if (subject to TSX and NYSE approval) the Holder is entitled to participate in such event on the same terms mutatis mutandis as if the
Holder had exercised the Warrants prior to or on the record date or effective date, as the case may be, of such event. Any such participation by the Holder is subject to regulatory approval; and 

 

	 	(vi)	 in any case in which this Warrant Certificate shall require that an adjustment shall become effective
immediately after a record date for an event referred to in Section 10(a) hereof, the Company may defer, until the occurrence of such event: 

  

	 	(A)	 issuing to the Holder, to the extent that the Warrants are exercised after such record date and before the
occurrence of such event, the additional Common Shares issuable upon such exercise by reason of the adjustment required by such event; and 

  

	 	(B)	 delivering to the Holder any distribution declared with respect to such additional Common Shares after such
record date and before such event; 

 provided, however, that the Company shall deliver to the Holder an appropriate
instrument evidencing the right of the Holder upon the occurrence of the event requiring the adjustment, to an adjustment in the Exercise Price or the number of Common Shares purchasable upon the exercise of the Warrants and to such distribution
declared with respect to any such additional Common Shares issuable on the exercise of the Warrants. 
  

	 	(c)	 At least 10 days prior to the earlier of the record date or effective date of any event which requires or might
require an adjustment in any of the rights of the Holder under this Warrant Certificate, including the Exercise Price or the number of Common Shares which may be purchased under this Warrant Certificate, the Company shall deliver to the Holder a
certificate of the Company specifying the particulars of such event and, if determinable, the required adjustment and the calculation of such adjustment. In case any adjustment for which a notice in this Section 10(c) has been given is not then
determinable, the Company shall promptly after such adjustment is determinable deliver to the Holder a certificate providing the calculation of such adjustment. The Company hereby covenants and agrees that the Company will not take any action which
might deprive the Holder of the opportunity of exercising the rights of subscription contained in this Warrant Certificate, during such 10 day period. 

  
 -11- 

	 	(d)	 In connection with any: (i) reclassification or redesignation of the Common Shares, any change of the
Common Shares into other shares or securities or any other capital reorganization involving the Common Shares other than as set forth in this Section 10; (ii) consolidation, amalgamation, arrangement or merger of the Company with or into
another body corporate which results in a reclassification or redesignation of the Common Shares or a change of the Common Shares into other shares or securities (including, without limitation, pursuant to a “take-over bid”, “tender
offer” or other acquisition of all or substantially all of the outstanding Common Shares); or (iii) sale, transfer or lease to another corporation of all or substantially all the property or assets of the Company, the Holder shall have the
right thereafter, upon payment of the Exercise Price in effect immediately prior to such action, to purchase upon exercise of each Warrant the kind and amount of shares and other securities and property which it would have owned or have been
entitled to receive after the happening of such reclassification, redesignation, consolidation, amalgamation, arrangement, merger, sale, transfer or lease had such Warrant been exercised immediately prior to such action, and the Holder shall be
bound to accept such shares and other securities and property in lieu of the Common Shares to which it was previously entitled; provided, however, that no adjustment in respect of dividends, interest or other income on or from such shares or other
securities and property shall be made during the term of a Warrant or upon the exercise of a Warrant. If necessary, as a result of any actions contemplated by this paragraph, appropriate adjustments shall be made in the application of the provisions
of this Warrant Certificate with respect to the rights and interests thereafter of the Holder to the end that the provisions shall thereafter correspondingly be made applicable as nearly as may reasonably be possible in relation to any shares or
other securities or property thereafter deliverable upon the exercise of the Warrants. The provisions of this paragraph shall similarly apply to successive consolidations, mergers, amalgamation, sales, transfers or leases. 

 

	11.	 U.S. Registration 

This Warrant and the Common Shares issuable upon exercise of this Warrant have not been and will not be registered under the U.S. Securities
Act or under state securities laws of any state in the United States. Accordingly, this Warrant may not be transferred or exercised in the United States or by or on behalf of a U.S. Person or a person in the United States unless an exemption is
available from the registration requirements of the U.S. Securities Act and applicable state securities laws and, if required by the Company, the holder of this Warrant has furnished an opinion of counsel of recognized standing in form and substance
reasonably satisfactory to the Company to such effect, as applicable. 
  

	12.	 Authorized Shares 

As a condition precedent to the taking of any action which would require an adjustment pursuant to Section 10 of this Warrant Certificate,
the Company shall take any action which may be necessary in order that the Company has issued and reserved in its authorized capital, and may validly and legally issue as fully paid and non-assessable, all of
the Common Shares (or other shares and securities, if applicable) which the Holder of the Warrants is entitled to receive on the exercise hereof. 
  

	13.	 Mutilated or Missing Warrant Certificate 

Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant Certificate and, in the case
of any such loss, theft or destruction, upon delivery of a bond or indemnity satisfactory to the Company, or, in the case of any such mutilation, upon surrender or cancellation of this Warrant Certificate, the Company will issue to the Holder a new
warrant certificate of like tenor, in lieu of this Warrant Certificate, representing the right to subscribe for and purchase the number of Common Shares which may be subscribed for and purchased hereunder. 

  
 -12- 

	14.	 Merger and Successors 

 

	 	(a)	 Nothing herein contained shall prevent any consolidation, amalgamation or merger of the Company with or into
any other Person or Persons, or a conveyance or transfer of all or substantially all of the properties and estates of the Company as an entirety to any Person lawfully entitled to acquire and operate same, provided, however, that the Person formed
by such consolidation, amalgamation, arrangement or merger or which acquires by conveyance or transfer all or substantially all of the properties and estates of the Company as an entirety shall, simultaneously with such amalgamation, arrangement,
merger, conveyance or transfer, assume the due and punctual performance and observance of all the covenants and conditions hereof to be performed or observed by the Company. 

 

	 	(b)	 In case the Company, pursuant to Section 14(a), shall be consolidated, amalgamated or merged with or into
any other Person or Persons or shall convey or transfer all or substantially all of its properties and estates as an entirety to any other Person, the successor Person formed by such consolidation, amalgamation or arrangement, or into which the
Company shall have been consolidated, amalgamated or merged or which shall have received a conveyance or transfer as aforesaid, shall succeed to and be substituted for the Company hereunder and such changes in phraseology and form (but not in
substance) may be made in this Warrant Certificate as may be appropriate in view of such amalgamation, arrangement, merger or transfer. 

  

	15.	 Amendment 

This Warrant Certificate may only be amended with the prior written consent of the Company and the Holder. 

 

	16.	 Severability 

If any term or other provision of this Warrant Certificate is invalid, illegal or incapable of being enforced under any applicable law or as a
matter of public policy, all other conditions and provisions of this Warrant Certificate shall nevertheless remain in full force and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced,
the Company and the Holder shall negotiate in good faith to modify this Warrant Certificate so as to effect the original intent of the Company and the Holder as closely as possible in a mutually acceptable manner in order that the provisions of this
Warrant Certificate be consummated as originally contemplated to the greatest extent possible. 
  

	17.	 Governing Law 

This Warrant Certificate shall be governed by and construed and interpreted in accordance with the laws of the Province of Ontario and the
federal laws of Canada applicable therein irrespective of the choice of laws principles. 

  
 -13- 

	18.	 Transferability 

Subject only to applicable securities laws, the Warrants represented by this Warrant Certificate are transferable by the Holder to any of its
Affiliates and the term “Holder” shall mean and include any successor, transferee or assignee of the current or any future Holder. The Warrants represented by this Warrant Certificate may be transferred by the Holder completing and
delivering to the Company the transfer form attached hereto as Schedule “B”. For greater certainty, the Warrants represented by this Warrant Certificate are not transferrable except as described in this Section 18 or with the prior
written consent of the Company. 
  

	19.	 Enurement 

This Warrant Certificate and all of its provisions shall enure to the benefit of the Holder and its permitted assigns and successors and shall
be binding upon the Company and its successors and permitted assigns. 
  

	20.	 Notice 

All notices, requests, claims, demands and other communications under this Warrant Certificate shall be in writing and shall be given or made
(and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service or by registered or certified mail (postage prepaid, return receipt requested) to the Holder and the Company at the following
addresses (or at such other address as shall be specified in a notice given in accordance with this Section 20): 
  

	 	(a)	 if to the Holder at: 

c/o Constellation Brands, Inc. 

207 High Point Drive, Bldg. 100 

Victor, New York 14564 

Attention: General Counsel 
 and
with a copy (which shall not constitute notice) to: 
 Osler, Hoskin & Harcourt LLP 

100 King Street West, Suite 6200 

Toronto, Ontario M5X 1B8 

Attention: Emmanuel Pressman and James R. Brown 
  

	 	(b)	 if to the Company at: 

1 Hershey Drive, 
 Smiths Falls,
ON K7A 0A8 
 Attention: Chief Executive Officer 

with a copy (which shall not constitute notice) to: 

Cassels Brock & Blackwell LLP 

40 King Street West, Suite 2100 

Toronto, Ontario M5H 3C2 

Attention: Jonathan Sherman 

  
 -14- 

	21.	 Further Assurances 

The Company shall promptly do, make, execute, deliver, or cause to be done, made, executed or delivered, all such further acts, documents and
things as the Holder may reasonably require from time to time for the purpose of giving effect to this Warrant Certificate and shall use reasonable efforts and take all such steps as may be reasonably within its power to implement to their full
extent the provisions of this Warrant Certificate. 
  

	22.	 Currency 

All dollar amounts referred to in this Warrant Certificate are in Canadian dollars. 

[Signature page follows] 

  
 -15- 

 IN WITNESS WHEREOF the Company has caused this Warrant Certificate to be executed by
a duly authorized signatory effective as of the date first written above. 
  

			
	CANOPY GROWTH CORPORATION
		
	By:	 	 
		 	Name:
		 	Title:

 ACKNOWLEDGEMENT 

IN WITNESS WHEREOF, the Holder hereby acknowledges, confirms and consents to the amendment and restatement of the Original
Warrant Certificate as set out in this Amended and Restated Warrant Certificate. 
  

			
	CBG HOLDINGS LLC
		
	By:	 	 
		 	Name:
		 	Title:

 SCHEDULE “A” 

SUBSCRIPTION FORM 
  

	TO:	 CANOPY GROWTH CORPORATION 

Terms which are not otherwise defined herein shall have the meanings ascribed to such terms in the Warrant Certificate held by the undersigned and issued by
Canopy Growth Corporation (the “Company”). 
 The undersigned hereby exercises the right to acquire
                                     Common Shares of the
Company in accordance with and subject to the provisions of such Warrant Certificate and herewith makes payment of the Exercise Price in full for the said number of Common Shares. 

The undersigned hereby confirms that an aggregate of
                                     Common Shares have been
purchased as contemplated by Section 9(a) of the Warrant Certificate. 
 (Please check the ONE box applicable): 

 

					
	☐	  	A	  	The undersigned holder (i) at the time of exercise of the Warrant is not in the United States; (ii) is not a U.S. Person (iii) is not exercising the Warrant on behalf of a U.S. Person or a person in the United States;
and (iv) did not execute or deliver this exercise form in the United States.
			
	☐	  	B.	  	The undersigned holder (i) purchased the Warrants for its own account or the account of another “accredited investor” as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (“Accredited
Investor”); (ii) is exercising the Warrants solely for its own account or for the account of such other Accredited Investor; (iii) each of it and such other person, if any, was an Accredited Investor on the date the Warrants were
acquired and is an Accredited Investor on the date of exercise of the Warrants; and (iv) the representations and warranties made by the holder or any beneficial purchaser, as the case may be, to the Company in connection with the acquisition of
the Warrants remain true and correct on the date hereof.
			
	☐	  	C.	  	The undersigned holder has delivered to the Company an opinion of counsel (which will not be sufficient unless it is from counsel of recognized standing and in form and substance reasonably satisfactory to the Company) to the effect
that an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws is available.

 The Common Shares are to be issued, registered and delivered as follows: 

 

			
	Name:	  	  

		
	Address in full:	  	  

			
		
		  	  

 Note: If further nominees are intended, please attach (and initial) a schedule giving these particulars. 

DATED this                  day of
                                    ,
20        . 

			
	  
	  	  

	  Signature Guaranteed	  	  (Signature of Warrantholder)
	  (if required)	  	
		  	  

		  	  Print full name
		
		  	  

		
		  	  

		  	  Print full address

 Note: 
 The
undersigned holder understands that unless Box A above is checked, the certificate representing the Common Shares issuable upon exercise of the Warrants will bear a legend restricting transfer without registration under the U.S. Securities Act and
applicable state securities laws unless an exemption from registration is available. Certificates representing such Common Shares will not be registered or delivered to an address in the United States unless Box B or Box C above is checked. If Box C
is checked, any opinion tendered must be in form and substance reasonably satisfactory to the Company. Holders planning to deliver an opinion of counsel in connection with the exercise of the Warrant should contact the Company in advance to
determine whether any opinions to be tendered will be acceptable to the Company. 
 If Box B or Box C is checked, any certificate representing the Common
Shares issued upon exercise of this Warrant will bear an applicable United States restrictive legend. 
 Instructions: 

The registered holder may exercise its right to receive Common Shares by completing this form and surrendering this form and the Warrant Certificate
representing the Warrants being exercised to the Company. 
 The signature on this Subscription Form must correspond in every particular with the name shown
on the face of the Warrant Certificate without alteration or any change whatsoever or this Subscription Form must be signed by a duly authorized signing officer of the Holder. If this Subscription Form is signed by a duly authorized signing officer
of the Holder, the Warrant Certificate must be accompanied by evidence of authority to sign. 
 If the Subscription Form indicates that Common Shares are to
be issued to a Person or Persons other than the registered holder of the Warrant Certificate or an affiliate of such registered holder, the endorsement must be signature guaranteed, in either case, by a Canadian chartered bank, or a member of a
recognized Securities Transfer Agents Medallion Program (STAMP). The stamp affixed thereon by the guarantor must bear the actual words “Signature Guarantee”, or “Signature Medallion Guaranteed” or in accordance with industry
standards. 
 The certificates will be mailed by registered mail to the Holder(s) at the address(es) appearing in this Subscription Form. 

If any Warrants represented by this certificate are not being exercised, a new Warrant Certificate will be issued and delivered to the Holder with the Common
Share certificates in accordance with the provisions of the Warrant Certificate. 

 SCHEDULE “B” 

TRANSFER FORM 
  

	TO:	 CANOPY GROWTH CORPORATION 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                                         
                                         
                           (include name and address of the transferee)
                                 (include number) Warrants exercisable for common
shares of Canopy Growth Corporation (the “Company”) registered in the name of the undersigned on the register of the Company maintained therefor, and hereby irrevocably appoints
                                         
                                the attorney of the undersigned to transfer the said
securities on the books maintained by the Company with full power of substitution. 
 THE UNDERSIGNED TRANSFEROR HEREBY CERTIFIES AND DECLARES that the
Warrants are not being offered, sold or transferred to, or for the account or benefit of, a “U.S. person” (as defined in Rule 902(k) of Regulation S under the United States Securities Act of 1933, as amended (the “U.S.
Securities Act”)) or a person within the United States unless the Warrants are registered under the U.S. Securities Act and any applicable state securities laws or unless an exemption from such registration is available. 

DATED this                  day of
                                    ,
20        . 
  

			
	  
	  	  

	  Signature Guaranteed	  	  (Signature of Warrantholder)
		  	
		  	  

		  	  Print full name
		
		  	  

		
		  	  

		  	  Print full address

 Instructions: 
 The
signature on this Transfer Form must correspond in every particular with the name shown on the face of the Warrant Certificate without alteration or any change whatsoever or this Subscription Form must be signed by a duly authorized signing officer
of the Holder. If this Subscription Form is signed by a duly authorized signing officer of the Holder, the Warrant Certificate must be accompanied by evidence of authority to sign. 

The endorsement must be signature guaranteed, in either case, by a Canadian chartered bank, or a member of a recognized Securities Transfer Agents Medallion
Program (STAMP). The stamp affixed thereon by the guarantor must bear the actual words “Signature Guarantee”, or “Signature Medallion Guaranteed” or in accordance with industry standards. 

If any Warrants represented by this certificate are not being transferred, a new Warrant Certificate will be issued and delivered to the Holder. 

 Form of Tranche C Amended Warrant Certificate 

(see attached) 

  
 Exhibit A-3 

 TRANCHE C 

COMMON SHARE PURCHASE WARRANT 
 THE
SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR U.S. STATE SECURITIES LAWS.
THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY, ONLY (A) TO CANOPY GROWTH CORPORATION (THE “CORPORATION”), (B) OUTSIDE THE UNITED STATES
IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE U.S. SECURITIES ACT
PROVIDED BY (I) RULE 144 THEREUNDER IF AVAILABLE OR (II) RULE 144A THEREUNDER, IF AVAILABLE, AND IN EACH CASE IN ACCORDANCE WITH APPLICABLE U.S. STATE SECURITIES LAWS, (D) IN ANOTHER TRANSACTION THAT DOES NOT REQUIRE REGISTRATION
UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS, OR (E) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT, PROVIDED THAT, IN THE CASE OF TRANSFERS PURSUANT TO (C)(I) OR (D) ABOVE, THE
HOLDER HAS, PRIOR TO SUCH TRANSFER, FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OR OTHER EVIDENCE OF EXEMPTION, IN EITHER CASE REASONABLY SATISFACTORY TO THE CORPORATION. DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE “GOOD
DELIVERY” IN SETTLEMENT OF TRANSACTIONS ON STOCK EXCHANGES IN CANADA.” 
 THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR
ON BEHALF OF A U.S. PERSON OR PERSON IN THE UNITED STATES UNLESS THIS WARRANT AND SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE OR
EXEMPTIONS FROM SUCH REGISTRATION REQUIREMENTS ARE AVAILABLE. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE U.S. SECURITIES ACT. 

WARRANTS TO PURCHASE COMMON SHARES OF 

CANOPY GROWTH CORPORATION 
  

					
	Warrant Certificate Number:	  		  	Number of Warrants:
			
	2018 – C-1	  		  	12,818,148
			
		  		  	Date:
			
		  		  	●, 2019

 Effective as of the date hereof, this Warrant Certificate amends,
re-evidences, restates, replaces and supersedes 12,818,148 common share purchase warrants issued by the Company to the Holder (as each such term is defined below) pursuant to the tranche B common share
purchase warrant dated November 1, 2018 (the “Original Warrant Certificate”). 

 THIS CERTIFIES THAT, for value received, CBG Holdings LLC (the “Holder”) is
entitled, at any time prior to the Expiry Time, to purchase, at the Exercise Price, one fully paid, validly issued and non-assessable Common Share for each Warrant vested and exercisable under this Warrant
Certificate, by surrendering to the Company, at its principal office at 1 Hershey Drive, Smith Falls, Ontario, K7A 0A8, this Warrant Certificate, together with a Subscription Form, duly completed and executed, and immediately available funds by wire
transfer of lawful money of Canada payable to or to the order of the Company for an amount equal to the Exercise Price multiplied by the number of Common Shares subscribed for, on and subject to the terms and conditions set forth below. 

Nothing contained herein shall confer any right upon the Holder to subscribe for or purchase any Common Shares at any time after the Expiry
Time, and from and after the Expiry Time, this Warrant Certificate and all rights hereunder shall be void and of no value. 
  

	1.	 Defined Terms 

Capitalized terms used in this Warrant Certificate, including the preamble, shall have the following meanings: 

“Adjustment Period” means the period commencing on the date hereof and ending at the Expiry Time. 

“Affiliate” means, with respect to any Person, any Person now or hereafter existing, directly or indirectly, Controlled by,
Controlling, or under common Control with, such Person, whether on or after the date hereof. 
 “Business Day” means a day
other than a Saturday, Sunday or other day on which commercial banks in Smiths Falls, Ontario are authorized or required by law to close. Any event the scheduled occurrence of which would fall on a day that is not a Business Day shall be deferred
until the next succeeding Business Day. 
 “Capital Reorganization” has the meaning ascribed to such term in
Section 10(a)(iv). 
 “Common Share” means a common share in the capital of the Company or such other shares or other
securities into which such common share is converted, exchanged, reclassified or otherwise changed, as the case may be, from time to time. 

“Company” means Canopy Growth Corporation, a corporation existing under the federal laws of Canada, and its successors and
assigns. 
 “Consent Agreement” means the consent agreement between the Holder and the Company dated April 18, 2019.

 “Control” means: 
  

	 	(a)	 in relation to a corporation, the direct or indirect beneficial ownership at the relevant time of shares of
such corporation carrying more than 50% of the voting rights ordinarily exercisable at meetings of shareholders of the Company where such voting rights are sufficient to elect a majority of the directors of the Company; 

 

	 	(b)	 in relation to a Person that is a partnership, limited liability company or joint venture, the direct or
indirect beneficial ownership at the relevant time of more than 50% of the ownership interests of the partnership, limited liability company or joint venture in circumstances where it can reasonably be expected that the Person can direct the affairs
of the partnership, limited liability company or joint venture; and 

  
 -2- 

	 	(c)	 in relation to a trust, the direct or indirect beneficial ownership at the relevant time of more than 50% of
the property settled under the trust; 

 and the words “ Controlled by”, “Controlling”
and similar words have corresponding meanings; the Person who directly or indirectly Controls a Controlled Person or entity shall be deemed to Control a corporation, partnership, limited liability company, joint venture or trust which is Controlled
by the Controlled Person or entity, and so on. 
 “Current Market Price” means, at the relevant time of reference, the price
per share equal to the volume-weighted average trading price of the Common Shares on the TSX for the five Trading Days immediately preceding the relevant record date. 

“Exercise Price ” means, at the time of exercise, the Current Market Price, as may be adjusted in accordance with
Section 5. 
 “Expiry Time” means 5:00 p.m. (Toronto time) on November 1, 2026. 

“NYSE” means the New York Stock Exchange. 

“Person” means an individual, corporation, partnership, unincorporated syndicate, unincorporated organization, trust, trustee,
executor, administrator, or other legal representative, or any group or combination thereof. 
 “Repurchase Period” means
the period commencing on April 18, 2019 and ending on the date that is 24 months after the date that all of the Tranche A Warrants have been exercised by the Holder. 

“Rights Offering” has the meaning ascribed to such term in Section 10(a)(ii). 

“Rights Period” has the meaning ascribed to such term in Section 10(a)(ii). 

“Special Distribution” has the meaning ascribed to such term in Section 10(a)(iii). 

“Subscription Form” means the form of subscription annexed hereto as Schedule “A”. 

“Trading Day” means a day on which the TSX is open for business. 

“Tranche A Warrants ” means the 88,472,861 Common Share purchase warrants represented by the tranche A amended and restated
warrant certificate issued by the Company to the Holder on the date hereof. 
 “Tranche B Warrants” means the 38,454,444
Common Share purchase warrants represented by the tranche B amended and restated warrant certificate issued by the Company to the Holder on the date hereof. 

“Tranche B Warrant Certificate” means the warrant certificate representing the Tranche B Warrants. 

“TSX” means the Toronto Stock Exchange. 

  
 -3- 

 “United States” means the United States of America, its territories and
possessions, any state of the United States and the District of Columbia. 
 “U.S. Person” means “U.S. person” as
defined in Rule 902(k) of Regulation S under the U.S. Securities Act. 
 “U.S. Securities Act” means United States
Securities Act of 1933, as amended. 
 “Warrants” means the tranche C Common Share purchase warrants represented by this
Warrant Certificate. 
  

	2.	 Vesting of Warrants 

The Warrants represented by this Warrant Certificate shall vest and become immediately exercisable once all Tranche A Warrants have been exercised in
accordance with their terms, and shall remain exercisable by the Holder, in whole or in part at any time, and from time to time, thereafter and prior to the Expiry Time. 
  

	3.	 Exercise of Warrants 

 

	 	(a)	 Subject to Section 2, the rights represented by this Warrant Certificate may be exercised by the Holder,
in whole or in part, by the surrender of this Warrant Certificate, with the attached Subscription Form duly executed, at the principal office of the Company at 1 Hershey Drive, Smiths Falls, Ontario K7A 0A8 (or such other office of the Company as it
may designate by notice in writing to the Holder at the address of such Holder appearing on the books of the Company at any time and from time to time during the period within which the rights represented by this Warrant Certificate may be
exercised) and upon payment to or to the order of the Company of immediately available funds by wire transfer of lawful money of Canada in an amount equal to the Exercise Price per Common Share multiplied by the aggregate number of Common Shares to
be issued on such exercise of this Warrant (as such amount may be adjusted in accordance with Section 5). In the event that the Holder subscribes for and purchases any such lesser number of Common Shares prior to the Expiry Time, the Holder
shall be entitled to receive a replacement Warrant Certificate, without charge, representing the unexercised balance of the Warrants as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant
Certificate shall have been so exercised. 

  

	 	(b)	 The Company agrees that the Common Shares so purchased shall be and be deemed to be issued to the Holder as the
registered owner of such Common Shares as of the close of business on the date on which both this Warrant Certificate shall have been surrendered and payment made for such Common Shares as aforesaid. Certificates for the Common Shares so purchased
shall be delivered to the Holder as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant Certificate shall have been so exercised. 

 

	4.	 Ability to Exercise 

Subject to Section 2, the Warrants may be exercised in whole or in part at any time and from time to time prior to the Expiry Time. After
the Expiry Time, all rights under any outstanding Warrants evidenced hereby, in respect of which the rights of subscription and purchase herein provided for shall not have been exercised, shall wholly cease and terminate and such Warrants shall be
void and of no value or effect. 

  
 -4- 

	5.	 Exercise Price Credit 

If, for any reason, the Company has not within the Repurchase Period, purchased for cancellation Common Shares required to be purchased
pursuant to section 2.3 of the Consent Agreement, the Company hereby agrees and acknowledges that the Holder will be credited an amount (the “Credit Amount”) that will reduce the aggregate exercise price otherwise payable by
the Holder upon each exercise of the Warrants represented by this Warrant Certificate equal to the difference between: 
  

	 	(a)	 $1,582,995,262; and 

  

	 	(b)	 the actual purchase price paid by the Company in purchasing Common Shares pursuant to section 2.3 of the
Consent Agreement. 

  

	6.	 No Fractional Common Shares 

No fractional Common Shares will be issuable upon any exercise of the Warrants and the Holder will not be entitled to any cash payment or
compensation in lieu of a fractional Common Share. 
  

	7.	 Not a Shareholder 

The holding of the Warrants shall not constitute the Holder a shareholder of the Company nor entitle the Holder to any right or interest in
respect thereof, except as expressly provided in this Warrant Certificate. 
  

	8.	 Covenants and Representations of the Company The Company covenants and agrees as follows:

  

	 	(a)	 this Warrant Certificate is a valid and binding obligation of the Company, enforceable against the Company in
accordance with its terms; 

  

	 	(b)	 all Common Shares which may be issued upon the exercise of the rights represented by the Warrants will, upon
issuance, be validly issued, fully paid and non-assessable, free from all taxes, liens and charges with respect to the issue thereof, except with respect to any applicable withholding taxes; and

  

	 	(c)	 during the period within which the rights represented by this Warrant Certificate may be exercised, the Company
will at all times have authorized and reserved a sufficient number of its Common Shares to provide for the exercise of the rights represented by this Warrant Certificate. 

 

	9.	 Covenant of the Holder 

 

	 	(a)	 The Holder covenants and agrees that in respect of each Common Share purchased by the Holder or any affiliate
of the Holder, including Greenstar Canada Investment Limited Partnership and Constellation Brands, Inc. and its Subsidiaries (as defined in National Instrument 45-106 – Prospectus Exemptions), (i) on the
TSX, the NYSE or any other stock exchange, marketplace or trading market on which the Common Shares are then listed; or (ii) through private agreement transactions with existing holders of Common Shares, the number of Warrants represented by
this Warrant Certificate shall be reduced by the number of Common Shares so acquired (up to an aggregate maximum reduction of 12,818,148 Common Shares less the number of Common Shares, if any, by which the Tranche B Warrants have been reduced
pursuant to section 9(a) of the Tranche B Warrant Certificate). 

  
 -5- 

	 	(b)	 At the time of exercise of the Warrants, the Holder shall confirm the number of Common Shares purchased as
contemplated by Section 9(a). 

  

	 	(c)	 For certainty, the aggregate reduction in the number of Warrants represented by this Warrant Certificate
pursuant to Section 9(a) hereof and in the number of Tranche B Warrants represented by the Tranche B Warrant Certificate pursuant to section 9(a) thereof shall not exceed 20,000,000 Warrants. 

 

	 	(d)	 The Holder shall have the right, but not the obligation, to surrender this Warrant Certificate at the principal
office of the Company at 1 Hershey Drive, Smiths Falls, Ontario K7A 0A8 (or such other office of the Company as it may designate by notice in writing to the Holder at the address of such Holder appearing on the books of the Company at any time and
from time to time during the period within which the rights represented by this Warrant Certificate may be exercised) and, if the Holder exercises such right, the Holder shall thereafter be entitled to receive a replacement Warrant Certificate,
without charge, representing the reduced balance of the Warrants as soon as practicable, and in any event within five Business Days, after the Warrants represented by this Warrant Certificate shall have been so surrendered and cancelled. If the
Holder does not exercise such right, this Warrant Certificate shall continue to evidence in full the Warrants and the number of Warrants indicated on the cover page of this Warrant Certificate shall be deemed to be reduced by the number of Warrants
contemplated by Section 9(a) hereof. 

  

	10.	 Anti-Dilution Protection 

 

	 	(a)	 The Exercise Price and the number of Common Shares issuable to the Holder upon the exercise of the Warrants
shall be subject to adjustment from time to time in the events and in the manner provided as follows: 

  

	 	(i)	 If at any time during the Adjustment Period the Company shall: 

 

	 	(A)	 fix a record date for the issue of, or issue, Common Shares to the holders of all or substantially all of the
outstanding Common Shares by way of a share dividend; 

  

	 	(B)	 fix a record date for the distribution to, or make a distribution to, the holders of all or substantially all
of the outstanding Common Shares payable in Common Shares or securities exchangeable for or convertible into Common Shares; 

  

	 	(C)	 subdivide the outstanding Common Shares into a greater number of Common Shares; or 

 

	 	(D)	 consolidate the outstanding Common Shares into a smaller number of Common Shares, 

(any of such events in subsections (A), (B), (C) and (D) above being called a “Common Share Reorganization”), the
Exercise Price shall be adjusted on the earlier of the record date on which holders of Common Shares are determined for the purposes of the Common Share Reorganization and the effective date of the Common Share Reorganization to the amount
determined by multiplying the Exercise Price in effect immediately prior to such record date or effective date, as the case may be, by a fraction: 

  
 -6- 

	 	(A)	 the numerator of which shall be the number of Common Shares outstanding on such record date or effective date,
as the case may be, before giving effect to such Common Share Reorganization; and 

  

	 	(B)	 the denominator of which shall be the number of Common Shares which will be outstanding immediately after
giving effect to such Common Share Reorganization (including, in the case of a distribution of securities exchangeable for or convertible into Common Shares, the number of Common Shares that would have been outstanding had such securities been
exchanged for or converted into Common Shares on such record date or effective date, as the case may be). 

 To the extent
that any adjustment in the Exercise Price occurs pursuant to this Section 10(a)(i) as a result of the fixing by the Company of a record date for the distribution of securities exchangeable for or convertible into Common Shares, the Exercise
Price shall be readjusted immediately after the expiry of any relevant exchange or conversion right to the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable after such expiry
and shall be further readjusted in such manner upon the expiry of any further such right. 
  

	 	(ii)	 If at any time during the Adjustment Period the Company shall fix a record date for the issue or distribution
to the holders of all or substantially all of the outstanding Common Shares of rights, options or warrants pursuant to which such holders are entitled, during a period expiring not more than 45 days after the record date for such issue (such period
being the “Rights Period”), to subscribe for or purchase Common Shares or securities exchangeable for or convertible into Common Shares at a price per share to the holder (or in the case of securities exchangeable for or convertible
into Common Shares, at an exchange or conversion price per share) at the date of issue of such securities of less than the Current Market Price of the Common Shares on such record date (any of such events being called a “Rights
Offering”), the Exercise Price shall be adjusted effective immediately after the record date for such Rights Offering to the amount determined by multiplying the Exercise Price in effect on such record date by a fraction:

  

	 	(A)	 the numerator of which shall be the aggregate of: 

 

	 	(1)	 the number of Common Shares outstanding on the record date for the Rights Offering, and 

 

	 	(2)	 the quotient determined by dividing 

 

	 	I.	 either (a) the product of the number of Common Shares offered during the Rights Period pursuant to the
Rights Offering and the price at which such Common Shares are offered, or (b) the product of the exchange or conversion price of the securities so offered and the number of Common Shares for or into which the securities offered pursuant to the
Rights Offering may be exchanged or converted, as the case may be, by 

  
 -7- 

	 	II.	 the Current Market Price of the Common Shares as of the record date for the Rights Offering; and

  

	 	(B)	 the denominator of which shall be the aggregate of the number of Common Shares outstanding on such record date
and the number of Common Shares offered pursuant to the Rights Offering (including in the case of the issue or distribution of securities exchangeable for or convertible into Common Shares the number of Common Shares for or into which such
securities may be exchanged or converted). 

 If by the terms of the rights, options, or warrants referred to in this
Section 10(a)(ii), there is more than one purchase, conversion or exchange price per Common Share, the aggregate price of the total number of additional Common Shares offered for subscription or purchase, or the aggregate conversion or exchange
price of the convertible or exchangeable securities so offered, shall be calculated for purposes of the adjustment on the basis of the lowest purchase, conversion or exchange price per Common Share, as the case may be. Any Common Shares owned by or
held for the account of the Company shall be deemed not to be outstanding for the purpose of any such calculation. To the extent that any adjustment in the Exercise Price occurs pursuant to this Section 10(a)(ii) as a result of the fixing by
the Company of a record date for the issue or distribution of rights, options or warrants referred to in this Section 10(a)(ii), the Exercise Price shall be readjusted immediately after the expiry of any relevant exchange, conversion or
exercise right to the Exercise Price which would then be in effect based upon the number of Common Shares actually issued and remaining issuable after such expiry and shall be further readjusted in such manner upon the expiry of any further such
right. 
  

	 	(iii)	 If at any time during the Adjustment Period the Company shall fix a record date for the issue or distribution
to the holders of all or substantially all of the outstanding Common Shares of: 

  

	 	(A)	 shares of the Company of any class other than Common Shares; 

 

	 	(B)	 rights, options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common
Shares (other than rights, options or warrants pursuant to which holders of Common Shares are entitled, during a period expiring not more than 45 days after the record date for such issue, to subscribe for or purchase Common Shares or securities
exchangeable for or convertible into Common Shares at a price per share (or in the case of securities exchangeable for or convertible into Common Shares at an exchange or conversion price per share) at the date of issue of such securities to the
holder of at least the Current Market Price of the Common Shares on such record date); 

  

	 	(C)	 evidences of indebtedness of the Company; or 

 

	 	(D)	 any property or assets of the Company; 

  
 -8- 

 and if such issue or distribution does not constitute a Common Share Reorganization or a
Rights Offering (any of such non-excluded events being called a “Special Distribution”), the Exercise Price shall be adjusted effective immediately after the record date for the Special
Distribution to the amount determined by multiplying the Exercise Price in effect on the record date for the Special Distribution by a fraction: 
  

	 	(1)	 the numerator of which shall be the difference between: 

 

	 	I.	 the product of the number of Common Shares outstanding on such record date and the Current Market Price of the
Common Shares on such record date, and 

  

	 	II.	 the fair value, as determined in good faith by the directors of the Company, to the holders of Common Shares of
the shares, rights, options, warrants, evidences of indebtedness or property or assets to be issued or distributed in the Special Distribution; and 

  

	 	(2)	 the denominator of which shall be the product obtained by multiplying the number of Common Shares outstanding
on such record date by the Current Market Price of the Common Shares on such record date. 

 Any Common Shares owned by or
held for the account of the Company shall be deemed not to be outstanding for the purpose of such calculation. To the extent that any adjustment in the Exercise Price occurs pursuant to this Section 10(a)(iii) as a result of the fixing by the
Company of a record date for the issue or distribution of rights, options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common Shares referred to in this Section 10(a)(iii), the Exercise Price shall be
readjusted immediately after the expiry of any relevant exercise, exchange or conversion right to the amount which would then be in effect based upon the number of Common Shares issued and remaining issuable after such expiry and shall be further
readjusted in such manner upon the expiry of any further such right. 
  

	 	(iv)	 If at any time during the Adjustment Period there shall occur: 

 

	 	(A)	 a reclassification or redesignation of the Common Shares, any change of the Common Shares into other shares or
securities or any other capital reorganization involving the Common Shares other than a Common Share Reorganization; 

  

	 	(B)	 a consolidation, amalgamation, arrangement or merger of the Company with or into another body corporate which
results in a reclassification or redesignation of the Common Shares or a change of the Common Shares into other shares or securities; 

  

	 	(C)	 the transfer of the undertaking or assets of the Company as an entirety or substantially as an entirety to
another company or entity; 

  
 -9- 

	 	
(any of such events being called a “Capital Reorganization”), after the effective date of the Capital Reorganization the Holder shall be entitled to receive, and shall accept,
for the same aggregate consideration, upon exercise of the Warrants, in lieu of the number of Common Shares to which the Holder was theretofore entitled upon the exercise of the Warrants, the kind and aggregate number of shares and other securities
or property resulting from the Capital Reorganization which the Holder would have been entitled to receive as a result of the Capital Reorganization if, on the effective date thereof, the Holder had been the registered holder of the number of Common
Shares which the Holder was theretofore entitled to purchase or receive upon the exercise of the Warrants. If necessary, as a result of any such Capital Reorganization, appropriate adjustments shall be made in the application of the provisions of
this Warrant Certificate with respect to the rights and interests thereafter of the Holder to the end that the provisions shall thereafter correspondingly be made applicable as nearly as may reasonably be possible in relation to any shares or other
securities or property thereafter deliverable upon the exercise of the Warrants. 

  

	 	(v)	 If at any time during the Adjustment Period any adjustment or readjustment in the Exercise Price shall occur
pursuant to the provisions of Sections 10(a)(i) or 10(a)(iii) of this Warrant Certificate, then the number of Common Shares purchasable upon the subsequent exercise of the Warrants shall be simultaneously adjusted or readjusted, as the case may be,
by multiplying the number of Common Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment or readjustment by a fraction which shall be the reciprocal of the fraction used in the adjustment or readjustment of the
Exercise Price. 

  

	 	(b)	 The following rules and procedures shall be applicable to adjustments made pursuant to Section 10(a) of
this Warrant Certificate: 

  

	 	(i)	 subject to the following sections of this Section 10(b), any adjustment made pursuant to
Section 10(a) of this Warrant Certificate shall be made successively whenever an event referred to therein shall occur; 

  

	 	(ii)	 no adjustment in the Exercise Price shall be required unless such adjustment would result in a change of at
least one percent in the then Exercise Price and no adjustment shall be made in the number of Common Shares purchasable or issuable on the exercise of the Warrants unless it would result in a change of at least one
one-hundredth of a Common Share; provided, however, that any adjustments which except for the provision of this Section 10(b)(ii) would otherwise have been required to be made shall be carried forward and
taken into account in any subsequent adjustment. Notwithstanding any other provision of Section 10(a) of this Warrant Certificate, no adjustment of the Exercise Price shall be made which would result in an increase in the Exercise Price or a
decrease in the number of Common Shares issuable upon the exercise of the Warrants (except in respect of a consolidation of the outstanding Common Shares); 

  
 -10- 

	 	(iii)	 if at any time during the Adjustment Period the Company shall take any action affecting the Common Shares,
other than an action or event described in Section 10(a) of this Warrant Certificate, which in the opinion of the directors of the Company would have an adverse effect upon the rights of the Holder, the Exercise Price and/or the number of
Common Shares purchasable under the Warrants shall, subject to any necessary regulatory approval, be adjusted in such manner and at such time as the directors of the Company may determine to be equitable in the circumstances, provided that no such
action shall be taken unless and until the Holder has been provided with notice of such proposed action and the consequences thereof; 

  

	 	(iv)	 if the Company sets a record date to determine holders of Common Shares for the purpose of entitling such
holders to receive any dividend or distribution or any subscription or purchase rights and shall thereafter and before the distribution to such holders of any such dividend, distribution or subscription or purchase rights legally abandon its plan to
pay or deliver such dividend, distribution or subscription or purchase rights, then no adjustment in the Exercise Price or the number of Common Shares purchasable under the Warrants shall be required by reason of the setting of such record date;

  

	 	(v)	 no adjustment in the Exercise Price or in the number or kind of securities purchasable on the exercise of the
Warrants shall be made in respect of any event described in Section 10 of this Warrant Certificate if (subject to TSX and NYSE approval) the Holder is entitled to participate in such event on the same terms mutatis mutandis as if the
Holder had exercised the Warrants prior to or on the record date or effective date, as the case may be, of such event. Any such participation by the Holder is subject to regulatory approval; and 

 

	 	(vi)	 in any case in which this Warrant Certificate shall require that an adjustment shall become effective
immediately after a record date for an event referred to in Section 10(a) hereof, the Company may defer, until the occurrence of such event: 

  

	 	(A)	 issuing to the Holder, to the extent that the Warrants are exercised after such record date and before the
occurrence of such event, the additional Common Shares issuable upon such exercise by reason of the adjustment required by such event; and 

  

	 	(B)	 delivering to the Holder any distribution declared with respect to such additional Common Shares after such
record date and before such event; 

 provided, however, that the Company shall deliver to the Holder an appropriate
instrument evidencing the right of the Holder upon the occurrence of the event requiring the adjustment, to an adjustment in the Exercise Price or the number of Common Shares purchasable upon the exercise of the Warrants and to such distribution
declared with respect to any such additional Common Shares issuable on the exercise of the Warrants. 
  

	 	(c)	 At least 10 days prior to the earlier of the record date or effective date of any event which requires or might
require an adjustment in any of the rights of the Holder under this Warrant Certificate, including the Exercise Price or the number of Common Shares which may be purchased under this Warrant Certificate, the Company shall deliver to the Holder a
certificate of the Company specifying the particulars of such event and, if determinable, the required adjustment and the calculation of such adjustment. In case any adjustment for which a notice in this Section 10(c) has been given is not then
determinable, the Company shall promptly after such adjustment is determinable deliver to the Holder a certificate providing the calculation of such adjustment. The Company hereby covenants and agrees that the Company will not take any action which
might deprive the Holder of the opportunity of exercising the rights of subscription contained in this Warrant Certificate, during such 10 day period. 

  
 - 11 - 

	 	(d)	 In connection with any: (i) reclassification or redesignation of the Common Shares, any change of the
Common Shares into other shares or securities or any other capital reorganization involving the Common Shares other than as set forth in this Section 10; (ii) consolidation, amalgamation, arrangement or merger of the Company with or into
another body corporate which results in a reclassification or redesignation of the Common Shares or a change of the Common Shares into other shares or securities (including, without limitation, pursuant to a “take-over bid”, “tender
offer” or other acquisition of all or substantially all of the outstanding Common Shares); or (iii) sale, transfer or lease to another corporation of all or substantially all the property or assets of the Company, the Holder shall have the
right thereafter, upon payment of the Exercise Price in effect immediately prior to such action, to purchase upon exercise of each Warrant the kind and amount of shares and other securities and property which it would have owned or have been
entitled to receive after the happening of such reclassification, redesignation, consolidation, amalgamation, arrangement, merger, sale, transfer or lease had such Warrant been exercised immediately prior to such action, and the Holder shall be
bound to accept such shares and other securities and property in lieu of the Common Shares to which it was previously entitled; provided, however, that no adjustment in respect of dividends, interest or other income on or from such shares or other
securities and property shall be made during the term of a Warrant or upon the exercise of a Warrant. If necessary, as a result of any actions contemplated by this paragraph, appropriate adjustments shall be made in the application of the provisions
of this Warrant Certificate with respect to the rights and interests thereafter of the Holder to the end that the provisions shall thereafter correspondingly be made applicable as nearly as may reasonably be possible in relation to any shares or
other securities or property thereafter deliverable upon the exercise of the Warrants. The provisions of this paragraph shall similarly apply to successive consolidations, mergers, amalgamation, sales, transfers or leases. 

 

	11.	 U.S. Registration 

This Warrant and the Common Shares issuable upon exercise of this Warrant have not been and will not be registered under the U.S. Securities
Act or under state securities laws of any state in the United States. Accordingly, this Warrant may not be transferred or exercised in the United States or by or on behalf of a U.S. Person or a person in the United States unless an exemption is
available from the registration requirements of the U.S. Securities Act and applicable state securities laws and, if required by the Company, the holder of this Warrant has furnished an opinion of counsel of recognized standing in form and substance
reasonably satisfactory to the Company to such effect, as applicable. 
  

	12.	 Authorized Shares 

As a condition precedent to the taking of any action which would require an adjustment pursuant to Section 10 of this Warrant Certificate,
the Company shall take any action which may be necessary in order that the Company has issued and reserved in its authorized capital, and may validly and legally issue as fully paid and non-assessable, all of
the Common Shares (or other shares and securities, if applicable) which the Holder of the Warrants is entitled to receive on the exercise hereof. 

  
 -12- 

	13.	 Mutilated or Missing Warrant Certificate 

Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant Certificate and, in the case
of any such loss, theft or destruction, upon delivery of a bond or indemnity satisfactory to the Company, or, in the case of any such mutilation, upon surrender or cancellation of this Warrant Certificate, the Company will issue to the Holder a new
warrant certificate of like tenor, in lieu of this Warrant Certificate, representing the right to subscribe for and purchase the number of Common Shares which may be subscribed for and purchased hereunder. 

 

	14.	 Merger and Successors 

 

	 	(a)	 Nothing herein contained shall prevent any consolidation, amalgamation or merger of the Company with or into
any other Person or Persons, or a conveyance or transfer of all or substantially all of the properties and estates of the Company as an entirety to any Person lawfully entitled to acquire and operate same, provided, however, that the Person formed
by such consolidation, amalgamation, arrangement or merger or which acquires by conveyance or transfer all or substantially all of the properties and estates of the Company as an entirety shall, simultaneously with such amalgamation, arrangement,
merger, conveyance or transfer, assume the due and punctual performance and observance of all the covenants and conditions hereof to be performed or observed by the Company. 

 

	 	(b)	 In case the Company, pursuant to Section 14(a), shall be consolidated, amalgamated or merged with or into
any other Person or Persons or shall convey or transfer all or substantially all of its properties and estates as an entirety to any other Person, the successor Person formed by such consolidation, amalgamation or arrangement, or into which the
Company shall have been consolidated, amalgamated or merged or which shall have received a conveyance or transfer as aforesaid, shall succeed to and be substituted for the Company hereunder and such changes in phraseology and form (but not in
substance) may be made in this Warrant Certificate as may be appropriate in view of such amalgamation, arrangement, merger or transfer. 

  

	15.	 Amendment 

This Warrant Certificate may only be amended with the prior written consent of the Company and the Holder. 

 

	16.	 Severability 

If any term or other provision of this Warrant Certificate is invalid, illegal or incapable of being enforced under any applicable law or as a
matter of public policy, all other conditions and provisions of this Warrant Certificate shall nevertheless remain in full force and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced,
the Company and the Holder shall negotiate in good faith to modify this Warrant Certificate so as to effect the original intent of the Company and the Holder as closely as possible in a mutually acceptable manner in order that the provisions of this
Warrant Certificate be consummated as originally contemplated to the greatest extent possible. 
  

	17.	 Governing Law 

This Warrant Certificate shall be governed by and construed and interpreted in accordance with the laws of the Province of Ontario and the
federal laws of Canada applicable therein irrespective of the choice of laws principles. 

  
 -13- 

	18.	 Transferability 

Subject only to applicable securities laws, the Warrants represented by this Warrant Certificate are transferable by the Holder to any of its
Affiliates and the term “Holder” shall mean and include any successor, transferee or assignee of the current or any future Holder. The Warrants represented by this Warrant Certificate may be transferred by the Holder completing and
delivering to the Company the transfer form attached hereto as Schedule “B”. For greater certainty, the Warrants represented by this Warrant Certificate are not transferrable except as described in this Section 18 or with the prior
written consent of the Company. 
  

	19.	 Enurement 

This Warrant Certificate and all of its provisions shall enure to the benefit of the Holder and its permitted assigns and successors and shall
be binding upon the Company and its successors and permitted assigns. 
  

	20.	 Notice 

All notices, requests, claims, demands and other communications under this Warrant Certificate shall be in writing and shall be given or made
(and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service or by registered or certified mail (postage prepaid, return receipt requested) to the Holder and the Company at the following
addresses (or at such other address as shall be specified in a notice given in accordance with this Section 20): 
  

	 	(a)	 if to the Holder at: 

c/o Constellation Brands, Inc. 

207 High Point Drive, Bldg. 100 

Victor, New York 14564 

Attention: General Counsel 
 and
with a copy (which shall not constitute notice) to: 
 Osler, Hoskin & Harcourt LLP 

100 King Street West, Suite 6200 

Toronto, Ontario M5X 1B8 

Attention: Emmanuel Pressman and James R. Brown 
  

	 	(b)	 if to the Company at: 

1 Hershey Drive, 
 Smiths Falls,
ON K7A 0A8 
 Attention: Chief Executive Officer 

with a copy (which shall not constitute notice) to: 

Cassels Brock & Blackwell LLP 

40 King Street West, Suite 2100 

Toronto, Ontario M5H 3C2 

Attention: Jonathan Sherman 

  
 -14- 

	21.	 Further Assurances 

The Company shall promptly do, make, execute, deliver, or cause to be done, made, executed or delivered, all such further acts, documents and
things as the Holder may reasonably require from time to time for the purpose of giving effect to this Warrant Certificate and shall use reasonable efforts and take all such steps as may be reasonably within its power to implement to their full
extent the provisions of this Warrant Certificate. 
  

	22.	 Currency 

All dollar amounts referred to in this Warrant Certificate are in Canadian dollars. 

[Signature page follows] 

  
 -15- 

 IN WITNESS WHEREOF the Company has caused this Warrant Certificate to be executed by
a duly authorized signatory effective as of the date first written above. 
  

			
	CANOPY GROWTH CORPORATION
		
	By:	 	 
		 	Name:
		 	Title:

 ACKNOWLEDGEMENT 

IN WITNESS WHEREOF, the Holder hereby acknowledges, confirms and consents to the amendment and restatement of the Original
Warrant Certificate as set out in this Amended and Restated Warrant Certificate. 
  

			
	CBG HOLDINGS LLC
		
	By:	 	 
		 	Name:
		 	Title:

 SCHEDULE “A” 

SUBSCRIPTION FORM 

TO:    CANOPY GROWTH CORPORATION 

Terms which are not otherwise defined herein shall have the meanings ascribed to such terms in the Warrant Certificate held by the undersigned and issued by
Canopy Growth Corporation (the “Company”). 
 The undersigned hereby exercises the right to acquire
                         Common Shares of the Company in accordance with and subject to the provisions of such Warrant
Certificate and herewith makes payment of the Exercise Price in full for the said number of Common Shares. 
 The undersigned hereby confirms that an
aggregate of                          Common Shares have been purchased as contemplated by Section 9(a) of the
Warrant Certificate. 
 (Please check the ONE box applicable): 
  

	 	A	 The undersigned holder (i) at the time of exercise of the Warrant is not in the United States;
(ii) is not a U.S. Person (iii) is not exercising the Warrant on behalf of a U.S. Person or a person in the United States; and (iv) did not execute or deliver this exercise form in the United States. 

 

	 	B.	 The undersigned holder (i) purchased the Warrants for its own account or the account of another
“accredited investor” as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (“Accredited Investor”); (ii) is exercising the Warrants solely for its own account or for the account of such other Accredited
Investor; (iii) each of it and such other person, if any, was an Accredited Investor on the date the Warrants were acquired and is an Accredited Investor on the date of exercise of the Warrants; and (iv) the representations and warranties
made by the holder or any beneficial purchaser, as the case may be, to the Company in connection with the acquisition of the Warrants remain true and correct on the date hereof. 

 

	 	C.	 The undersigned holder has delivered to the Company an opinion of counsel (which will not be sufficient unless
it is from counsel of recognized standing and in form and substance reasonably satisfactory to the Company) to the effect that an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws is
available. 

 The Common Shares are to be issued, registered and delivered as follows: 

 

			
	Name:	  	  

		
	Address in full:	  	  

			
		
		  	  

 Note: If further nominees are intended, please attach (and initial) a schedule giving these particulars. 

DATED this                  day of
                                ,
20        . 

					
	  
	 		  	  

	Signature Guaranteed	 		  	(Signature of Warrantholder)
			
	(if required)	 	        	  	  

		 		  	Print full name
			
		 		  	  

			
		 		  	  

		 		  	Print full address

 Note: 
 The
undersigned holder understands that unless Box A above is checked, the certificate representing the Common Shares issuable upon exercise of the Warrants will bear a legend restricting transfer without registration under the U.S. Securities Act and
applicable state securities laws unless an exemption from registration is available. Certificates representing such Common Shares will not be registered or delivered to an address in the United States unless Box B or Box C above is checked. If Box C
is checked, any opinion tendered must be in form and substance reasonably satisfactory to the Company. Holders planning to deliver an opinion of counsel in connection with the exercise of the Warrant should contact the Company in advance to
determine whether any opinions to be tendered will be acceptable to the Company. 
 If Box B or Box C is checked, any certificate representing the Common
Shares issued upon exercise of this Warrant will bear an applicable United States restrictive legend. 
 Instructions: 

The registered holder may exercise its right to receive Common Shares by completing this form and surrendering this form and the Warrant Certificate
representing the Warrants being exercised to the Company. 
 The signature on this Subscription Form must correspond in every particular with the name shown
on the face of the Warrant Certificate without alteration or any change whatsoever or this Subscription Form must be signed by a duly authorized signing officer of the Holder. If this Subscription Form is signed by a duly authorized signing officer
of the Holder, the Warrant Certificate must be accompanied by evidence of authority to sign. 
 If the Subscription Form indicates that Common Shares are to
be issued to a Person or Persons other than the registered holder of the Warrant Certificate or an affiliate of such registered holder, the endorsement must be signature guaranteed, in either case, by a Canadian chartered bank, or a member of a
recognized Securities Transfer Agents Medallion Program (STAMP). The stamp affixed thereon by the guarantor must bear the actual words “Signature Guarantee”, or “Signature Medallion Guaranteed” or in accordance with industry
standards. 
 The certificates will be mailed by registered mail to the Holder(s) at the address(es) appearing in this Subscription Form. 

If any Warrants represented by this certificate are not being exercised, a new Warrant Certificate will be issued and delivered to the Holder with the Common
Share certificates in accordance with the provisions of the Warrant Certificate. 

 SCHEDULE “B” 

TRANSFER FORM 
  

	TO:	 CANOPY GROWTH CORPORATION 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto (include name and address of the transferee)
                                 (include number) Warrants exercisable for
common shares of Canopy Growth Corporation (the “Company”) registered in the name of the undersigned on the register of the Company maintained therefor, and hereby irrevocably appoints
                                         
                                        the
attorney of the undersigned to transfer the said securities on the books maintained by the Company with full power of substitution. 
 THE UNDERSIGNED
TRANSFEROR HEREBY CERTIFIES AND DECLARES that the Warrants are not being offered, sold or transferred to, or for the account or benefit of, a “U.S. person” (as defined in Rule 902(k) of Regulation S under the United States Securities Act
of 1933, as amended (the “U.S. Securities Act”)) or a person within the United States unless the Warrants are registered under the U.S. Securities Act and any applicable state securities laws or unless an exemption
from such registration is available. 
 DATED this
                 day of
                                ,
20        . 
  

			
		  	  

	Signature Guaranteed	  	(Signature of Warrantholder)
		
		  	  

		  	Print full name
		
		  	  

		
		  	  

		  	Print full address

 Instructions: 
 The
signature on this Transfer Form must correspond in every particular with the name shown on the face of the Warrant Certificate without alteration or any change whatsoever or this Subscription Form must be signed by a duly authorized signing officer
of the Holder. If this Subscription Form is signed by a duly authorized signing officer of the Holder, the Warrant Certificate must be accompanied by evidence of authority to sign. 

The endorsement must be signature guaranteed, in either case, by a Canadian chartered bank, or a member of a recognized Securities Transfer Agents Medallion
Program (STAMP). The stamp affixed thereon by the guarantor must bear the actual words “Signature Guarantee”, or “Signature Medallion Guaranteed” or in accordance with industry standards. 

If any Warrants represented by this certificate are not being transferred, a new Warrant Certificate will be issued and delivered to the Holder. 

 EXHIBIT B 

FORM OF APPROVAL RESOLUTION 
 BE IT
RESOLVED AS AN ORDINARY RESOLUTION THAT: 
  

	(1)	 Canopy Growth Corporation (the “Company”) is hereby authorized to issue such number of common
shares in the capital of the Company (the “Common Shares”) as is necessary to allow the Company to acquire 100% of the issued and outstanding subordinate voting shares, assuming conversion of the issued and outstanding proportionate
voting shares and multiple voting shares of Acreage Holdings, Inc. (“Acreage”) pursuant to a plan of arrangement (the “Arrangement”) in accordance with an arrangement agreement between the Company and Acreage (the
“Arrangement Agreement”), as more particularly described in the management information circular of the Company (the “Company Circular”) (as the Arrangement may be, or may have been, modified or amended in accordance
with its terms), including, but not limited to, the issuance of Common Shares upon the exercise of convertible securities of Acreage and the issuance of Common Shares for any other matters contemplated by or related to the Arrangement;

  

	(2)	 the Company is hereby authorized to issue up to such number of Common Shares to CBG Holdings LLC
(“CBG”) and/or Greenstar Canada Investment Limited Partnership (“GCILP”) as is necessary to satisfy the top-up right held by CBG and GCILP pursuant to the terms of the second
amended and restated investor rights agreement dated as of April 18, 2019 between CBG, GCILP and the Company, as more particularly described in the Company Circular; 

 

	(3)	 the Company is hereby authorized to amend the terms of the 88,472,861 issued and outstanding Tranche A warrants
and the 51,272,592 issued and outstanding Tranche B warrants of the Company held by CBG, collectively exercisable to acquire up to an aggregate of 139,745,453 Common Shares, in accordance with the terms and conditions of the certificates evidencing
such warrants and pursuant to the terms and conditions of the consent agreement dated as of April 18, 2019 between CBG and the Company, as more particularly described in the Company Circular; and 

 

	(4)	 notwithstanding that this resolution has been duly passed by the holders of the common shares of the Company,
the directors of the Company are hereby authorized and empowered, if they decide not to proceed with the aforementioned resolution, to revoke this resolution at any time prior to the closing date of the Arrangement, without further notice to or
approval of the shareholders of the Company; 

  

	(5)	 any one or more directors or officers of the Company is hereby authorized, for and on behalf and in the name of
the Company, to execute and deliver, whether under corporate seal of the Company or otherwise, all such agreements, forms, waivers, notices, certificates, confirmations and other documents and instruments, and to do or cause to be done all such
other acts and things, as in the opinion of such director or officer may be necessary, desirable or useful for the purpose of giving effect to the foregoing resolutions and the matters authorized thereby, such determination to be conclusively
evidenced by the execution and delivery of such document, agreement or instrument or the doing of any such act or thing. 

 EXHIBIT C 

FORM OF VOTING SUPPORT AGREEMENT 

(see attached) 

 SUPPORT AGREEMENT 

April ●, 2019 
 To the Undersigned Securityholder of
Canopy Growth Corporation: 
 Reference is made to the Consent Agreement (the “Consent Agreement”) dated as of the date of this letter
agreement between CBG Holdings LLC (“CBG”) and Canopy Growth Corporation (“Canopy”) and to the Arrangement Agreement dated as of the date of this letter agreement between Canopy and Acreage Holdings Inc. Unless
otherwise defined herein, all capitalized terms referred to herein shall have the meanings attributed thereto in the Consent Agreement. 
 We understand
that you (the “Locked-Up Securityholder”) beneficially own, or exercise control or direction over, directly or indirectly, the number of Canopy Shares (as defined below) set forth in Schedule
A attached hereto. 
 The Locked-Up Securityholder agrees to vote in favour of the Approval Resolution (and in
favour of any actions required in furtherance of the actions contemplated thereby) at any meeting of the securityholders of Canopy, however called, for the purpose of approving the Approval Resolution (the “Meeting”): (i) all of the
Common Shares beneficially owned by the Locked-Up Securityholder, or over which the Locked-Up Securityholder exercises direction and control, directly or indirectly, in
his or her personal capacity (the “Canopy Shares”), which are set forth and described in Schedule A attached hereto and forming part hereof and (ii) any and all other Common Shares hereafter acquired or controlled by the Locked-Up Securityholder in his or her personal capacity either directly or indirectly before the record date in respect of the Meeting including, for the avoidance of doubt, all Common Shares issued upon the
exercise or surrender of the outstanding securities convertible into, or exchangeable for, Common Shares; ((i) and (ii) are collectively referred to as the “Locked- Up Securityholder’s Canopy Securities”), and to otherwise
support the transactions contemplated by the Consent Agreement (the “Transactions”), subject to the terms and conditions of this letter agreement. 
  

	1.	 Covenants of the Locked-Up Securityholder 

For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and subject to the terms and conditions hereof, from the date
hereof until the termination of this letter agreement in accordance with Section 3, the Locked-Up Securityholder hereby covenants and agrees as follows: 

 

	 	(a)	 to vote (or cause to be voted), all of the Locked-Up
Securityholder’s Canopy Securities in favour of the Approval Resolution and any actions required in furtherance of the actions contemplated thereby at the Meeting; 

 

	 	(b)	 to vote (or to cause to be voted), all of the Locked-Up
Securityholder’s Canopy Securities at any meeting of securityholders of Canopy against any resolution or transaction which would in any manner, frustrate, prevent, impede, delay or nullify any of the Transactions, which for greater certainty
shall not preclude the Locked-Up Securityholder from voting in its sole discretion in relation to matters undertaken at the Meeting or any subsequent Canopy annual, special or annual and special meeting that
do not affect the Transactions; 

  

	 	(c)	 not to grant or agree to grant any proxy or other right to vote any of the
Locked-Up Securityholder’s Canopy Securities (other than as permitted under subsections 1(a) and 1(b) hereof), or enter into any voting trust, vote pooling or other agreement with respect to the right to
vote, call meetings of shareholders or give consents or approval of any kind as to any of the Locked-Up Securityholder’s Canopy Securities; 

  
 - 2 - 

	 	(d)	 not to sell, transfer, assign, convey or otherwise dispose of, or enter into any agreement or understanding
relating to the sale, transfer, assignment, conveyance or other disposition of, any of the Locked-Up Securityholder’s Canopy Securities prior to the record date in respect of the Meeting to any person
other than to: (i) CBG or any of its subsidiaries (as such term is defined in the Securities Act (Ontario)); (ii) an affiliate or associate (as such terms are defined in the Securities Act (Ontario)) of such Locked-Up Securityholder provided that such affiliate or associate first agrees with CBG to be bound by the terms hereof; (iii) a self-directed registered retirement savings account in which the Locked-Up Securityholder is the beneficiary; or (iv) any person with the prior written consent of CBG, acting in its sole discretion; and 

 

	 	(e)	 except to the extent permitted hereunder, not to take any action, directly or indirectly, which may reasonably
be expected to adversely affect, delay, hinder, upset or challenge the successful completion of the Transactions. 

  

	2.	 Representations and Warranties 

The Locked-Up Securityholder represents and warrants to CBG that: 

 

	 	(a)	 the Locked-Up Securityholder is authorized and has the authority to
execute and deliver this letter agreement and carry out the transactions contemplated hereby and this letter agreement is a valid and binding agreement enforceable against the Locked-Up Securityholder in
accordance with its terms; 

  

	 	(b)	 the Locked-Up Securityholder is the beneficial owner of, or exercises
control and direction over, the number of Canopy Shares set forth in Schedule A hereto, and the Canopy Shares are the only securities in the capital of Canopy conferring voting rights at the Meeting beneficially owned by the Locked-Up Securityholder or over which he, she or it exercises control or direction; 

  

	 	(c)	 the Locked-Up Securityholder’s Canopy Securities are not subject
to any shareholders’ agreements, voting trust or similar agreements or any right or privilege (whether by law, pre-emptive or contractual) capable of becoming a shareholders’ agreement, voting trust
or other agreement affecting such Locked-Up Securityholder’s Canopy Securities or any interest therein or right thereto, including, without limitation, the voting of any such shares, other than pursuant
to this letter agreement; and 

  

	 	(d)	 other than pursuant to this letter agreement, the Locked-Up
Securityholder has not previously granted or agreed to grant any proxy or any other right to vote any of the Locked-Up Securityholder’s Canopy Securities in respect of any meeting of securityholders of
Canopy that is currently in force, and has not entered into a voting trust, vote pooling or other agreement with respect to his, her or its right to vote, call meetings of securityholders of Canopy or give consents or approvals of any kind as to the
Locked-Up Securityholder’s Canopy Securities. 

  

	3.	 Termination 

The respective rights and obligations hereunder of CBG and the Locked-Up Securityholder shall cease and this letter
agreement shall terminate on the earlier of: (a) the Closing; (b) the date on which this letter agreement is terminated by the mutual written agreement of the parties hereto; and (c) the date the Consent Agreement is terminated in
accordance with its terms. 
  

	4.	 Fiduciary Obligations 

Notwithstanding any other provision of this Agreement, CBG hereby agrees and acknowledges that the Locked-Up
Securityholder is bound hereunder solely in his capacity as a shareholder of the Company and that the provisions hereof shall not be deemed or interpreted to bind the Locked-Up Securityholder in his capacity
as a director or officer of the Corporation. Nothing in this Agreement shall: (a) limit or affect any actions or omissions taken by the Locked-Up Securityholder in his capacity as a director or officer of
the Corporation, and no such actions or omissions shall be deemed a breach of this Agreement or (b) be construed to prohibit, limit or restrict the Shareholder from fulfilling his fiduciary duties as a director or officer of the Corporation.

  
 - 3 - 

	5.	 Notices 

All notices to be given to a party hereunder shall be in writing and delivered personally or by overnight courier, addressed, in the case of the Locked-Up Securityholder, to the address set forth in the signature page of the Locked-Up Securityholder set forth in this letter agreement, and in the case of CBG, at the
following address: 
 c/o Constellation Brands, Inc. 

207 High Point Drive, Bldg. 100, 

Victor, New York 14564 

Attention:            General Counsel 

and to: 
 Osler, Hoskin & Harcourt LLP

 1 First Canadian Place, Suite 6200 

Toronto, Ontario M5X 1B8 

Attention:            Emmanuel Pressman and James R. Brown 

 

	6.	 Further Assurances 

The Locked-Up Securityholder shall from time to time and at all times hereafter at the request of CBG but without
further consideration, do and perform all such further acts, matters and things and execute and deliver all such further documents, deeds, assignments, agreements, notices and writings and give such further assurances as shall be reasonably required
for the purpose of giving effect to this letter agreement. 
  

	7.	 Enurement 

This letter agreement will be binding upon and enure to the benefit of CBG, the Locked-Up Securityholder and their
respective executors, administrators, successors and permitted assigns. 
  

	8.	 Applicable Law 

This letter agreement shall be governed and construed in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein
and each of the parties hereto irrevocably attorns to the jurisdiction of the courts of the Province of Ontario. 
  

	9.	 Severability 

If any provision of this letter agreement is determined to be void or unenforceable, in whole or in part, it shall be severable from all other provisions
hereof and shall be deemed not to affect or impair the validity of any other provision hereof and each such provision is deemed to be separate and distinct. 
  

	10.	 Enforcement 

The parties agree that irreparable damage would occur in the event that any of the provisions of this letter agreement were not performed in accordance with
their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this letter agreement and to enforce specifically the terms and provisions hereof in
any court of the Province of Ontario in addition to any other remedy to which such party is entitled at law or in equity. 
  

	11.	 Entire Agreement 

This letter agreement supersedes all prior agreements between the parties hereto with respect to the subject matter hereof and contains the entire agreement
among the parties with respect to the subject matter hereof. This letter agreement may not be modified or waived, except expressly by an instrument in writing signed by all the parties hereto. No waiver of any provision hereof by any party shall be
deemed a waiver by any other party nor shall any such waiver be deemed a continuing waiver of any matter by such party. 

  
 - 4 - 

	12.	 Counterparts 

This letter agreement may be signed in counterparts which together shall be deemed to constitute one valid and binding agreement and delivery of such
counterparts may be effected by means of facsimile or e-mail or electronic transmission. 
 [The
next page is the signature page.] 

  
 - 5 - 

 This letter agreement shall be effective and enforceable in accordance with its terms effective as of the
date that the Consent Agreement is executed by the parties thereto. 
  

			
	Yours truly,
	
	CBG HOLDINGS LLC
		
	Per:	 	 
		 	Name:
		 	Title:

 [Voting Support Agreement] 

 ACCEPTANCE 

For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Locked-Up
Securityholder hereby irrevocably accepts the foregoing as of the          day of April, 2019. 
  

					
	  
	 	    	  	  

	WITNESS	 		  	SECURITYHOLDER
			
	  
	 		  	  

	Witness Name (please print)	 		  	Name of Locked-Up Securityholder (please print)

  

					
	ADDRESS OF LOCKED-UP SECURITYHOLDER:	  	
		
	  
	  	
		
	  
	  	
		
	  
	  	
		
	  
	  	
		
	  
	  	
	Facsimile Number:	  		  	
			
	E-mail:	  	  
	  	
		  	  
	  	
		
	With a copy of notices to:	  	
		
	                        Canopy Growth Corporation	  	
	                        1 Hershey Drive,	  	
	                        Smiths Falls, Ontario K7A 0A8	  	
	                        Attention:	  	 Phil Shaer, Chief Legal Officer
	  	
	                        Email:	  	 phil.shaer@canopygrowth.com
	  	

 [Voting Support Agreement] 

 SCHEDULE A 
  

			
	Common Sharescgc-ex1011_2932.htm

Exhibit 10.11

 

November 20, 2019

 

Phil Shaer

BY HAND

 

RE:Executive Employment Agreement

 

Dear Phil:

We are pleased to make an offer of full-time employment to you pursuant to the terms and conditions contained within this employment agreement (the “Agreement”).  Your initial position will be Chief Legal Officer reporting to the President of Tweed Inc. (the “Company”).  

	
1.
	
Duties and Responsibilities 

Your primary duties are set out in the job description attached to this agreement as Schedule “A”. You agree to perform the duties of your position diligently and to the best of your ability. We may need to make reasonable changes to these duties as necessary, to achieve our organizational objectives and you agree to accept those changes provided that reasonable notice of those changes is provided to you in advance.

	
2.
	
Effective Date

You will begin working for Tweed on March 15, 2016 or such other date that may be mutually agreed between you and the Company.

	
3.
	
Compensation and Benefits

 

You will be paid two hundred and ninety thousand dollars ($290,000.00) per year subject to statutory and benefits deductions.

 

In addition to your base salary, you are entitled to be considered for a discretionary annual performance bonus of no more than $95,000.

 

Until such time as you are providing services to Tweed on a full-time basis you shall not be paid any salary. You expressly agree that as a duly qualified practitioner of law, the Minimum Wage protections established by the Employment Standards Act, 2000 do not apply to you pursuant to section 2 of O Reg. 285/01.

 

You will be entitled to apply for the health and insurance benefits, if any, offered to all eligible employees after your three (3) month probationary period described below has been satisfied.  The terms and carrier of the Company’s health and insurance benefits are subject to change from time to time, at the Company’s sole discretion.

 

 

You will be eligible to participate in Tweed’s stock option plan, as approved by the Board and as amended from time to time (the “Stock Option Plan”).  The vesting and exercise of stock options (“options”) is governed by the Stock Option Plan and related documentation except as modified by the terms of this agreement.  Please note that options will not vest during any period of notice or pay in lieu of notice in connection with the resignation of your employment or termination of employment without cause.  The termination date for the purpose of your entitlement in respect of any options that you are granted by the Board will be the date that either you or Employer provide the other with notice of resignation or termination of employment.

	
4.
	
Vacation Entitlement

You are entitled to four (4) weeks of vacation per full calendar year. Vacation time is to be scheduled with the approval of your supervisor or manager subject to business requirements.

Any vacation that you take in any given year shall count first towards your two-week statutory allowance and then towards any additional vacation time you are entitled to under our policy. You may carry-over a maximum of five (5) days vacation with your supervisor or manager’s written approval.  

Vacation pay will be provided to you on the basis of base salary alone except as otherwise required by statute.  If you have taken vacation time before it is earned, we may deduct the applicable amount from any payments owing to you when your employment ends.

	
5.
	
Policies

It will be a condition of your employment with the Company that you adhere to all Company rules and policies. The Company reserves the right to revise, revoke, or introduce new rules and policies, as the Company may deem necessary from time to time, and you will also be required to abide by any changes in the rules and policies, once they come into effect

	
6.
	
End of Employment

Although it is difficult to contemplate ending our relationship when it is just beginning, it is mutually beneficial to determine our respective obligations ahead of time. Accordingly, your employment may cease under any of the following circumstances:

	
i)
	
Resignation

You may resign from your employment by giving us not less two (2) weeks’ written notice. If we do not require you to report to work during the resignation period, we will continue your salary to the end of the two (2) week period. 

 

 

	
ii)
	
Termination Without Cause 

Your employment may be terminated by the Company at any time without cause upon providing you with the following:

	
 
	
i.
	
A lump sump payment equal to one (1) times your then current base salary;

	
 
	
ii.
	
Continuation of all benefits for a period of one (1) year from the date of termination, or payment in lieu of same, excluding disability, accidental death and dismemberment and life insurance benefits which will end at the end of the minimum notice period required by the Employment Standards Act, 2000 (the “ESA”);

	
 
	
iii.
	
Any RSU’s vesting after the date of termination shall continue to vest to the extent permitted by the plan over the one (1) year period following termination; and

	
 
	
iv.
	
Any unvested stock options help by you shall continue to vest over the one (1) year following termination

The receipt of any payments or other benefits pursuant to this Section 6 ii) will be subject to (1) you signing a full and final release in favour of the Company and its related parties (the “Release”) and (2) you executing any documents necessary to resign as a director and/or officer of the Company and its affiliates. No payments or other benefits will be paid or provided until the Release is executed.

You will not be required to mitigate the amount of any payment contemplate by this Agreement, nor will any earnings that you may receive from any other source reduce such payment.

The foregoing terms do not apply if your employment ends due to frustration of contract resulting from your disability. In that case, the Company will provide you with the minimum pay in lieu of notice plus payment of the minimum severance (if any) prescribed by the ESA. For these purposes, “disability” means physical or mental incapacity or disability that prevents you from performing the essential duties of your position, with no reasonable prospect of timely recovery, subject always to the Company’s accommodation obligations under applicable Human Rights Legislation. 

In the even that the above terms (or any other term of this Agreement) does not meet or exceed the minimum requirements of the ESA, to the extent of such conflict the minimum provisions of the ESA shall apply and the Company shall instead provide you with such combination of notice, pay in lieu of such notice at the Company’s option, severance pay and other benefits and entitlements as may be required to meet the minimum requirements under the ESA and no more.

 

	
iii)
	
Termination For Cause 

We may terminate your employment for just cause at any time without notice, pay in lieu of notice, severance pay, or other liability. For the purposes of this agreement, just cause includes, but is not limited to:

	
 
	
•
	
a material breach of this agreement or our employment policies;

	
 
	
•
	
unacceptable performance standards;

	
 
	
•
	
theft, dishonesty or falsifying records, including providing false information as part of your application for employment;

	
 
	
•
	
intentional destruction, improper use or abuse of company property;

	
 
	
•
	
violence in the workplace;

	
 
	
•
	
obscene conduct at our premises property or during company-related functions at other locations;

	
 
	
•
	
harassment of your co-workers, supervisors, managers, customers, suppliers or other individuals associated with Tweed;

	
 
	
•
	
insubordination or willful refusal to take directions;

	
 
	
•
	
intoxication or impairment in the workplace;

	
 
	
•
	
repeated, unwarranted lateness, absenteeism or failure to report for work; or

	
 
	
•
	
personal conduct that prejudices Tweed’s reputation, services or morale. 

Any payments made pursuant to the above provisions are in full satisfaction of any amounts owing to you including statutory entitlements and common law damages in any way related to your employment.

We reserve the right to make fundamental changes to your employment, including changes to your duties and compensation, upon giving you notice in accordance with clause 6(ii) above.

 

	
iv)
	
Change of Control

 

In this Agreement the term “Change of Control” shall mean:

 

	
 
	
(a)
	
Any person or related group of persons acquires possession directly or indirectly, of the power to direct or cause the direction of the management or policies of the Company or Canopy Growth Corporations (“CGC”), whether through the ability to exercise voting power, by contract, or otherwise. Without limiting the foregoing, each of the following shall be deemed to be a “Change of Control”: (A) a person or related group of persons acquires the ability to nominate a majority of the directors on the board of directors of the Company or CGC through contract or otherwise: or (B) a person or related group of persons acquires securities of the Company or CGC to which are attached more than 50% of the votes that may be cast to elect directors of the corporation are beneficially owned by that person or related group of persons: or

	
 
	
(b)
	
The sale or disposition of all or substantially all of the assets of the Company or CGC to a non-affiliated party; or

	
 
	
(c)
	
The merger, amalgamation, arrangement or consolidations (or similar transaction) of the Company or CGC with or into any other non-affiliated corporation in which the 

 

	
 
		
shareholders of the Company or CGC, as applicable, prior to such transaction do not, in the aggregate, hold securities of the Company or CGC, as applicable, to which are attached more than 50% of the votes that may be cast to elect directors of the corporation.

 

If at any time during the term of the Agreement: the Company or CGC undergoes a Change of Control and either:

 

	
(a)
	
Your employment is terminated by the Company for any reason other than for just cause within one (1) year following such Change of Control; or

	
(b)
	
You resign your employment with the Company within sixty (60) days following either of the following events:

	
 
	
(i)
	
You are demoted or your responsibilities are materially reduced without your consent, in either case within one (1) year following the date of such Change of Control; or

	
 
	
(ii)
	
Your overall target rate of compensation is reduced within the one (1) year             months following the date of such Change of Control;

 

You shall be entitled to receive the payments and benefits set out in Section 6 ii) as though your employment had been terminated by the Company without cause in accordance with such Section 6 ii) and any RSUs and unvested stock options held by you as of the date of termination shall by deemed to be fully vested as of the date of termination and shall be exercisable thereafter in accordance with the terms of the CGC omnibus incentive plan. For greater certainty the execution of a Release and other documents required by Section 6 ii) shall be a pre-condition to such payments.

 

For greater certainty, a determination by the Company that you will not be paid some or all of a discretionary bonus shall not be considered to be a reduction in your overall target rate of compensation for the purposes of the foregoing. 

 

For greater certainty, the terms of this section 6 iv) shall apply to each and every event that occurs during the term of this Agreement that meets the definition of “Change of Control”. 

 

	
7.
	
Protection of Business Interests

Like most organizations, Tweed must protect itself from unfair competition. Therefore, we have established the following restrictions to protect our valid business interests. You understand these provisions and agree that they are reasonable in light of all of the circumstances, including the availability to you of employment in areas and fields that are not restricted by this agreement.

 

	
(a)
	
Confidentiality

In the course of your employment, you will receive confidential information about Tweed and its clients.  For the purposes of this agreement, confidential information includes but is not limited to:

	
 
	
•
	
processes, research and development information;

	
 
	
•
	
trade secrets;

	
 
	
•
	
information about Tweed’s operations, including products and services offered;

	
 
	
•
	
financial information, such as pricing and rate information;

	
 
	
•
	
documents, records or other information concerning Tweed’s sales or marketing strategies;

	
 
	
•
	
client lists, records and information including lists of present and prospective clients and related information;

	
 
	
•
	
information relating to employees, vendors and contractors of Tweed including employment status, vendor/contractor status, personnel records, performance information, compensation information and job history;

	
 
	
•
	
privileged information, including advice received from professional advisors such as legal counsel and financial advisors; and

	
 
	
•
	
information contained in Tweed’s manuals, training materials, plans, drawings, designs, specifications and other documents and records belonging to Tweed, even if such information has not been labeled or identified as confidential.

Information will not be considered confidential for the purposes of this agreement if:

	
 
	
i)
	
it was rightfully in your possession prior to your employment with Tweed;

	
 
	
ii)
	
it was publicly available through legitimate means; or

	
 
	
iii)
	
it was received by you in a non-confidential manner from a third party that was not under obligation to Tweed to maintain such information in confidence.

You understand that disclosure of confidential information would be highly detrimental to Tweed’s best interests and agree:

	
 
	
i)
	
to take precautions to protect and maintain Tweed’s confidential information;

	
 
	
ii)
	
to only release confidential information to those authorized to receive it, and then only on a need-to-know basis;

	
 
	
iii)
	
not to disclose, publish or disseminate to any unauthorized person, at any time either during your employment or after it ends, confidential information;

	
 
	
iv)
	
not to remove any confidential information from Tweed’s premises without our express permission

	
 
	
v)
	
not to make improper use, either directly or indirectly, of confidential information; and

	
 
	
vi)
	
to safeguard against unintentionally disclosing confidential information (e.g., by not discussing confidential information in public or on a cell phone and by not working with confidential information on a laptop in public, or transmitting such information by unsecured means).

 

 

When your employment ends, you must immediately return all materials or property belonging to Tweed. You agree not to retain, reproduce or use any confidential or proprietary information or property belonging to Tweed.  A detailed Intellectual Property and Confidentiality Agreement is attached (Schedule “B”) for your review and signature.

 

	
(b)
	
Non-Solicitation

In recognition of the access you will have to our processes, employees and clients, you agree that during your employment and for a period of one year after it ends, you will not, either directly or indirectly, communicate with Tweed’s employees or clients for the purpose of inducing them to end their relationship with Tweed.

 

	
(c)
	
Non-Competition

In light of the nature of your position and the close relationship you will have with our clients, it is important for us to limit interference with our business. Therefore, during your employment and for twelve (12) months thereafter you will not on your own behalf nor shall you work at, work for, be employed by, provide services to, engage with, or assist in anyway, whether or not for remuneration, recognition, or reward any person, corporation, or organization, whether or not such organization is operated for profit, that sells or intends to sell marijuana or provides marijuana-related services or products in any jurisdiction in which CGC or its subsidiaries has operations. Without limiting the generality of the foregoing, as of the date hereof such jurisdictions include Canada, USA, Brazil, Columbia, Czech Republic, Germany, United Kingdom, Australia, South Africa, Lesotho, Poland and Italy.

 

	
(d)
	
Conflict of Interest

To enable you to meet the demands of your position, we require your full attention. Accordingly, while you are employed with us, you must devote yourself exclusively to the business of Tweed. You agree that you will not engage in any other business activity or employment during your employment, without Tweed’s prior written approval. Tweed agrees not to withhold such approval unreasonably.

You confirm that your employment with us does not violate any agreement or understanding to which you are currently bound including any existing non-competition, non-solicitation or confidentiality agreements. You further agree to indemnify and save harmless Tweed against all losses, costs, damages, expenses, penalties, fines and other amounts for which it may be found liable at law with respect to your breach of any such agreement.

 

	
(e)
	
Conditional Offer

 This offer of employment is conditional upon completion, to the Company’s satisfaction, of the following background checks:

 

●          Criminal Background Check

 

 

You agree to sign and return any forms or consents and take any steps necessary for the Company to conduct the above-noted background checks as required by the Company.  You also agree that the Company may use the services of a third-party background checking firm to conduct some or all of these background checks, and that the Company may provide your personal information, including any forms and consents, to the background checking firm for this purpose.

 

You also agree that this offer of employment is conditional upon the Company being satisfied, in its discretion, with the results of the background checks.  If the Company is not satisfied, we regret that you will not become an employee of the Company.  You agree that in the event that you do not become an employee of the Company, you will have no claims against the Company arising out of the Company’s decision or the checks referenced herein.

 

	
8.
	
General

This agreement constitutes our entire employment agreement and supersedes any previous written or verbal agreements between us. If any term of this agreement is found to be invalid or unenforceable, in whole or in part, the validity or enforceability of any other provision will not be affected.

This agreement will continue to govern our employment relationship regardless of any changes to your employment including, but not limited to, changes to your position, location of employment, hours of work, compensation and benefits.

 

Any modifications to this agreement must be in writing and signed by both of us. No waiver of a breach of any term of this agreement is binding unless it is in writing and signed by the party waiving it. Unless otherwise specified, the waiver will be limited to the specific breach waived.

 

In the event that any provision or part of this Agreement is deemed void or invalid by a court of competent jurisdiction, the remaining provisions or parts shall be and remain in full force and effect.

 

This agreement is governed by the laws of the province of Ontario. References in this agreement to the Employment Standards Act, 2000, SO 2000, c 41 include any amendments or successor legislation.

 

Your employment is subject to the applicable federal employment laws as amended from time to time.

 

[Balance of Page Blank. Execution Page Follows.]

 

 

We encourage you to review this offer of employment with legal counsel but at your own expense. In order to provide you with appropriate time, please return an executed copy of this employment package by March 18, 2016.  If we have not received the signed documents (or we have agreed in writing to extend your offer of employment to another date in the future), this offer will become null and void.

 

	
/s/ Mark Zekulin
	
 
	
 
	
November 20, 2019

	
Mark Zekulin
	
 
	
Dated
	
 

	
CEO
	
 
	
 

 

 

 

I have had sufficient time to review this agreement and have been advised to review it with a lawyer. If I did not do so, it is because I understood the terms of the Employer’s offer and did not feel that I needed legal advice. I understand and accept the terms of this agreement and am signing it voluntarily.

 

	
/s/
	
 
	
November 22, 2019

	
 
	
 
	
 

	
Phil Shaer
	
 
	
Dated

 

 

 

SCHEDULE “A”

 

JOB DESCRIPTION

 

 

Position:Chief Legal Officer 

 

Responsibilities

 

	
 
	
•
	
Establish and direct the strategic long-term goals, policies, and procedures to guide CGC’s legal and human resource functions.

	
 
	
•
	
Provide legal services to the organization while ensuring compliance to applicable legislation and undertaking risk management.

	
 
	
•
	
Work closely with executives and various legal staff to enhance and/or develop, implement and enforce policies and procedures that will improve overall operations and effectiveness.

	
 
	
•
	
Provide legal advice and counsel for the various aspects of the organization's operations.

	
 
	
•
	
Provide representation as required at law hearings and other judicial proceedings.

	
 
	
•
	
Keep abreast of changes in applicable legislation pertaining to industry and employment, providing report as necessary.

	
 
	
•
	
Ensure all policies and documentation are fully compliant under applicable legislation.

	
 
	
•
	
Conduct legal research and prepare reports and presentations as requested.

	
 
	
•
	
Field all legal and compliance inquiries from key stakeholders.

	
 
	
•
	
Address and identify internal areas of concern, endeavoring to provide resolution so as to not progress to a legal matter.

	
 
	
•
	
Analyze departmental operations and identify areas requiring improvement.

	
 
	
•
	
Participate in organizational negotiation and mediation as required.

	
 
	
•
	
Provide counsel with regards to negotiations and contracts.

	
 
	
•
	
Oversee Risk Management activities. 

	
 
	
•
	
Other duties shall be assigned as required.

 

 

 

SCHEDULE “B”

INTELLECTUAL PROPERTY AND 

CONFIDENTIAL INFORMATION AGREEMENT

 

This Intellectual Property and Confidential Information Agreement (the “Agreement”) is entered into between Tweed Inc. (the “Company”) and Employee (the “Employee”).  In the event this Agreement has been entered into with an independent contractor or sub-contractor, the independent contractor or sub-contractor as the case may be shall be referred to, for the purposes of this Agreement only and for simplicity, as an Employee. Any references to an independent contractor or a sub-contractor as an employee in this Agreement are not admissions that the Company and the independent contractor or sub-contractor are engaged in an employment relationship.   

Whereas the Company is offering the Employee employment or continued employment and has an interest in protecting its confidential information and other proprietary information and related rights; 

And whereas the Employee recognizes the importance of protecting the Company’s confidential information and other proprietary information and related rights is a fundamental term of the Employee’s employment; 

NOW THEREFORE, in consideration of the Company hiring, promoting or continuing to employ the Employee and/or for other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged by the parties), the Employee and the Company hereby agree as follows:

	
1.
	
Definitions

“Confidential Information” means all of the materials and information (whether or not reduced to writing and whether or not patentable or protected by copyright) provided by the Company to the Employee, or which is available to the Employee during the course of the Employee’s employment, including, without limitation the following:

information regarding the Company’s business operations, Developments (as defined below), methods and practices, recruiting and training policies, including marketing strategies, product plans (including unannounced products), product pricing, margins, hourly rates, per diems and information regarding the financial affairs of the Company;

customer lists, quotations or proposals given to customers, requirements of specific customers, and the names of the suppliers to the Company and the nature of the Company’s relationships with these clients and suppliers;

 

information regarding the business operations, methods and practices, including marketing strategies, product plans (including unannounced products), product pricing, margins, hourly rates and financial affairs of the Company’s stakeholders;

technical and business information of or regarding the clients, customers or stakeholders of the Company, obtained in order to enable or assist the Company in providing such clients, customers or stakeholders with products and services, including information regarding the business operations, methods and practices and product plans of such clients, customers or stakeholders;

any other trade secret or confidential or proprietary information received by the Company from third parties and in the possession or control of the Company; and 

any other materials or information related to the Company’s business which are not generally known to others, regardless of whether such information is in paper or electronic format or any other format;

provided that, Confidential Information shall not include information which: a) is generally known or in the public domain at the time of disclosure; or b) though originally Confidential Information becomes generally available to the public through no fault of the Employee, as of the date of its becoming part of the public knowledge; or c) is required to be disclosed by any law, regulation, governmental body, or authority or by court Order provided that before disclosure is made, notice of the requirement is provided to the Company, and to the extent possible in the circumstances, the Company is afforded an opportunity to dispute the requirement.

The absence of any notice indicating confidentiality on any material will not imply that same is not Confidential Information.

“Developments” include, without limitation any methods, processes, procedures, systems, inventions (whether patentable or not), devices, discoveries, concepts, know-how, data, databases, technology, products, software (in executable and source code formats), templates, documentation, specifications, compilations, designs, reports, trade-marks, and any enhancements, modifications, or additions to the foregoing or to any products owned, marketed or used by the Company which relate, directly or indirectly, to the Company’s present or reasonably foreseeable business and which are developed, created, generated or reduced to practice by the Employee, alone or jointly with others, during the Employee’s employment, whether during or after working hours and whether or not resulting from the use of the premises or property of the Company.

	
2.
	
Non-Disclosure of Confidential Information

At all times during and subsequent to the termination of the Employee’s employment, the Employee shall keep in strictest confidence and trust the Confidential Information, the Employee shall take all necessary precautions against unauthorized disclosure of the Confidential Information, and the Employee shall not directly or indirectly disclose, allow access to, transmit or transfer the Confidential Information to a third party, nor shall the Employee copy or reproduce the Confidential Information except as may be reasonably required for the Employee to perform the Employee’s duties for the Company.

 

	
3.
	
Restricted Use of Confidential Information

At all times during and subsequent to the termination or cessation of the Employee’s employment, the Employee shall not use the Confidential Information in any manner except as reasonably required for the Employee to perform the Employee’s duties for the Company.

Upon the request of the Company and in any event upon the termination or cessation of the Employee’s employment, the Employee shall immediately return to the Company all materials, including all copies in whatever form, containing the Confidential Information which are in the Employee’s possession or under the Employee’s control.

	
4.
	
Ownership of Confidential Information and Developments

The Employee acknowledges and agrees that the Employee shall not acquire any right, title or interest in or to the Confidential Information.

The Employee agrees to make full disclosure to the Company of each Development promptly after its creation.

With the sole exception of any intellectual property owned by (and not merely licensed to) the Employee prior to the making of this Agreement, which is also enumerated by the Employee in the attached Schedule “C” prior to the execution of this Agreement, the Employee hereby assigns and transfers to the Company, and agrees that the Company shall be the exclusive owner of, all of the Employee’s right, title and interest to each Development and any enhancement, modification, or addition to any of the intellectual property enumerated in Schedule “C” or any of the intellectual property that is marketed or used by the Company which relate, directly or indirectly, to the Company’s present or reasonably foreseeable business and which are developed, created, generated or reduced to practice by the Employee, alone or jointly with others, during the Employee’s employment, whether during or after working hours and whether or not resulting from the use of the premises or property of the Company, throughout the world, including all trade secrets, patent rights, copyrights and all other intellectual property rights therein.

The Employee further agrees to cooperate fully at all times during and subsequent to the Employee’s Employment with respect to signing further documents and doing such acts and other things reasonably requested by the Company to confirm such transfer of ownership of rights, including intellectual property rights, effective at or after the time the Development is created and to obtain patents or copyrights or the like covering the Developments. The Employee agrees that the Company, its assignees and their licensees are not required to designate the Employee as the author of any Developments. The Employee agrees that the obligations in this subparagraph (c) shall continue beyond the termination of the Employee’s employment with respect to Developments created during the Employee’s employment.

 

The Employee acknowledges that the Company shall alone have the right to apply for, prosecute, defend and obtain Letters Patent of invention, copyright registration, industrial design registration in any and all counties of the world with respect to any such invention, discovery, development or improvement, copyright material or industrial design created.

The expense of applying for and obtaining the Letters Patent, copyright registration and industrial design registration referred to in this Agreement shall be borne entirely by the Company.

It is agreed that the Company shall not be entitled to those inventions, discoveries, developments and improvements made by the Employee prior to the time the Employee was engaged in employment by the Company; it being understood and agreed that the inventions, discoveries, developments and improvements enumerated in Schedule “C” constitute the inventions, discoveries, developments and improvements made by the Employee, and the Employee hereby acknowledges that there are no inventions, discoveries, developments and improvements made prior to the employment of the Employee by the Company and which are the property of the Employee other than those that are enumerated in Schedule “C”.

The Employee hereby grants a power of attorney to the Company to have the Company execute on the Employee’s behalf all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Company and its successors, assigns and nominees sole and exclusive rights, title and interest in and to such Developments, and any copyrights, patents, trade-marks, industrial designs (design patents), topographies (mask work rights) or other intellectual property rights relating thereto.

The Employee hereby waives in whole all moral rights which the Employee may have in the Developments, including the right to the integrity of the Developments, the right to be associated with the Developments, the right to restrain or claim damages for any distortion, mutilation or other modification of the Developments, and the right to restrain use or reproduction of the Developments in any context and in connection with any product, service, cause or institution. The Employee will confirm any such waiver from time to time as requested by the Company.

 

	
5.
	
No Conflicting Obligations

The Employee acknowledges and represents to the Company that the Employee’s performance during the period of the Employee’s employment shall not breach any agreement or other obligation to keep confidential the proprietary information of any prior employer or client of the Employee or any other third party.  The Employee further acknowledges and represents that the Employee is not bound by any agreement or obligation with any third party that conflicts with any of the Employee’s obligations under this Agreement.

 

The Employee represents and agrees that the Employee will not bring to the Company and shall not use in the performance of the Employee’s work with the Company, any trade secrets, confidential information and other proprietary information of any prior employer or client of the Employee or any other third party.  The Employee represents and agrees that in the Employee’s work creating Developments the Employee will not knowingly infringe the intellectual property rights, including copyright, of any third party.

	
6.
	
Enforcement

The Employee acknowledges and agrees that damages may not be an adequate remedy to compensate the Company for any breach of the Employee’s obligations contained in this Agreement, and accordingly the Employee agrees that in addition to any and all other remedies available to it, the Company shall be entitled to seek relief by way of a temporary or permanent injunction to enforce the obligations contained in this Agreement.  Such relief shall be in addition to and not in lieu of any other remedies available the Company at law or in equity.

	
7.
	
Returning the Company Documents

The Employee agrees that upon the termination of the Employee’s employment the Employee will deliver to the Company (and will not keep in the Employee’s possession or deliver to anyone else) any and all Confidential Information and proprietary information including, without limitation, devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items belonging to the Company, together with any third party information received by the Employee. In the event of the termination of the Employee’s employment, the Employee agrees to sign and deliver to the Company the “Termination Certificate” attached hereto as Schedule “E”.  Notwithstanding the foregoing, the Employee shall be entitled to keep personal copies of (i) the Employee’s compensation records, (ii) this Agreement, and (iii) the Employee’s letter of offer.

	
8.
	
General

This Agreement shall be governed by and construed in accordance with the laws in force in the Province of Ontario and any laws of Canada applicable thereto.

If any provision of this Agreement is wholly or partially unenforceable for any reason, such unenforceable provision or part thereof shall be deemed to be omitted from this Agreement without in any way invalidating or impairing the other provisions of this Agreement.

The obligations herein may not be changed or modified, released or terminated, in whole or in part, except in writing signed by the President of the Company and the Employee.

This Agreement supersedes all previous agreements, if any, between the Company and the Employee with respect to the subject matter of this Agreement.  The Employee agrees, however, that this Agreement does not purport to set forth all of the terms and conditions of 

 

the Employee’s employment and the Employee has other obligations to the Company that are not set forth in this Agreement.

The rights and obligations under this Agreement shall survive the termination of the Employee’s employment and shall enure to the benefit of and shall be binding upon (i) the Employee’s heirs and personal representatives; (ii) the successors and assigns of the Employee; and (iii) the successors and assigns of the Company.

THE EMPLOYEE HAS READ THIS AGREEMENT, UNDERSTANDS IT, HAS HAD THE OPPORTUNITY TO OBTAIN INDEPENDENT LEGAL ADVICE IN RESPECT OF IT, AND AGREES TO ITS TERMS.  

The Employee acknowledges having received a fully executed copy of this Agreement.

 

IN WITNESS WHEREOF, this Agreement has been executed by the parties hereto as of the      ___15________th day of   __March_ , 2016.

 

			
	
SIGNED, SEALED AND DELIVERED in the presence of:
	
)
	
/s/ Phil Shaer

	
 
	
)
	
 

	
 
	
)
	
 

	
 
	
)
	
 

	
 
	
 
	
 

	
Witness
	
)
	
Phil Shaer

	
 
	
)
	
 

 

			
	
Tweed Inc. 

	
By:
	
/s/ Mark Zekulin

	
 
	
Name:
	
Mark Zekulin

	
Title:
	
President

 

 

 

SCHEDULE “C”

ENUMERATION OF INTELLECTUAL PROPERTY OWNED BY THE EMPLOYEE 

PRIOR TO THE MAKING OF THIS AGREEMENT

 

 

Patents

 

Please list all those patents both received and applied for using the table below.

 

				
	
Description
	
Jurisdiction
	
Patent No.
	
Date Received or Applied For

	
 

 
	
 
	
 
	
 

	
 

 
	
 
	
 
	
 

	
 

 
	
 
	
 
	
 

	
 

 
	
 
	
 
	
 

 

If additional space is required, please tick this box � and attach additional pages as required using the format of the table shown above.

 

Licenses

 

Please describe all intellectual property, were patented, trademarked, or otherwise protected or not, licensed to third parties by you using the table below.

 

		
	
Description of License
	
Licensed To:

	
 

 
	
 

	
 

 
	
 

	
 

 
	
 

	
 

 
	
 

 

If additional space is required, please tick this box � and attach additional pages as required using the format of the table shown above.

 

 

 

SCHEDULE “D”

ENUMERATION OF INTELLECTUAL PROPERTY OWNED BY THE EMPLOYEE 

PRIOR TO THE MAKING OF THIS AGREEMENT

 

 

Copyrights, trademarks, registered trademarks, and other forms of intellectual property.

 

Please use the table below to list all other registered intellectual property owned by you prior to the making of this Agreement.

 

 

				
	
Description
	
Jurisdiction
	
Registration Number
	
Date Received 

	
 

 
	
 
	
 
	
 

	
 

 
	
 
	
 
	
 

	
 

 
	
 
	
 
	
 

	
 

 
	
 
	
 
	
 

	
 

 
	
 
	
 
	
 

 

If additional space is required, please tick this box � and attach additional pages as required using the format of the table shown above.

 

Acknowledgement

 

You hereby acknowledge that, the items listed in the tables above (and any attached sheets, if necessary) constitute the full and complete list of intellectual property owned by you prior to making this Agreement with Tweed Inc.

 

	
Date:
	
 
	
 

	
 
	
 
	
 

	
Signed:
	
 
	
 

	
 
	
 
	
Phil Shaer

 

 

APPENDIX “E”

TO INTELLECTUAL PROPERTY AND CONFIDENTIAL INFORMATION AGREEMENT

Termination Certificate

 

To:Tweed Inc. ( the “Company”)

	
Re:
	
Intellectual Property and Confidential Information Agreement (the “Agreement”) between the Company and the undersigned employee.

This is to certify that I do not have in my possession, nor have I failed to return, nor have I transferred to any third party, any confidential or proprietary information belonging to the Company, its subsidiaries, affiliates, successors, assigns, clients, customers or stakeholders, including without limitation, devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items.  I further certify that I have complied with all the terms of the Agreement signed by me, including the reporting of any Developments, inventions and original works of authorship (as defined therein), conceived or made by me (solely or jointly with others) covered by that Agreement.

I further agree that, in compliance with the Agreement, I will preserve as confidential all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, other original works of authorship, customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its clients, customers or stakeholders.

 

	
Date:
	
 
	
 

	
 
	
 
	
 

	
Signed:
	
 
	
 

	
 
	
 
	
Phil Shaer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]